Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions

A single medicine oxalic acid or oxalate composition or "magic bullet" and method of treatment or prevention of warm-blooded animals including humans and pets for infectious or pathogenic microbial, bacterial, or viral disease, chemopreventiong of bacterial or viral infections, and the like, is provided which includes at least one therapeutically effective form of oxalic acid or oxalate selected from oxalic acid in a free acid, ester, lactone or salt form and oxalate including sodium oxalate, oxalic acid dihydrate, anhydrous oxalic acid, oxamide, and oxalate salts, natural or processed foods including molds, plants or vegetables containing oxalic acid or oxalate, beverages, liquids or juices containing oxalic acid or oxalate, additives containing oxalic acid or oxalate, and combinations thereof. The composition may also contain a pharmaceutically acceptable carrier or diluent for the therapeutically effective form of oxalic acid or oxalate. Methods are provided including the steps of periodically administering, by topical, oral, or parenteral application, a therapeutically effective dosage of a composition including at least one therapeutically effective form of oxalic acid or oxalate and improving chemotherapy reducing the intake of oxalic acid or oxalate blockers such as citric acid, ascorbic acid, (vitamin C), pyridoxine hydrochloride (vitamin B6), calcium, alcohol, resins, clays, foods containing calcium, beverages containing alcohol, citric acid, or ascorbic acid, red meat or white meat of fowl containing pyridoxine hydrochloride, or other foods nutritional supplements or beverages containing oxalic acid or oxalate blockers.

REFERENCE TO A MICROFICHE APPENDIX 
Not Applicable. 
BACKGROUND OF THE INVENTION 
The present invention is directed to oxalic acid or oxalate compositions 
and methods of producing such compositions and for utilizing oxalic acid 
or oxalate compositions including solutions, mixtures, products, creams, 
rinses, and the like, in the treatment, control, prevention, remedy or the 
like of infectious or pathogenic bacterial, viral and other diseases or 
conditions in humans and in other animals. 
Conventional medicine treats infectious or pathogenic bacterial diseases of 
humans and other warm-blooded animals with antibiotics, sulfonamides, 
antiseptic or antibacterial ointments or creams, and the like. 
Further, skin areas are sanitized or sterilized following injury or prior 
to surgery, for example, with antiseptic or antimicrobial agents such as 
alcohol, iodine, hydrogen peroxide, and other antibacterial compounds or 
chemicals to kill all the bacteria and prevent infection. 
Viral infections are more difficult to treat since antibiotics and other 
drugs used to treat bacterial infections are administered only to boost 
the immune system and prevent secondary bacterial infections, but do not 
cure or treat the viral infection. Viral multiplication may be interrupted 
by a variety of chemicals at various stages. One group of chemicals blocks 
nucleic acid synthesis while a second group interferes with protein 
synthesis. These known chemicals do not completely eliminate or cure the 
virus so that viral infection can recur such as in herpes simplex. 
Further, in the treatment of viral infections, the immune system is 
boosted to help the body's natural immune system fight the virus. For 
example, the patient is given large doses of vitamins and the like. 
Recently, it has been advertised that zinc and echinacea help reduce the 
length of a cold (infectious viral disease) but do not actually cure the 
disease. 
The Human Immunodeficiency Virus (HIV) causes Acquired Immunodeficiency 
Syndrome (AIDS). The virus attacks certain white blood cells, called 
T-cells, and weakens the body's immune system. AIDS occurs when an 
HIV-infected person develops a life threatening condition or their number 
of disease fighting T-cells becomes dangerously low. Recently, it was 
reported that among persons ages 25-44 years HIV infection is now the 
leading cause of death in men and third leading cause in women in the U.S. 
In 1995, approximately 40,000 Americans contracted HIV. Worldwide, one 
million people died from AIDS in 1996 and reported cases increased by 19 
percent. 
It has been about 15 years since the HIV/AIDS virus was first identified. 
Tragically, the AIDS epidemic has claimed over 4.5 million lives 
worldwide. Today, significant strides are being made in understanding the 
virus and ways to battle the disease. There are at least 42 approved 
medicines and over 120 drugs currently being developed by pharmaceutical 
company researchers to fight HIV/AIDS. 
As in the treatment of infectious bacterial disease, the treatment of 
viruses including HIV/AIDS involves the use of one or more 
chemotherapeutic agents to prevent, slow or stop the reproduction of the 
bacteria or virus. 
A new class of medicines called protease inhibitors when combined with one 
or more of the established HIV/AIDS medicines, have shown to work together 
to attack the HIV virus at different stages of its progression. This 
combination or "cocktail" therapy has been shown to reduce the level of 
HIV in the bloodstream by up to 99 percent in some patients, thereby 
potentially halting or slowing the advancement of the disease. 
More than 1.3 million cases of cancer will be diagnosed this year. Over a 
trillion dollars has been spent on trying to find a cure for cancer. In 
1971, the U.S. committed itself to waging a "war" on cancer with the 
National Cancer Act of 1971. Prior to the advent of the present invention, 
a so-called "magic bullet" or a single medicine or treatment that will 
cure cancer has not been found. Conventional cancer treatments include 
invasive surgery to remove tumors and cancers and treatment with 
radioactive or chemical poisonous oncological chemotherapies which cause 
weakness, hair loss, weight loss, reduced immunity, and the like. 
Much has been published recently about beta carotene, antioxidants, 
vitamins, and foods such as garlic for the treatment of cancer and 
infection. Also, studies have been done on the relationship between stress 
and reduced immune system and susceptibility to disease and cancer because 
of stress. 
Oxalic acid or ethanedioic acid (C.sub.2 H.sub.2 O.sub.4), is a 
dicarboxylic acid and is present in many plants and vegetables, notably in 
those of the Oxalis and Rumex families, where it often occurs in the cell 
sap of the plants as the potassium or calcium salt (oxalate, Tables I-IV). 
Oxalic acid is also a product of the metabolism of many molds. Several 
species of Penicillum and Aspergillus convert sugar into calcium oxalate 
with a 90 percent yield under optimum conditions. Oxalic acid is also made 
by passing carbon monoxide into concentrated NaOH or heating sodium 
formate in the presence of NaOH. 
Oxalic acid dohydrate, monoclinic tablets, prisms, and granules are 
considered poisonous. Anhydrous oxalic acid is crystallized from glacial 
acetic acid and is orthorhombic with the crystals being pyramidal or 
elongated octahedral. 
Oxalic acid is listed as being caustic and corrosive to the skin and mucous 
membranes. Ingestion may cause severe gastroenteritis, with vomiting, 
diarrhea, or melena. Renal damage can occur as a result of formation of 
excessive calcium oxalate crystals. Convulsions, coma, or death from 
cardiovascular collapse can also occur. 
Conventional uses of oxalic acid include as an analytical reagent, in 
calico printing and dying, for bleaching straw and leather, removing paint 
or varnish, rust or ink stains, cleaning wood, and manufacturing oxalates, 
blue ink, celluloid, intermediates and dyes, in metal polishes, in 
purifying methanol, for decolorizing crude glycerol, for stabilizing 
hydrocyanic acid, as a general reducing agent, in ceramics and pigments, 
in metallurgy as a cleanser, in the paper industry, in photography, in 
process engraving, in rubber manufacturing, in making glucose from starch, 
as a condensing agent in organic chemistry, and as a veterinary hemostatic 
agent when mixed in 5 percent solution with 5 percent malonic acid. 
As described in "Oxalic Acid in Biology and Medicine" by A. Hodgkinson, 
1977, oxalic acid was formerly used intravenously as a hemostatic agent 
and topically as an antiseptic in man and other animals but this was 
discontinued because of its toxicity and the danger of precipitating 
insoluble calcium oxalate in the tissues. Oxalic acid is a relatively 
strong acid having a first dissociation constant being exceeded by that of 
only a few halogen-substituted carboxylic acids. Oxalic acid forms neutral 
and acid salts with monovalent metals and ammonia. Oxalic acid forms a 
number of oxalates or salts including calcium oxalate, potassium oxalate, 
sodium oxalate, strontium oxalate, magnesium oxalate, and the like. Oxalic 
acid also inhibits the activity of a number of enzymes possibly due to the 
competition between oxalate and a structurally similar substrate of the 
enzyme. Precipitation as the calcium salt is the classical method of 
separating oxalic acid from other substances. Although calcium oxalate is 
generally considered to be an insoluble salt this is a relative term and 
its solubility in water is actually 6-7 mg/l at room temperature. 
Biological fluids contain many substances that affect the solubility or 
rate of crystallization of calcium oxalate or co-precipitate with the 
salt. For example, magnesium, polyphosphates and other polyelectrolytes 
affect the solubility or rate of crystallization of calcium oxalate while 
phosphate and sulphate ions, uric acid and citric acid co-precipitate with 
the salt. 
Further, as reported in a literature including "Oxalic Acid in Biology and 
Medicine", poisoning from oxalic acid in animals and man has been 
recognized since the beginning of the 19th Century. The death rate from 
oxalate poisoning has declined supposedly because of a decreased use of 
oxalic acid in domestic cleaning fluids. Examples of chronic poisoning by 
absorption of oxalic acid through the skin and by inhalation have been 
reported. The range of lethal doses in acute poisoning is wide, varying 
between 2 and 30 g and depending upon a variety of factors such as the 
form in which the acid or its salt is taken and the amount of food, 
particularly calcium, which is present in the stomach and intestine. Death 
has occurred as early as 3 minutes and as late as 14 days after ingestion. 
Symptoms of acute oxalic acid toxicity in man can be divided into those 
caused by a local corrosive action and those resulting from absorption and 
excretion of the soluble oxalate. If a high concentration or the solid 
form is taken, the local effects may be predominant and death may result 
from acute hemorrhagic gastroenteritis without development of symptoms 
depending on absorption. If death does not result from local corrosive 
action then symptoms develop from the systemic effects and from renal 
insufficiency. The cardiovascular, neuromuscular and central nervous 
systems are markedly affected. The skin is pale, cold and clammy, the 
pulse is weak and the blood pressure and temperature are low. Numbness and 
tingling may develop in the extremities and cramp-like muscular and 
abdominal pain may be extremely severe. Local or generalized muscular 
twitchings occur and may progress to marked tetany and convulsive 
seizures. The central nervous system may show evidence of excitation or 
depression, varying from an acute maniacal state to stupor and coma. Death 
results from cardiovascular collapse or depression of the central nervous 
system. Renal involvement is frequent and even if the patient survives the 
severe local or systemic effects, death may ultimately occur from renal 
insufficiency, which dominates the picture from the second day. Oliguria 
develops and may progress to anuria. 
Hence, there is a need for oxalic acid or oxalate compositions and methods 
of producing such compositions and for treating, preventing, impeding, 
retarding, delaying, controlling, or the like, infectious or pathogenic 
microbial, bacterial, viral disease, cancers, tumors, neoplasms, and other 
diseases or conditions in warm-blooded animals including humans and pets. 
BRIEF SUMMARY OF THE INVENTION 
In accordance with the present invention, oxalic acid or oxalate 
compositions and methods of producing such compositions and for treating, 
preventing, controlling, impeding, and the like infectious or pathogenic 
bacterial, viral, microbial, and other diseases and conditions in 
warm-blooded animals including humans and pets is provided which includes 
an effective amount of at least one therapeutically effective form of 
oxalic acid or oxalate for controlling, treating, managing, preventing, or 
the like, diseases caused by germs, bacteria, or viruses such as 
Escherichia coli, salmonella, staphylococci, streptococci, colds, 
influenza, pneumonia, various blood and urine bacterial infections, and 
the like, for preventing the reproduction or new growth of cancers, 
tumors, infectious or pathogenic bacteria, viruses, or other disease, or 
for otherwise therapeutically treating warm-blooded animals including 
humans and pets. 
In accordance with the present Invention, an oxalic acid composition or 
remedy has been shown to reduce the length and severity of the common 
cold. An oxalic acid composition or remedy may be used as an antibacterial 
treatment for Moraxella bovis, an agent that causes "pink eye" in cattle. 
An oxalic acid composition is an effective anti-adherence agent in the 
treatment of cryptosporidium protozoa. 
The therapeutically effective form of oxalic acid or oxalate is an oxalic 
acid or oxalate which provides the beneficial effect and is selected, for 
example, from the group of oxalic acid in a free acid, ester, lactone or 
salt form, oxalate including sodium oxalate, a nutritional supplement 
containing at least one form of oxalic acid or oxalate oxalic acid 
dihydrate, anhydrous oxalic acid, oxamide, oxalate salts, processed foods 
containing at least one form of oxalic acid or oxalate, beverages, liquids 
or juices containing at least one form of oxalic acid or oxalate additives 
containing one form of oxalic acid or oxalate, or combinations thereof, 
compositions including oxalic acid or oxalate, a therapeutic quantity of 
oxalic acid or oxalate composition, source of oxalic acid or oxalate, 
nutritional product, supplement, solution, agent, curative, remedy, 
control, impediment, food, feed stuff, rinse, mouthwash, mouth rinse, 
wash, formulation, dosage, pharmaceutical agent, dietary supplement, 
intermediate, product, composition, anti-AIDS or anti-HIV agent, vaccine, 
immune system stimulant, substance, drug, chemopreventive, chemical, 
chemosurgical agent, chemotherapy agent, chemotherapeutic agent, solution, 
solute, slurry, mixture, medicine, medication, salve, ointment, balm, 
cream, analgesic, medicinal agent, treating agent, preventing agent, 
retarding agent, impeding agent, delaying agent, controlling agent, 
anabolic agent, health improving agent, health-supplementary food, 
enriched fraction, oncological or oncologic agent, tumor treating agent, 
disease treating agent, infection treating agent, fungal treatment, 
microbial treatment, bacterial treatment, antimicrobial agent, and the 
agent for treating, controlling, improving, preventing, the symptoms of 
infectious or pathological diseases such as bacterial, viral, microbial, 
and the like, as well as a supplemental composition or treatment to be 
used in conjunction with conventional compositions and treatments, and the 
composition may also contain a pharmaceutically acceptable carrier or 
diluent for the therapeutically effective form of oxalic acid or oxalate. 
Also in accordance with the present invention a method is provided for 
controlling, treating, managing, or the like bacteria and virus infections 
in warm-blooded animals and pets including the steps of administering an 
effective amount of a therapeutically effective form of oxalic acid or 
oxalate. The method may include the further step of reducing the intake of 
oxalic acid or oxalate blockers such as citric acid, ascorbic acid 
(vitamin C), pyridoxine hydrochloride (vitamin B6), calcium, alcohol, 
resins, clays, and combinations thereof. Oxalic acid or oxalate blockers 
also include dairy products containing calcium, fruits, coconut, beverages 
containing alcohol, ascorbic acid or citric acid, red meat or white meat 
of fowl containing pyridoxine hydrochloride, or other foods, nutritional 
supplements or beverages containing alcohol, citric acid, ascorbic acid, 
pyridoxine hydrochloride, resins, and combinations thereof. 
In accordance with the present invention, an oxalic acid or oxalate blocker 
is any mineral, chemical, compound, material, plant, food, beverage, 
additive, supplement, or the like which blocks, inhibits, reduces, or 
binds with or otherwise reduces or eliminates the beneficial effect of 
oxalic acid or oxalate. For example, calcium from dairy products tends to 
bind with oxalic acid in the intestine (calcium oxalate) and prevents the 
oxalic acid from being absorbed into the blood stream. 
In accordance with yet another embodiment of the present invention, a diet 
is provided for treating, controlling, preventing, impeding, or the like 
bacteria or virus infections in warm-blooded animals including pets and 
humans. The diet includes adding to the regular diet a dietary supplement 
of at least one therapeutically effective form of oxalic acid or oxalate. 
Further the diet may include reducing the intake of oxalic acid or oxalate 
blockers. 
In accordance with yet still another embodiment of the present invention, a 
veterinary compositions and methods are provided for controlling, 
treating, managing, or the like bacterial infections, viral infections and 
the like for preventing the re-infection of bacterial or viral infections, 
or for otherwise therapeutically treating warm-blooded animals including 
cats and dogs. The composition may include a pharmaceutically acceptable 
carrier or diluent for the therapeutically effective form of oxalic acid 
or oxalate. The method for controlling, treating, or managing bacterial 
and viral infections in warm-blooded animals including dogs and cats 
includes the steps of periodically administering a therapeutically 
effective dosage of a veterinary composition containing at least one 
therapeutically effective form of oxalic acid or oxalate. 
In accordance with a further embodiment of the present invention, 
compositions and methods for treating, preventing, controlling, impeding, 
or the like auto-immune related bacterial and viral diseases such as HIV, 
SLE, AIDS, and the like include compositions containing a therapeutically 
effective amount of at least one therapeutically effective form of oxalic 
acid or oxalate. The method of treating, preventing or controlling 
auto-immune related diseases, preventing, lessening or controlling the 
destruction of the body's immune system, or purifying the blood includes 
the steps of periodically administering a composition having a 
therapeutically effective amount of at least one therapeutically effective 
form of oxalic acid or oxalate. 
In accordance with still another embodiment of the present invention, a 
therapeutic composition in cream or ointment form for topical 
administration of oxalic acid or oxalate is provided which includes at 
least one therapeutically effective form of oxalic acid, a solvent, and a 
cream or ointment base. 
In accordance with still another embodiment of the present invention, a 
veterinary composition includes conventional pet food ingredients except 
for the elimination or reduction of oxalic acid or oxalate blockers and 
the addition of a therapeutically effective quantity of at least one 
therapeutically effective form of oxalic acid or oxalate. 
In accordance with yet another embodiment of the present invention, an oral 
rinse, pill, gel cap, tablet, powder, capsule, or the like for 
controlling, treating or managing bacterial or viral disease or for 
otherwise therapeutically treating the mouth area is provided which 
includes a dilute concentration or solution of an least one 
therapeutically effective form of oxalic acid or oxalate. 
In accordance with yet another embodiment of the present invention, a 
pharmaceutical composition to be administered orally to humans is provided 
which includes a mixture of a nontoxic ingestible carrier and a 
therapeutically effective form of oxalic acid or oxalate. 
In yet another embodiment of the present invention, a therapeutic 
composition in lozenge or cough drop form for oral administration of 
oxalic acid or oxalate is provided which includes at least one 
therapeutically form of oxalic acid or oxalate and an ingestible carrier 
of dextrose, microcrystalline cellulose, povidone, magnesium stearate, and 
the like. 
In accordance with yet another embodiment of the present invention, a 
composition for treating parvo virus in animals including canines is 
provided which includes a therapeutically effective amount of at least one 
therapeutically effective form of oxalic acid or oxalate. 
In accordance with still yet another embodiment of the present invention, 
an improved human or pet treat includes the addition of a microgram amount 
of at least one therapeutically effective form of oxalic acid or oxalate. 
In accordance with another embodiment of the present invention, a 
composition for daily mouth rinse and gargle is provided for treating, 
controlling or managing bacterial and viral diseases and includes a 
nontoxic carrier or diluent, such as distilled water, for the 
therapeutically effect form of oxalic acid or oxalate. 
In yet another embodiment of the present invention, a composition and 
method are provided for treating, controlling and managing bacterial and 
viral infections of the chest with the composition including at least one 
therapeutically effective form of oxalic acid or oxalate. 
In accordance with another embodiment of the present invention, a 
pharmaceutical composition to be administered orally to humans is provided 
which includes a mixture of nontoxic ingestible carrier such as sorbitol, 
fructose, sucrose, lactose or distilled water and a therapeutically 
effective form of oxalic acid or oxalate. 
In yet still another embodiment of the present invention, a composition is 
provided for treating, controlling or managing bacterial and viral 
diseases of the nasopharynx and sinuses. Also, a method of treating, 
lessening or controlling the diseases of the nasopharynx and sinuses is 
provided by administering by nasal spray a composition containing nontoxic 
ingestible carrier and a therapeutically effective form of oxalic acid or 
oxalate. 
One object of the present invention is the provision of a novel therapeutic 
composition including a pharmaceutically acceptable carrier or diluent 
containing a therapeutically effective amount of at least one 
therapeutically effective form of oxalic acid or oxalate. Another object 
of the present invention is the provision of a method of therapeutically 
treating warm-blooded animals including humans and pets with such a 
therapeutic composition. 
A further object of the present invention is the provision of an oxalic 
acid or oxalate pharmaceutical composition, a therapeutic quantity of 
oxalic acid or oxalate composition, source of oxalic acid or oxalate, 
nutritional product, supplement, solution, agent, curative, control, 
remedy, impediment, food, feed stuff, rinse, mouthwash, mouth rinse, wash, 
formulation, dosage, pharmaceutical agent, dietary supplement, 
intermediate, product, composition, anti-AIDS or anti-HIV agent, vaccine, 
immune system stimulant, substance, drug, chemo-preventive, chemical, 
chemosurgical agent, chemotherapy agent, chemotherapeutic agent, solution, 
solute, slurry, mixture, medicine, medication, salve, ointment, balm, 
cream, analgesic, medicinal agent, treating agent, preventing agent, 
retarding agent, impeding agent, delaying agent, controlling agent, 
anabolic agent, health improving agent, health-supplementary food, 
enriched fraction, oncological or oncologic agent, tumor treating agent, 
disease treating agent, infection treating agent, fungal treatment, 
microbial treatment, bacterial treatment, antimicrobial agent, and the 
agent for treating, controlling, improving, preventing, the symptoms of 
infections or pathological diseases such as bacterial, viral, and the 
like, as well as a supplemental composition or treatment to be used in 
conjunction with conventional compositions and treatments, or the like. 
Another object of the present invention is the provision of a method of 
treating animals including humans with at least one form of oxalic acid or 
oxalate. 
Yet another object of the present invention is the provision of a 
veterinary composition containing oxalic acid dihydrate. 
Another object of the present invention is an oxalic acid or oxalate 
composition and method for the treating, preventing, controlling, 
impeding, or the like auto-immune related diseases such as HIV, AIDS, SLE, 
and the like. 
Yet another object of the present invention is the provision of a method of 
delaying, preventing, controlling, or treating infectious or pathogenic 
microbial, bacterial or viral disease, and the like by lessening the 
effects of the disease. 
A further object of the invention is the provision of a mouth wash or 
antibacterial rinse including a therapeutically effective amount of oxalic 
acid or oxalate. 
Still another object of the present invention is the provision of a 
veterinary composition and method of controlling, treating or managing 
bacterial diseases, viral diseases, and the like or for otherwise 
therapeutically treating warm-blooded animals including dogs and cats 
utilizing a composition including at least one therapeutically effective 
form of oxalic acid or oxalate. 
Yet another object of the invention is the process for preparing an 
anti-bacterial and anti-viral agent including the steps of mixing at least 
one therapeutically effective form of oxalic acid or oxalate with a 
pharmaceutically acceptable carrier or diluent. 
Yet another object of the present invention is an improved pet food 
including a therapeutically effective quantity of at least one form of 
oxalic acid or oxalate and/or the elimination or reduction of oxalic acid 
or oxalate blockers. 
Still another object of the present invention is the provision of a 
composition and method for treating parvo virus in animals. 
Yet another object of the present invention is the provision of a 
pharmaceutical composition to be administered orally to humans including a 
mixture of a non-toxic ingestible carrier and a therapeutically effective 
form of oxalic acid or oxalate. 
A further object of the present invention is the provision of a multi 
vitamin or multi vitamin and mineral supplement including at least one 
therapeutically effective form of oxalic acid or oxalate. 
Still another object of the present invention is the provision of a 
processed food item including a therapeutically effective amount of at 
least one therapeutically effective form of oxalic acid or oxalate.

DETAILED DESCRIPTION OF THE INVENTION 
The story begins with two toy poodles, Turk and Taka. These animals lived a 
normal house life. Except for the occasional trip or walk to the nearby 
reservoir, their territory was the house and backyard. As young pups they 
were full of energy and, of course, very spoiled. Habits, mostly bad ones, 
were easily formed, such as eating people food, some of which, according 
to a veterinarian, would not hurt them. Turk became fond of SNICKERS.RTM. 
brand candy bars, especially the small bite-size kind, and also carrots 
and beets, both of which are appearing in some commercial dog foods today. 
During this time, Turk's owner, the present applicant and inventor, was 
doing a great deal of traveling, averaging one trip a week, and he always 
kept a small SNICKERS.RTM. bar near the front door in case he returned 
home without one. Another one of Turk's favorite treats was the small 
soybean crackers in oriental cocktail mix, which Turk's owner ate 
constantly when he was home. 
When Turk was about a year and six or seven months old, Turk began to slow 
down. Turk's eagerness to play left him, and his appetite diminished 
except for the little treats mentioned above. Turk was drinking much more 
water and had frequent accidents in the house, especially at night. Turk's 
color changed from a parfait tinge to a solid white, and just before his 
death, to a dull grayish-white. 
When Turk began to vomit occasionally after eating or drinking, Turk's 
owner became concerned and took Turk to the veterinarian. The examination 
revealed nothing, and the veterinarian diagnosed Turk as having 
indigestion and gave Turk some medicine. Turk's condition worsened, and so 
Turk was returned to the veterinarian. Blood and urine samples were taken, 
and test results revealed that Turk's urine was watery, but otherwise all 
right. The blood however, showed a high white cell count, and the 
veterinarian thought there might be an infection and prescribed pills. One 
single pill brought on violent vomiting. Turk's owner stopped giving Turk 
the pills and started Turk on amoxicillin. 
Turk's condition worsened, so Turk was taken to the animal hospital center 
where they determined Turk's kidneys were failing. Turk was put on an IV 
due to severe dehydration. The doctors stated that they could not treat 
Turk unless Turk's owner could tell them what poison or chemical Turk had 
ingested. For the next several days Turk's owner went on a frantic search 
for answers. Turk's owner contacted a number of agencies for possible 
clues to the poisoning: Tri-County Health Department; two toxicologists 
with the EPA; the U.S. Corps of Engineers, who assured him that they test 
the reservoir daily for contaminants; and UCLA and University of Illinois 
poison centers. Heavy rains would bring standing water into the backyard, 
so Turk's owner tracked down the owners of a stable and a nursery that 
used to operate in the area before the houses were built, to see if they 
had used any type of toxic sprays. Turk's owner contacted nurseries from 
which he had recently bought plants. Turk's owner even contacted the 3M 
Company, since new carpeting with SCOTCHGARD.RTM. had been installed. 
Turk's owner asked all neighbors who had pets to find out if their pets 
had become sick. 
Turk's owner also called veterinary clinics to find out if they had 
diagnosed similar cases recently. He also searched every square foot of 
the house, garage, and storage building looking for chemicals, especially 
antifreeze. Out of desperation, Turk's owner pleaded with the 
veterinarians to list poisons that had the same fingerprint, and he would 
then choose one so veterinarians could begin treatment. The veterinarians 
declined. When blood began to appear in Turk's stool and vomit, and the 
kidneys had shut down, Turk was put to sleep. Turk's owner vowed that with 
God's help he would find out what had destroyed Turk. 
The attending veterinarian at the veterinary hospital was an organ 
specialist and professor at Colorado State University. The veterinarian 
extended his sympathy and after a few other exchanges he informed Turk's 
owner that there is one substance very damaging to renal tissue--oxalates. 
The owner drove directly to his company's quality control department lab 
where he cornered a chemist and questioned him about oxalates. The chemist 
said that an oxalate is a compound found in trees, mainly oaks. The 
owner's curiosity was running high, and as soon as he could break away 
from work, he went straight for a dictionary. Oxalate is defined as a salt 
or ester of oxalic acid, and the acid definition refers back to the oak 
tree. Oxalic acid is further defined as an industrial chemical used in 
textile and dye manufacturing as a bleaching agent. From the dictionary, 
he went to the chemical books, found oxalic acid and got promptly lost in 
a maze of formulae and equations. The owner eliminated oxalates or oxalic 
acid from his mind as a cause of Turk's death. What did stay in his mind 
was Turk's death, and again he renewed his vow to find the answer. He 
could not get Turk out of his thoughts, because every time he looked at 
Taka, Turk's brother, he wondered why Turk had died and not Taka? 
One outside activity of Turk's owner was, and still is, gardening. 
Naturally, he had a subscription for the organic gardening magazine, and 
perused through every article. In the April 1986 edition he came across an 
article by Judith Benn Hurley, "Calcium From Your Garden," and up popped 
the word oxalate. Imagine his surprise, an industrial chemical, a poison, 
in a magazine on organic gardening. 
Once again the search was on. The owner wrote a letter to Ms. Hurley 
describing his research, the reason for it, and asked if she had anymore 
information on oxalates she could share. The reply he received provided 
him with more information than he could have hoped for. Her reply sent him 
to the library, to the section containing books on nutrition. He read many 
volumes and was amazed by the amount of information available on plant 
life and the effects of plant vitamins on maintaining human life. His 
effort was rewarded when he found a volume Let's Get Well by Adelle Davis, 
1965. It contains the perfect finger print of Turk's death. Chapter 19, 
page 239 states the following: 
When both vitamin B6 and magnesium are undersupplied, the kidneys are 
further damaged by sharp crystals of oxalic acid combined with calcium, 
and as much as three-quarters of the kidney may be replaced by scar 
tissue. Children with oxalic acid kidney stones frequently have high blood 
pressure and kidneys so damaged that they become progressively worse, 
causing death from kidney failure early in life. 
The owner's mind went back to information he had gathered concerning the 
use of beagles in testing because their organs are more like those of a 
child than any other animal. How true the statements, "love them to death" 
and also "kill them with kindness." The owner believed that he had 
inadvertently killed Turk by feeding him candy bars, soybean crackers, 
beets, carrots, and who-knows-what-else that might have been very high in 
oxalate, oxalic acid or both. He believed that these snacks saturated 
Turk's system to a point where Turk's kidneys could no longer function. 
When that happened, the acid began to destroy renal tissue. As the tissue 
was being destroyed, Turk's condition worsened until other vital functions 
were affected. Turk's owner also believed that since oxalates and oxalic 
acid suppress calcium, no healthy red blood cells were being produced. The 
blood in Turk's system had to have been totally saturated with oxalic 
acid. When all the renal tissue was destroyed, the kidneys shut down and 
swelling began due to edema. There was no hope for recovery. 
Taka was not affected because he did not crave or eat soybean crackers, 
beets or carrots, nor the SNICKERS.RTM. brand candy bars with peanuts. 
When the owner realized what caused Turk's death, he put Taka on an 
oxalate/oxalic acid-free diet. Some weeks after putting Taka on the diet, 
the color of Taka's coat, which had faded, began returning to normal. 
Knowing that a human could suffer from an excess of oxalates and oxalic 
acid, the owner put himself on a similar diet as well. 
Several significant events occurred beginning with the return of the color 
of Taka's coat while on the oxalate-free diet. The owner began to watch 
for signs in his own hair and noticed that his graying seemed to have at 
least slowed down. Since the owner was due for a physical, he checked into 
a clinic and stated he had some minor pain in his chest on the left side 
where lie had muscles torn in a car accident many years earlier. During 
the exam, the doctor decided to be safe and ordered an EKG. In prepping 
for the EKG, the nurse shaved his chest where the transducer cups would be 
placed, and then with a small orbital sander removed some of the dead skin 
for better contact. Weeks after the exam when the hair began growing out, 
it was black instead of gray or white. 
Many mornings before starting the oxalate-free diet, the owner would get 
out of bed with a dull backache, and occasionally it would really spasm 
when he would lean over the wash basin while brushing his teeth. He 
complained and swore he would get a new mattress, believing it to be the 
cause of the backaches. By the end of the day the ache would be gone and 
out of mind. When the backaches stopped, he realized it was his kidneys 
and knew it was the soybean crackers and nuts in the oriental mix and 
other related items that had raised his oxalate level to the point it 
began bothering his kidneys. 
After retirement, Turk's owner was planning to move and some friends 
stopped by to visit. One evening while having cocktails with the friends, 
they began talking about health and age, etc. One of the ladies mentioned 
she needed bypass surgery, but it could not be scheduled because her red 
blood cell count was low, and the doctors could not get it to rise, even 
though she was on a third medication. Turk's owner's research had paid 
off. He gave his organic gardening magazine to the lady and urged her to 
read the article by Judith Benn Hurley. He explained to her that the 
reason her red cell count was low was because of her diet. She ate very 
little meat, a primary source of pyridoxine (vitamin B6), did not drink 
much soda pop, orange or pineapple juice (all high in citric acid), and 
only consumed alcohol in moderate quantities. Her diet contained items 
high in oxalic acid, like spinach, her favorite salad. The owner mentioned 
that in his research he had discovered there were three chemicals that 
would counteract the oxalic acid--pyridoxine hydrochloride (vitamin B6), 
citric acid, and alcohol. He gave her a handful of 50 mg vitamin B6 pills 
and suggested she take one immediately and then one a day for the first 
week, and then one every other day. Three weeks later she told him that 
the doctor had just scheduled her operation. 
Turk's owner had also noticed that he did not have the recurring attacks of 
heartburn he had prior to changing his diet and taking vitamin B6. He 
thought it a great discovery. 
Then Turk's owner moved to Arkansas. His stepdaughter, who is married and 
living nearby, worked at a local hospital. One day she began running a 
high fever in the range of 104.degree.-106.degree., went home, and went 
straight to bed. The fever fell, and the next couple of days she returned 
to work only to have the fever return after a couple of hours. She went 
home and the cycle repeated. She mentioned this to a doctor in the 
emergency room and a series of tests were ordered looking for a virus, an 
infection, even a tubular conception. Turk's owner became involved, 
because after listening to long, sometimes whispered conversations between 
his wife and stepdaughter, he asked what the trouble was. His wife 
explained what had happened and that the doctor was looking for some type 
of urinary tract or vaginal infection, but there were no positive 
cultures. When he heard that the stepdaughter experienced burning and 
irritation when urinating, he asked his wife why they did not think about 
diet. His stepdaughter was eating primarily salad bar meals loaded with 
oxalic acid. He had his wife immediately take a bottle of vitamin B6 pills 
to his stepdaughter with a suggestion to take two pills immediately, 
another one after twelve hours, and one a day after that for the next 
week. In two days her fever was gone, and she went back to work. After the 
third day all symptoms were gone and she was back to normal as best they 
could ascertain. Other people who complained of back pain without having 
muscle or spine problems found relief after Turk's owner suggested taking 
vitamin B6. 
One day while drying off after a shower, Turk's owner noticed a mole-type 
growth on the inside of his right thigh. He had not noticed it before, and 
shortly after that, a growth began at the end of his right eyebrow near 
the bridge of his nose. As the growth on the thigh became bigger, so did 
his curiosity. He picked at the growth until some of it came off and it 
bled. Now curiosity turned to concern. A month later the growth on the 
thigh reappeared and the growth on the eyebrow grew larger. He would check 
both growths every day and they were always on his mind. He believes it 
was his obsession with Turk that guided his thoughts to oxalic acid. This 
acid is readily available in foods people eat, so why would God put a 
substance in food He provided to sustain life, if that same substance by 
assaulting the kidneys can kill life? It just did not make sense. That 
question constantly ran through his mind begging to be answered. Night 
after night, hours were spent turning and tossing in restless sleep, 
searching and searching for an answer. He had read every article in every 
magazine he could get his hands on about foods thought to help in the 
fight against cancer, antioxidants, free radicals, and anti-rust in the 
blood. One night his mind stopped on one particular item. It was a 
sentence he had read about foods, and the importance they play in health 
and healing. "The acid in strawberries is thought to help prevent prostate 
cancer." Acid--there it was, that is the word that halted his mental 
computer. When he woke up, questions began running through his mind. If 
oxalic acid would destroy healthy renal tissue, could it possibly destroy 
sick tissue first? Is cancer not considered to be sick cells? Are these 
free radicals sick cells? What about antioxidants? Are there really 
different types of cancer, or are they a similar type of sick cell just in 
different parts of the body? Why are there different types of 
chemotherapies? 
There were just too many questions. He had to go back and start with his 
initial question. He asked a dear friend, a devout Christian, whether the 
Bible states that God put everything on earth that man needs? At the same 
time he went on a very high oxalic acid diet and avoided citric acid and 
reduced his intake of pyridoxines and alcohol to a minimum. His dear 
friend came back and said she told her Bible class of his request. They 
searched the Bible and noted three places that mention God providing for 
all of man's needs. What is significant is that articles describing food 
groups for cancer prevention, especially the vegetable groups, name those 
that have significant amounts of oxalic acid as per USDA Bulletin #11 
(Table I). At this time he became convinced it was not the beta carotene, 
the vitamin C, or anything else that was the cancer fighter--it was oxalic 
acid. Once again he started asking himself questions. Would oxalic acid 
destroy sick cells before healthy cells? The only answer he could come up 
with is the affirmative. 
The story continues with the submittal of U.S. provisional application Ser. 
No. 60/006,785, filed Nov. 15, 1995, U.S. patent application Ser. No. 
08/629,538, filed Apr. 9, 1996, and U.S. provisional application Ser. No. 
60/036,983, filed Jan. 29, 1997, entitled OXALIC ACID OR OXALATE 
COMPOSITIONS AND METHODS OF TREATMENT FOR BACTERIAL DISEASES AND VIRAL 
DISEASES IN HUMANS AND ANIMALS, by Francis J. Hart, all three applications 
being hereby incorporated by reference. 
After placing himself on a high oxalic acid or oxalate diet, the growth on 
Turk's owner's thigh began to disappear and shortly thereafter the growth 
on his eyebrow as well. Eventually both growths were completely gone. 
Another sign of the result of the high oxalic acid diet was the 
disappearance of a couple of polyps around the anal orifice. These had 
appeared when he went on the low oxalate/low oxalic acid diet, and now 
when he reversed the diet these growths disappeared. 
Later, his own daughter informed him that her mother was having a lot of 
stomach or digestive problems and was due for exploratory surgery. During 
the operation they discovered cancer in the abdominal cavity and removed 
all possible, estimated at 80 percent. There was cancer in the bladder, 
and they planned an extensive chemotherapy program. However, a specialty 
lab in California which received the tissue sample, determined it was a 
rare type of cancer, with no known treatment. His daughter, who was at her 
mother's side constantly, agreed to try his oxalic acid procedure. With 
his suggestion and the help of a juicer, she prepared a mixture of 
carrots, spinach, parsley, and chives. He suggested she try to get her 
mother to drink six to eight ounces of the mixture at least three times a 
day. At the start, her mother complained of the taste, so he suggested she 
mix some V8.RTM. juice with the mixture to enhance the flavor. This 
worked, and her mother began to drink the mixture. He felt that by having 
it in liquid form, more oxalic acid would enter her system more rapidly 
and begin to attack the sick cells. On the third day after her mother 
began drinking the mixture, his daughter talked with the nurse who said, 
"In the morning when she took the patient's vital signs they were the best 
since the patient had come to the hospital. Her temperature was down, 
blood pressure was down, and pulse rate was near normal." In addition, the 
yellowish skin color began to change. Then, for reasons unknown, her 
mother stopped drinking the mixture. Shortly after that her mother passed 
away. 
Later, Turk's owner learned of a close friend who had prostate cancer, 
initially treated with a radiation implant which failed to keep the growth 
in check, and now would be undergoing chemotherapy. He urged his friend 
with prostate cancer to try his oxalic acid dietary treatment. He sent an 
explanatory letter with copies of articles about the vegetables along with 
a list of items containing oxalates and oxalic acid. Later, he talked with 
his friend who gave him some revealing data. Prior to starting the oxalic 
acid dietary treatment, his friend had been to an oncologist because the 
cancer was spreading into the pelvic area and his PSA count was 350. When 
his friend returned to his primary care physician months later after being 
on the oxalic acid diet, he was feeling better, his PSA was down to 246, 
and the doctor was surprised because he did not think his patient would 
survive long enough to see him again. It seemed the doctor knew the 
chemotherapy would not work and it may have been given just so his friend 
would not despair. Turk's owner sent a copy of the Judith Been Hurley 
article to his friend and believed that low calcium in the bone marrow was 
probably the reason his friend with prostate cancer was tired and felt 
pain in the thigh and pelvic area. 
Turk's owner, the Applicant, further investigated to try to better 
establish the relationship between oxalic acid and pyridoxine 
hydrochloride (vitamin B6) and oxalic acid treatment for the reduction of 
tumors. An Irish Setter, a 70-75 lb., 14 year-old specimen, had a very 
noticeable tumor on the mouth, had been diagnosed with multiple tumors 
which a biopsy confirmed to be melanoma (skin cancer), and was to be 
euthanized. The oral tumor was in an area easily examined. The oral tumor 
had been removed several years ago, when it was confirmed as malignant, 
but it had grown back. The question was posed if a high oxalic acid or 
oxalate diet supposedly works on humans, would it not also work on this 
dog? They felt confident, since The Merck Manual does state that 90 
percent of cancers are due to environment and nutrition. And so, they 
embarked on taking the Setter off canned dog food (high in pyridoxines) 
and feeding a regular dry high protein dog food mixed with three or four 
boiled carrots and topped with chopped parsley. The canine was started on 
a diet of three or four medium sized boiled carrots, mixed with 
approximately 11/2 pounds of dry dog food. Three to five days after 
starting on the diet, the canine showed an improvement in appetite and 
energy. After three weeks of being on this diet, there was a noticeable 
reduction in size and appearance of the tumor on the canine's mouth. 
Almost a month after starting on the above diet, the canine's diet was 
changed to a mixture of about one pound of boiled carrots, one teaspoon of 
garlic, one-quarter cup chopped fresh parsley, and one and one-half pounds 
of dry dog food containing no citric acid. This diet was varied based on 
the canine's condition with the mouth tumor being measured and recorded by 
a veterinarian. The mouth tumor exhibited expansion or swelling and 
reduction cycles. The canine's urine was tested for oxalate count and a 
result showed about 50 mg per liter of oxalic acid. 
After about five months on this diet, the canine produced feces including 
mucous and intestinal membrane. Upon this happening all oxalic acid or 
oxalate addition to the canine's diet was stopped. It is believed that a 
high level of oxalic acid or oxalate intake causes a sloughing off of the 
interior surface of the small intestine including old bacteria, food, 
waste, and intestinal cells and membrane. After about a month, urine was 
drawn from the canine to test for oxalate count the canine's oxalic acid 
urine count was reduced to 24 mg/L. Three days later, the canine was 
restarted on a diet having about 1 gram of oxalic acid added to one pound 
of dry dog food. A canine urine oxalic acid scale was calculated based on 
a scale of 0-40 mg/L for a 70 kg human, and adjusting this for a 25 kg 
canine to have a desired range of about 0-14 mg/L. The canine was started 
on a new diet of approximately one and one-half pounds of dry dog food to 
1 gram of oxalic acid dihydrate dissolved in about three ounces of water 
and mixed together and adding one-half can of Pedigree.RTM. brand canned 
dog food (61/2 oz. can) to add protein to the diet. A little more than two 
weeks later the diet was changed to reduce the oxalic acid dose to 500 mg 
per day and the canine was given four beef strips (approximately 25 grams) 
with 27 percent protein each evening. Thirty days later the dose was 
dropped to 300 mg oxalic acid/day. Two weeks later the dose was dropped to 
50 mg oxalic acid/day. Two weeks later the dose was dropped to 20 mg 
oxalic acid per day which was maintained till the animal was euthanized. 
The canine's mouth tumor had reduced in size in an eleven month period. 
The oxalic acid dihydrate was purchased from Swift Chemical Company, 
Rogers, Arkansas, and dissolved in water to use as a food additive to the 
canine diet. 
Much to their surprise, the dog seemed to crave the carrots and parsley. 
The Setter's activity increased steadily to the point where he actively 
competed with a four-year old Doberman and a nine-month old Rottweiler. 
The diet was working. What was once a large saggy sack of black tissue 
visibly hanging from the Setter's mouth changed to a considerably smaller 
and firmer growth. The reduction in the growth of the oral tumor slowed 
over time; however, it must be remembered that the tumor took nearly six 
years to achieve the mass it once was. They continued to monitor the 
Setter's condition, and felt that the reduction in the size of the tumor 
was a positive sign that the oxalic acid or oxalate was working. An 
autopsy of the Irish Setter revealed the malignant melanoma with 
metastasis, adrenal gland pheochromocytoma, acute cystitis, the urinary 
bladder mucosa appeared diffusely thickened, granular and hemorrhagic in 
appearance with the presence of moderate amounts of a turbid reddish-brown 
urine, a large encapsulated necrotic mass within the omental adipose 
tissue, with no other significant gross lesions noted within other areas 
of the oral cavity, larynx, esophagus, trachea, lungs, heart, spleen, 
kidneys, musculoskeletal system, and gastrointestinal tract. Hence, it 
appears that the oxalic acid or oxalate diet did not damage any of the 
dog's organs or kidneys. It is believed that the lesions (scars) in the 
lungs of the canine, may indicate that oxalic acid or oxalate had 
eliminated growths in the lungs. 
In accordance with another case study, a dog at a pound was given one gram 
of oxalic acid dihydrate in a gel cap one hour prior to meal time for 
seven days with no adverse effects. The dog's appetite increased as well 
as energy and activity. 
In accordance with another case study a human adult female subject with 
possible cervical cancer found multiple growths on her cervix by 
self-examination. The subject started on an increased oxalic acid or 
oxalate and reduced oxalic acid or oxalate blocker diet, and in less than 
one month she reported that the smallest growth was reducing in size. The 
subject remained very strictly on the diet and a week later reported that 
the smallest growth was gone with only a rough spot remaining. A few days 
later the subject reported that the next size growth seemed to be 
reducing. Less than a month later, the subject reported that the large 
growth was considerably reduced. This process continued and less than a 
year after starting on the increased oxalic acid or oxalate diet, the 
subject reported that one small growth remained which was only noticeable 
during her menstrual period. 
In accordance with another case study, an adult male human subject 
suffering from a brain tumor, had been through all the different 
conventional treatments including surgery, chemotherapy, and radiation 
treatment. The tumor was never totally removed and remained malignant. The 
subject was told of the possible beneficial effects of oxalic acid or 
oxalate and began on a treatment regimen of four heaping soup spoons of 
dried parsley daily and a reduction of oxalic acid or oxalate blockers. 
This should equate to approximately four grams of oxalic acid per day. 
Three to four months later, the subject had a CAT scan where the tumor was 
examined and did not show any growth. The subject also had visible signs 
of noticeable improvement in health. Approximately six months after 
starting on the enhanced oxalic acid or oxalate diet, the subject was much 
more active and friendly towards others. Approximately eight months after 
starting on the enhanced oxalic acid diet the subject was very excited 
about the diet, feeling much better. The subject had expected and 
experienced the toxic effects of indigestion, diarrhea, and the sloughing 
off of the interior surface of the intestine. The subject also indicated 
that the tumor was in the inactive stage. Also the subject indicated that 
his memory and thinking capability had returned and he could now 
accomplish functions he could not prior to following the diet. He was in 
the process of rebuilding an engine, replacing a carburetor, changing an 
oil pan, changing the oil and spark plugs, and other activities that prior 
to starting on the enhanced oxalic acid or oxalate diet were impossible. 
Doctors had not given this patient much time to live, and it is believed 
that the enhanced oxalic acid or oxalate diet with reduced blockers had 
treated, controlled, or otherwise beneficially affected his brain tumor 
and overall health. He was still alive and functioning better after nine 
months. 
An adult female in her sixties was terminally ill with leukemia with tumors 
in her lymph nodes and she had stopped chemotherapy treatment. She was 
told about the possible beneficial effect of oxalic acid or oxalate and 
started on a daily intake of about 1 to 11/2 g/day oxalic acid or oxalate 
and almost no oxalic acid or oxalate blockers. It was hard for her to 
swallow so she was on a liquid diet because of the swelling of the lymph 
nodes in and around her mouth and throat. After 5-7 days of administration 
of oxalic acid or oxalate in dilute solution she was able to eat again due 
to the shrinkage of tumors in the lymph nodes. This dramatic effect in 
such a short time indicates that the intake of oxalic acid was treating 
her condition or disease and benefiting the individual. 
In another case study, an adult female was diagnosed with a tumor 
(endometrial) in the uterus. The tumor was removed by laser and she was to 
undergo chemotherapy. She heard of the oxalic acid treatment of the 
present invention, and went on the diet having increased intake of oxalic 
acid or oxalate and reduced intake of oxalic acid or oxalate blockers. 
After several months of being on the diet, her blood tests were negative 
on cancer and she did not have to undergo conventional oncological 
chemotherapy. 
In accordance with another case study, a Doberman pincher was diagnosed 
with bone cancer (sarcoma) of the left hind leg. The dog had previously 
been put on medication for arthritis because it would not use or lower its 
left hind leg. After being diagnosed with cancer confirmed with X-ray, the 
dog was placed on a diet of oxalic acid enhanced dogfood containing about 
2 grams of oxalic acid dihydrate dissolved in water and added to 
conventional dry dogfood. Within 4 days, the dog had lowered its left hind 
leg and used it frequently in activity with a companion dog. A few days 
later, the dog began taking steps on the left hind leg with a slight limp. 
The dog's condition continued to improve and it's diet was changed to 
reduce the oxalic acid to about 1 gram of oxalic acid/per day. After a 
couple of weeks the dog's condition continued to improve so the dosage of 
oxalic acid was reduced to about 500 mg/per day. The dog appears to be 
walking with no pain and an X-ray revealed an increase in bone material in 
the area of the sarcoma and a decrease or reduction in the size of the 
area affected by the sarcoma. After being on the oxalic acid diet for 
about 30 days, the dog appeared to have no pain during physical exam and 
was walking normally. 
In another case study, an adult female was diagnosed with stomach cancer 
and scheduled for surgery. She began the increased oxalic acid or oxalate 
and reduced oxalic acid or oxalate blocker diet and when she went in to 
have the surgery done, they discovered that her tumor had turned to 
liquid. Her diet or treatment regimen included a low intake of red meat or 
white meat of fowl, a low intake of soda pop or other beverages containing 
citric acid, a low intake of foods containing citric acid, an intake of 
about 4 ounces of carrot juice per day with 2 ounces taken in the morning 
and 2 ounces in the evening, and a low intake of alcohol. Apparently, the 
oxalic acid in the carrot juice may have turned the tumor cells into a 
liquid and all that was necessary was for the liquid to be drained. 
In another case study, an adult female having breast cancer started on a 
high oxalic acid or oxalate and low oxalic acid or oxalate blocker diet. 
The growth of the cancer was reduced and in less than 2 months of being on 
the diet her blood work showed a large reduction in the cancer in the 
blood and that the cancer was in regression. Her condition improved so 
much so that the doctors stopped conventional chemotherapy treatment. 
In another case study, an adult female with breast cancer went on a diet 
including an intake of about 4 ounces of carrot juice per day along with 
chicken broth. In about 8 weeks she was sent home from the hospital, she 
was walking, went to the mall and was eating potato chips. Previously, she 
had been hospitalized and on a liquid diet. 
In accordance with another case study, an adult female suffering from 
breast cancer went on an increased oxalic acid diet, stopped using the 
microwave oven to cook foods, stopped chemotherapy treatments, cut 
CAT-scans down to once a month, and in a short time her blood was tested 
and showed that it was clean of cancer cells and the breast cancer 
appeared to have stopped growing. 
Based on this history, it is believed that oxalic acid or oxalate will, at 
a minimum, reduce the size of tumors; especially if pyridoxine 
hydrochloride, citric acid, ascorbic acid, calcium and alcohol are 
eliminated from the diet as much as possible. This dietary procedure needs 
to be continued until the tumor or growth is eliminated. If the individual 
experiences backaches due to kidney irritation, urinary tract irritations, 
and/or severe heartburn, vitamin B6 (pyridoxine hydrochloride) can be 
taken to help eliminate the discomfort. Since calcium, pyridoxine 
hydrochloride, citric acid, ascorbic acid and alcohol block oxalic acid or 
oxalate, the individual should work his/her dietary therapy up to the 
point of experiencing the discomforts stated and then back off slightly 
from oxalic acid or oxalate intake. It is also believed that the converse 
is also true - insufficient oxalic acid or oxalate may allow tumors to 
grow. 
Since certain cancers in animals are believed to be caused by viruses, it 
was postulated by the present inventor, that oxalic acid or oxalate may be 
useful in treating infectious or pathogenic bacterial, viral, or other 
microbial diseases in addition to treating cancers, tumors, neoplasms, and 
the like. 
This invention relates generally to methods and compositions containing 
oxalic acid or oxalate or related compounds for providing therapeutic 
effects such as the control, prevention, or treatment of cancer, tumors, 
neoplasia, infectious or pathogenic bacterial, viral, or other microbial 
diseases, etc. It was initially discovered that a lack of oxalic acid or 
oxalate in the diet of a human, allowed or promoted the growth of tumors, 
growths, or other neoplasia. It was then discovered that the ingestion or 
administration of a therapeutic quantity of oxalic acid, oxalate or foods 
containing high levels of oxalic acid or oxalate can deter, reduce, or 
prevent the growth or spread of cancer, tumors, or other neoplasia. Then, 
it was discovered that an oxalic acid solution controlled, prevented, or 
treated infectious or pathogenic bacterial or viral diseases such as 
colds, flu, sore throat, and the like. 
It has also been discovered that the therapeutic effect of oxalic acid or 
oxalate can be inhibited by an increased ingestion or administration of 
oxalic acid or oxalate blockers including, for example, calcium, alcohol, 
citric acid, ascorbic acid (vitamin C), pyridoxine hydrochloride (vitamin 
B6), etc. Other oxalic acid or oxalate blockers include binding agents 
such as clay, resins, and indigestible fibers. Radiation, strong 
electromagnetic waves or fields, electron bombardment, excessive heat, and 
bases such as sodium bicarbonate serve to decompose, neutralize or 
otherwise reduce the beneficial effect of oxalic acid. There may also be 
pharmaceuticals which interfere with the absorption or beneficial activity 
of oxalic acid or oxalates. Also, the therapeutic effect of oxalic acid or 
oxalate can be enhanced by decreasing or eliminating the ingestion or 
administration of one or more of these blockers and/or increasing the 
ingestion of oxalic acid or oxalate. Oxalic acid or oxalate enhancers 
which increase the beneficial effect of oxalic acid or oxalate include 
long chain fatty acids and the like which bind with or otherwise eliminate 
oxalic acid blockers such as calcium. 
High levels of oxalic acid or oxalate can produce side effects of diarrhea, 
indigestion, damage to the digestive tract, and kidney damage or renal 
failure. Hence, prolonged ingestion or administration of high quantities 
of oxalic acid or oxalate should be avoided so that the beneficial 
therapeutic effect of the reduction, control, or treatment of tumors, 
cancers, neoplasia, neoplasms, infectious or pathogenic bacterial, viral, 
or other disease can be enjoyed without harm to other systems or parts of 
the body. 
As mentioned above, oxalic acid or ethanedioic acid (C.sub.2 H.sub.2 
O.sub.4), is a dicarboxylic acid and is present in many plants and 
vegetables, notably in those of the Oxalis and Rumex families, where it 
often occurs in the cell sap of the plants as the potassium or calcium 
salt (oxalate, Tables I-IV). Oxalic acid is also a product of the 
metabolism of many molds. Several species of Penicillum and Aspergillus 
convert sugar into calcium oxalate with a 90 percent yield under optimum 
conditions. Oxalic acid is also made by passing carbon monoxide into 
concentrated NaOH or heating sodium formate in the presence of NaOH. 
Oxalic acid dihydrate, monoclinic tablets, prisms, and granules are 
considered poisonous. Anhydrous oxalic acid is crystallized from glacial 
acetic acid and is orthorhombic with the crystals being pyramidal or 
elongated octahedral. 
Oxalic acid is listed as being caustic and corrosive to the skin and mucous 
membranes. Ingestion may cause severe gastroenteritis, with vomiting, 
diarrhea, or melena. Renal damage can occur as a result of formation of 
excessive calcium oxalate crystals. Convulsions, coma, or death from 
cardiovascular collapse can also occur. 
Common uses of oxalic acid include as an analytical reagent, in calico 
printing and dying, for bleaching straw and leather, removing paint or 
varnish, rust or ink stains, cleaning wood, and manufacturing oxalates, 
blue ink, celluloid, intermediates and dyes, in metal polishes, in 
purifying methanol, for decolorizing crude glycerol, for stabilizing 
hydrocyanic acid, as a general reducing agent, in ceramics and pigments, 
in metallurgy as a cleanser, in the paper industry, in photography, in 
process engraving, in rubber manufacturing, in making glucose from starch, 
as a condensing agent in organic chemistry, and as a veterinary hemostatic 
agent when mixed in 5 percent solution with 5 percent malonic acid. 
As described in "Oxalic Acid in Biology and Medicine" by A. Hodgkinson, 
1977, oxalic acid was formerly used intravenously as a hemostatic agent 
and topically as an antiseptic in man and other animals but this was 
discontinued because of its toxicity and the danger of precipitating 
insoluble calcium oxalate in the tissues. Oxalic acid is a relatively 
strong acid having a first dissociation constant being exceeded by that of 
only a few halogen-substituted carboxylic acids. Oxalic acid forms neutral 
and acid salts with monovalent metals and ammonia. Oxalic acid forms a 
number of oxalates or salts including calcium oxalate, potassium oxalate, 
sodium oxalate, strontium oxalate, magnesium oxalate, and the like. Oxalic 
acid also inhibits the activity of a number of enzymes possibly due to the 
competition between oxalate and a structurally similar substrate of the 
enzyme. Precipitation as the calcium salt is the classical method of 
separating oxalic acid from other substances. Although calcium oxalate is 
generally considered to be an insoluble salt this is a relative term and 
its solubility in water is actually 6-7 mg/l at room temperature. 
Biological fluids contain many substances that affect the solubility or 
rate of crystallization of calcium oxalate or co-precipitate with the 
salt. For example, magnesium, polyphosphates and other polyclectrolytes 
affect the solubility or rate of crystallization of calcium oxalate while 
phosphate and sulphate ions, uric acid and citric acid co-precipitate with 
the salt. 
Also as described in "Oxalic Acid in Biology and Medicine", oxalic acid and 
its salts are widely distributed among the higher plants. Oxalic acid is 
sometimes present in plants as the free acid, but more usually, however, 
it is present as a soluble or insoluble salt, for example, the acid and 
neutral sodium and potassium salts and the ammonium salt. Calcium oxalate 
is the most common insoluble salt but relatively large amounts of 
magnesium oxalate occur together with calcium oxalate in plants such as 
beet root, spinach, and buckwheat. Under conditions of calcium deficiency, 
strontium, magnesium, or barium oxalate can be substituted for calcium 
oxalate in a wide variety of plant species depending upon the mineral 
environment. 
Further, as mentioned in "Oxalic Acid in Biology and Medicine", there have 
been many studies of the oxalate content of individual foodstuffs (see 
Tables I-IV), but few estimates have been made of the total daily intake 
of oxalate by animals or man (see Table V). This is surprising in view of 
the effect of oxalate on calcium availability and the high incidence of 
calcium oxalate renal stones in many parts of the world. As shown in Table 
V, the reported numbers for daily oxalate intake range from 70-980 mg/per 
day of anhydrous acid for healthy adult males. However, this information 
was based on the study of diets which contain no oxalate-rich foods other 
than tea which is the largest single source of the acid in typical English 
diets. If an average serving (60 g) of spinach or rhubarb had been 
included then the oxalate intake would have risen to between 400 and 600 
mg/day but these levels are not typical for this country. Wide variations 
in oxalate intake may occur in countries such as India where vegetables 
rather than dairy products provide the main source of minerals and where 
many of the plants used as vegetables contain high concentrations of 
oxalate. Some indication of these variations has been provided by a study 
which found intakes ranging from 78-2045 mg/day depending on the season in 
the rural population of Udaipur, India. A relatively high intake was also 
found among upper-income groups in urban areas and was attributed to a 
high intake of tea and green, leafy vegetables, compared with lower-income 
groups. 
As reported in "Oxalic Acid in Biology and Medicine", when taken with food, 
ingested oxalate is poorly absorbed from the gastrointestinal tract. 
Although oxalate absorption appears to be unaffected by metabolic 
inhibitors it is reduced by the presence of calcium which lowers the 
concentration of free oxalate ions. It is well known, for example that 
calcium oxalate is absorbed less readily than sodium oxalate and 
absorption is also reduced by the oral administration of cholestyramine 
(anion exchange resin which has a strong affinity for oxalate ions). 
Conversely, oxalate absorption is increased when the dietary intake of 
calcium is reduced and this is reflected in an increased urinary excretion 
of oxalate. In addition to a low calcium diet, the intake of dysodium 
ethylenediamine tetra-acetic acid (EDTA) appears to increase the 
absorption of oxalate by complexing of calcium with EDTA in the intestinal 
lumen leaving more oxalate free to be absorbed. 
Also as reported in "Oxalic Acid in Biology and Medicine", the most 
important precursors of urinary oxalate in man are ascorbic acid, glycine, 
and dietary oxalate. Excretion of oxalate is also increased by the 
ingestion of a variety of substances including glycine, glutamic acid, 
purines, gelatin, and ascorbic acid. Conversely, excretion has been 
reported to be reduced by the administration of pyridoxine and magnesium 
oxide. Less than half of the normal dietary intake of oxalic acid can be 
accounted for by absorption into the body or excretion in the faces. The 
remainder of the normal dietary intake of oxalic acid appears to be 
destroyed by a bacterial action in the large intestine. With a dietary 
intake of about 130 mg/day, more than 50 mg/day appears to be destroyed by 
bacterial action. 
Also as reported in "Oxalic Acid in Biology and Medicine", large 
discrepancies have been reported in the "normal" concentration of oxalic 
acid in mammalian blood. Early studies obtain values ranging from 2-4 
mg/100 ml of blood. Another study indicated that the normal blood 
concentration is probably less than 1 mg/100 ml of blood. Improved testing 
methods have given results in normal values within the range of 100 
.mu.g/100 ml to 800 .mu.g/100 ml. More recent tests of human plasma have 
produced normal oxalic acid concentration ranging from 11.8-14.3 .mu.g/100 
ml of blood in man and 52.6 to 74.4 .mu.g/100 ml of blood in sheep (see 
Table VI). A mean value of 288 .mu.g of anhydrous oxalic acid/100 ml was 
reported for normal human blood, a figure which is probably much nearer to 
the normal value. 
Feeding experiments and radioisotope studies have indicated that a 
considerable number of compounds are precursors of oxalic acid in animals 
and man, for example, glycine, glyoxylic acid, glycolic acid, 
ethyleneglycol, ascorbic acid, and tryptophan (Oxalic Acid in Biology and 
Medicine). Studies with ascorbic acid have shown that the main excretory 
products of vitamin C in man are oxalate, ascorbic acid, and 
dehydroascorbic acid. From 17-40 percent of administered ascorbic acid was 
excreted as oxalic acid. 
As reported in "Oxalic Acid in Biology and Medicine", a high oxalate intake 
reduces the intestinal absorption of calcium because of the formation of 
insoluble calcium oxalate and prolonged exposure to such a diet may lead 
to loss of bone mineral, particularly if the diet is also deficient in 
calcium or vitamin D. This situation is unlikely to occur very often in 
western countries where there is a plentiful supply of milk and other 
dairy products and oxalate-rich foods are relative uncommon. However, in 
developing countries such as India the situation is often quite different 
because tropical vegetables frequently with a high oxalate content provide 
the main source of minerals and the total oxalate intake may well exceed 
the calcium intake in certain seasons. Dietary oxalate is poorly absorbed 
on a normal diet containing adequate amounts of calcium. 
Further, as reported in literature including "Oxalic Acid in Biology and 
Medicine", poisoning from oxalic acid in animals and man has been 
recognized since the beginning of the 19th Century. The death rate from 
oxalate poisoning has declined supposedly because of a decreased use of 
oxalic acid in domestic cleaning fluids. Examples of chronic poisoning by 
absorption of oxalic acid through the skin and by inhalation have been 
reported. The range of lethal doses in acute poisoning is wide, varying 
between 2 and 30 g and depending upon a variety of factors such as the 
form in which the acid or its salt is taken and the amount of food, 
particularly calcium, which is present in the stomach and intestine. Death 
has occurred as early as 3 minutes and as late as 14 days after ingestion. 
Symptoms of acute oxalic acid toxicity in man can be divided into those 
caused by a local corrosive action and those resulting from absorption and 
excretion of the soluble oxalate. If a high concentration or the solid 
form is taken, the local effects may be predominant and death may result 
from acute hemorrhagic gastroenteritis without development of symptoms 
depending on absorption. If death does not result from local corrosive 
action then symptoms develop from the systemic effects and from renal 
insufficiency. The cardiovascular, neuromuscular and central nervous 
systems are markedly affected. The skin is pale, cold and clammy, the 
pulse is weak and the blood pressure and temperature are low. Numbness and 
tingling may develop in the extremities and cramp-like muscular and 
abdominal pain may be extremely severe. Local or generalized muscular 
twitchings occur and may progress to marked tetany and convulsive 
seizures. The central nervous system may show evidence of excitation or 
depression, varying from an acute maniacal state to stupor and coma. Death 
results from cardiovascular collapse or depression of the central nervous 
system. Renal involvement is frequent and even if the patient survives the 
severe local or systemic effects, death may ultimately occur from renal 
insufficiency, which dominates the picture from the second day. Oliguria 
develops and may progress to anuria. 
Infection with oxalic acid producing fungi of aspergillus may result in 
massive deposition of calcium oxalate at the sight of infection and also 
renal oxalosis, leading to renal failure (Oxalic Acid in Biology and 
Medicine). Patients undergoing treatment with steroids, immunosuppressive 
drugs or cytotoxic agents are particularly liable to develop fungal 
infections and the increasing use of these drugs in malignancy and organ 
transplantation may be expected to lead to an increased incidence of 
aspergillosis infection. 
Oxamide (ethanediamide, oxalamide, oxalic acid diamide, or ethanedioic acid 
diamide, or C.sub.2 H.sub.4 N.sub.2 O.sub.2) is metabolized in the body to 
form oxalic acid. 
In accordance with the present invention, therapeutically effective amounts 
of at least one therapeutically effective form of oxalate or oxalic acid 
including, oxalic acid dihydride, anhydrous oxalic acid, potassium 
oxalate, sodium oxalate, oxamide, plants or vegetables containing oxalic 
acid or the potassium salt thereof, or combinations thereof are 
administered periodically to prevent, control, or treat infectious or 
pathogenic bacterial, viral, or other microbial diseases or conditions 
and/or neoplasia, cancers, tumors, neoplasms, and the like. Further, these 
compounds are administered along with a therapeutically effective 
reduction in the administration or ingestion of oxalic acid or oxalate 
blockers such as calcium, potassium, vitamin C, vitamin B6, citric acid, 
alcohol, or combinations thereof. 
Also, in accordance with the present invention, severe gastroenteritis, 
vomiting, diarrhea, melena, renal disease, renal damage, convulsions, 
coma, cardiovascular collapse, and the like caused by oxalic acid are 
treated or prevented by limiting or by reducing oxalic acid or oxalate 
intake and/or administering therapeutic quantities of oxalic acid or 
oxalate blockers such as calcium, alcohol, potassium, citric acid, vitamin 
B6, vitamin C, and combinations thereof. 
Oxalic acid dihydrate is commercially available in powdered, granular or 
crystal form or in liquid form for use as an industrial cleanser or 
solvent preparation. 
In accordance with the present invention, oxalic acid may be present in a 
free acid, ester, lactone, or salt form. Also, oxalic acid, oxalate or 
related compound having the desired beneficial effect may be used as a 
composition, additive, supplement, remedy, and the like alone or in 
combination to prevent, control, or treat cancer, tumors, neoplasia, 
neoplasms, infectious or pathogenic bacterial or viral diseases, and the 
like. 
In accordance with the present invention, a therapeutic composition may be 
formed by adding oxalic acid dihydrate to food or drink to provide for the 
oral ingestion of a therapeutically effective quantity of oxalic acid. 
A therapeutic composition of oxalic acid or oxalate compound of the present 
invention may be prepared by forming a food or drink including plants or 
vegetables high in oxalic acid or oxalate, for example carrots, carrot 
juice, chives, parsley, beets, spinach, or combinations thereof (see 
Tables I-IV). 
A therapeutic composition of the present invention in the form of a daily 
supplement, pill, gel cap, pharmaceutical, or the like is prepared by 
placing a therapeutically effective amount of oxalic acid or oxalate 
compound in pill form for oral ingestion as directed. 
A therapeutic composition of the present invention in cream or ointment 
form for topical administration of oxalic acid is prepared by mixing a 
dilute concentration of oxalic acid in a solvent such as distilled water, 
ethanol, acetone, propylene glycol or polysorbate to form a solution which 
is then mixed in a conventional manner with a commonly available cream or 
ointment base such as hydrophilic ointment or petrolatum. Therapeutic 
compositions of the instant invention may also be formulated in gel, 
lotion, spray, stick or powder form. 
It is believed that the therapeutic effect of the oxalic acid or oxalate in 
treating tumors, cancers, neoplasia, neoplasms, infectious or pathogenic 
microbial, bacterial or viral diseases, and other disorders affecting 
humans involves the administration whether it be topical, oral, by 
injection, suppository, or the like of a therapeutic and beneficial 
quantity of oxalic acid in one of its free acid, salt, or other forms to 
cause contact of oxalic acid with the bacteria or virus, and/or to elevate 
the blood oxalic acid level to between 350 .mu.g/100 mL and 450 .mu.g/100 
mL, preferably 425 .mu.g/100 mL and/or the urine oxalate level to between 
40 mg/L and 80 mg/L, preferably 60 mg/L for a 70K human. 
Also in accordance with the present invention in the treatment of canines, 
an oxalic acid or oxalate level chart for canines and felines differs from 
that for humans in that the desired therapeutic effect can be produced 
from 14 mg/L to 50 mg/L, preferably 22 mg/L oxalate level in the urine of 
a 25 K animal as compared with 40 mg/L to 80 mg/L, preferably 60 mg/L in 
the human urine. Likewise, the normal blood oxalic acid level of an animal 
such as canine or feline differs from that of humans. 
Along this line, it has been determined that about 1 gram per day intake of 
oxalic acid provides about a 22 mg/L level of oxalate in the urine of a 25 
Kilogram (K) canine. 
In accordance with one embodiment of the present invention, a multiple 
vitamin formula having oil and water soluble vitamins with minerals in 
tablet form with a suggested use to take one tablet daily with a full 
glass of distilled water preferably within an hour of a meal or as 
directed by a physician, includes about 100 mg oxalic acid together with 
5,000 IU vitamin A, 60 mcg vitamin C, 400 IU vitamin D, 30 IU vitamin E, 
25 mg vitamin K, 1.5 mg thiamin (vitamin B1), 1.7 mg riboflavin (vitamin 
B2), 20 mg niacin, 2 mg vitamin B6, 400 mcg folate, 6 mcg vitamin B12, 30 
mcg biotin, 10 mg pantothenic acid, 162 mg calcium, 18 mg iron, 109 mg 
phosphorus, 150 mcg iodine, 100 mg magnesium, 15 mg zinc, 20 mcg selenium, 
2 mg copper, 2.5 mg manganese, 25 mcg chromium, 25 mcg molybdenum, 36.3 mg 
chloride, 40 mg potassium, 5 mcg nickel, 10 mcg tin, 2 mg silicon, 10 mcg 
vanadium, and 150 mcg boron. Such a multiple vitamin formula with added 
minerals provides a 100% daily value of at least vitamin A, vitamin C, 
vitamin D, vitamin E, vitamin B1, vitamin B2, niacin, vitamin B6, pholate, 
vitamin B12, pantothenic acid, iron, iodine, zinc, and copper. A daily 
value has not been established for oxalic acid. Each tablet would contain 
the following ingredients: oxalic acid or oxalate, oxalic acid dihydrate, 
anhydrous oxalic acid, or other form of oxalic acid or oxalate, or 
combinations thereof together with dicalcium phosphate, magnesium oxide, 
potassium chloride, ascorbic acid, ferrous fumarate, calcium carbonate, 
gelatin, starch, cellulose, dl-alpha, tocopherol acetate, hydroxypropyl 
methylcellulose, croscarmellose sodium, sodium starch glycolate, 
niacinamide, zinc oxide, silicon dioxide, D-calcium pantothenate, sodium 
metasilicates and oxides, titanium dioxide, hydroxypropyl cellulose, 
polyethylene glycol 3350, manganese sulfate, magnesium stearate, 
pharmaceutical glaze, polysorbate 80, pyridoxin hydrochloride, copper 
oxide, povidone, sodium and potassium borates, riboflavin, vitamin A, 
acetate, thiamin mononitrate, beta carotene, resin, folic acid, potassium 
iodide, chromium chloride, ergocalciferol, sodium molybdate, sodium 
selenate, yellow 6 lake, sodium metavanadate, stannous chloride, nickelous 
sulfate, phytonadione, biotin (U.S.P. method 2), and cyanocobalamin 
(U.S.P. method 2). This product would be formulated per official U.S.P. 
standards to meet disintegration or dissolution, weight, purity, and 
potency requirements. 
An alternative embodiment of the present invention would include a multiple 
vitamin and mineral tablet or daily supplement including oxalic acid in 
one of its forms or oxalate together with all the above mentioned vitamins 
and minerals except those which serve as oxalic acid or oxalate blockers. 
For example, the inclusion of oxalic acid or oxalate blockers would be 
eliminated or greatly reduced so as to prevent blocking the beneficial 
effect of the oxalic acid or oxalate. Such blockers include calcium, 
potassium, vitamin B6, vitamin C, citric acid, alcohol, magnesium, resin, 
etc. 
In accordance with at least one embodiment of the present invention, oxalic 
acid or oxalate is used for the treatment of infectious or pathogenic 
microbial, viral, bacterial, or other diseases of warm-blooded animals 
including humans, dogs, and the like. 
In accordance with a particular embodiment of the present invention, oxalic 
acid or oxalate is used in a method of therapeutically treating a human 
including administering a therapeutically effective dosage of oxalic acid, 
oxalic acid salt, oxalic acid ester, or other therapeutically effective 
form thereof, in an amount and for a period of time sufficient to provide 
the desired effect. 
The method as described above wherein the oxalic acid is in the form of a 
free acid. 
The method as described above wherein the acid is in salt form. 
The method described above wherein the oxalic acid, oxalate or other 
therapeutically effective form thereof is administered periodically for a 
period of time sufficient to achieve at least a clinically discernible 
effect, for example, a reduction in infection or the size of a tumor. 
The method as described above wherein the oxalic acid, oxalate or other 
therapeutically effective form thereof is administered periodically for a 
period of time sufficient to achieve at least a substantial therapeutic 
effect, for example the eradication of infection or a tumor. 
The method as described above wherein the oxalic acid or oxalate is 
administered daily. 
The method as described above wherein the period of time is at least one 
month. 
The method as described above wherein after one month the oxalic acid is 
administered on a weekly basis. 
The method as described above wherein the oxalic acid, oxalate or other 
therapeutically effective form thereof is present in a therapeutically 
acceptable composition including a carrier. 
The method as described above wherein the composition is a powder, tablet, 
gel cap, lotion, cream, gel, ointment, solution, mixture, food, 
nutritional supplement, formulation, transdermal patch, drops, or 
combination thereof. 
In accordance with one embodiment of the present invention, a 
therapeutically effective dosage of oxalic acid or oxalate is administered 
on a periodic basis by the ingestion of one or more foods including oxalic 
acid in one of its therapeutically effective forms including free acid, 
salt, ester, lactone, anhydride, dihydrate, diamide, or the like. 
In accordance with a particular example, a four pound sourdough bread loaf 
is made from conventional bread ingredients including flour, water, yeast, 
and sourdough and has added thereto two rounded tablespoons of dried, 
chopped parsley which is mixed with the other ingredients to be disbursed 
throughout the loaf. These two rounded tablespoons of dried parsley 
provide approximately 2 grams of oxalic acid or oxalate in the loaf of 
bread. Hence, half of the loaf contains about 1 gram, 1/4 of the loaf 
contains about 1/2 gram, 1/18 of the loaf contains 1/4 of a gram, and 1/16 
of the loaf contains about 1/8 of a gram of oxalic acid. 
In accordance with one embodiment of the present invention, the above 
described loaf of oxalic acid or oxalate containing sourdough bread is 
used in a method of therapeutically treating a warm-blooded animal by 
having the animal periodically ingest a portion of the loaf. For example, 
in the treatment of an adult male human, he could ingest daily up to about 
1/2 of a loaf of this bread to achieve a dosage of oxalic acid of up to 
about 1 gram oxalic acid per day. This dosage may be reduced after a 
period of time and given a certain health condition to 1/2 gram or less 
oxalic acid per day, and, as such, 1/4 loaf or less of the bread per day. 
The above described oxalic acid or oxalate containing sourdough bread does 
not include any salt, sugar or preservatives since the oxalic acid serves 
as a preservative. 
In using oxalic acid or oxalate as a therapeutic agent, one must be careful 
to administer the proper dosage given certain health conditions or in 
order just to maintain a healthy condition since an overdose of oxalic 
acid or oxalate can cause indigestion, to heartburn, backache, or severe 
problems such as renal failure, heart failure, diarrhea, vomiting, 
convulsions, melena, and the like. It is believed that a proper balance 
should be maintained between oxalic acid, oxalate and their blocking 
agents such as potassium, barium, calcium, copper, magnesium, silver, 
strontium, alcohol, citric acid, vitamin B6, vitamin C, and the like. If a 
high dosage of oxalic acid or oxalate would reduce calcium levels, 
potassium levels, magnesium levels, and the like necessary for proper 
heart functioning, it is necessary to limit the administration of oxalic 
acid or oxalate to the minimum dosage necessary to provide the desired 
therapeutic effect without causing undesired side effects or health 
problems. 
In accordance with the present invention, the dosage of oxalic acid or 
oxalate is monitored and altered as necessary by monitoring the oxalic 
acid or oxalate levels in the urine and/or blood in the patient, whether 
that patient be a human, canine, or the like. Also in accordance with the 
present invention, the amount of blockers such as calcium, vitamin B6, 
vitamin C, citric acid, alcohol, or combinations thereof are monitored in 
the urine and/or blood of the patient. 
It has been discovered that the body of an animal such as human or canine 
is a complex chemical factory which requires a particular balance of 
compounds, chemicals, vitamins, minerals, nutrients, and the like to 
provide for and maintain optimum health of the animal. It is believed that 
too little oxalic acid or oxalate in the animal may allow for the advent 
of neoplasia, tumors, cancers, growths, neoplasms, bacterial or viral 
disease, and the like, while too much oxalic acid or oxalate may cause 
back pain (due to kidney trouble), heartburn, indigestion, heart trouble, 
nerve trouble, and the like. Thus, it is recommended that each individual 
case be studied and that the proper dosage of a therapeutically effective 
amount of oxalic acid, oxalate, enhancers, and/or blockers be administered 
on a periodic basis at one level to maintain proper health by preventing 
neoplasia, tumors, growths, neoplasms, bacterial or viral disease, and the 
like, at a different level to treat, combat, control, or eradicate tumors, 
growths, cancers, neoplasia, bacterial or viral disease, or to cleanse the 
blood, and at a third intermediate level once the blood is clean and 
relatively free of infectious or pathogenic bacteria or viruses, cancer, 
tumor, neoplasm or neoplasia cells, to combat, reduce the size of, or 
treat an existing tumor, cancer, growth, neoplasm or infectious bacterial 
or viral disease, or the like. Since each person or animal is different, 
and their body chemistries operate in at least some small fashion 
differently than other persons or animals, the administration of a 
therapeutically effective dosage of oxalic acid, oxalate, enhancers, 
and/or blocking agents should be reevaluated and monitored on a regular 
basis by, for example, physical examination, X-ray, CAT scan, MRI imaging, 
sonogram, biopsy, blood analysis, urine analysis, fecal analysis, as well 
as other conventional diagnostic techniques. It is believed that a proper 
balanced diet including foods containing oxalic acid in one of its forms 
including oxalate which may be metabolized by a human or other 
warm-blooded animal can serve to maintain proper health, extend life, 
increase the quality of life, increase energy, increase cranial activity, 
prevent neoplasia, tumors, cancers, neoplasms, infectious bacterial, 
viral, or microbial disease, etc., help to combat viruses, bacteria, 
improve the immune system, and provide other beneficial short term and 
long term health effects. 
Some forms of oxalic acid or oxalate which may prove beneficial to humans 
and other warm-blooded animals, include ethanedioic acid (free acid), 
ethanedioic acid anhydride, ethanedioic acid tri-potassium salt, 
ethanedioic acid barium salt, ethanedioic acid copper salt, ethanedioic 
acid diamide, ethanedioic acid diamonium salt, ethanedioic acid diethyl 
ester, ethanedioic acid dimethyl ester, ethanedioic acid disodium salt, 
ethanedioic acid magnesium salt, ethanedioic acid silver salt, ethanedioic 
acid strontium salt, ethanedioic acid dihydrate, dicarboxylic acid, as 
well as other forms of oxalic acid or oxalate which may be metabolized by 
the body, injected into the circulatory system, administered by 
transdermal patch, administered by suppository, administered by topical 
application, wash, gargle, ointment, and the like, to provide the desired 
therapeutic effect. Although one or more of the above may be considered 
poisons to humans or other warm-blooded animals, the proper administration 
of a selected dosage is believed to be therapeutically effective and 
instrumental in the treatment, prevention, and control of disease, and 
maintenance of good health. It is not uncommon for an agent which is a 
poison to provide a beneficial effect. Aspirin is one of the myriad of 
hundreds or thousands of poisons which provide a beneficial effect to 
warm-blooded animals when administered in a proper dosage. 
It is believed that oxalic acid or oxalate may be one of the primary causes 
of the onset of osteoporosis. Too much oxalic acid or oxalate in the diet 
may reduce the calcium in the body to a point of causing or aggravating 
osteoporosis. Hence, the treatment and prevention of osteoporosis is the 
control of the oxalic acid, oxalate and calcium levels. Women in a high 
risk group for osteoporosis should be careful to increase calcium intake 
and decrease oxalic acid or oxalate intake to prevent, treat, or control 
osteoporosis. 
It is believed that oxalic acid or oxalate may be a blood purifying agent 
which in addition to controlling, treating, or eradicating infectious 
bacteria or viruses and abnormal cells, oxalic acid in the blood may 
control cholesterol and plaque or fat buildup. Thus, the periodic or daily 
administration of a certain quantity of oxalic acid in one of its 
therapeutically effective forms including oxalate may serve to not only 
purify the blood, but also control, treat, or effect cholesterol, plaque, 
and fat buildup in the cardiovascular system or in the brain, and in so 
doing improve and maintain good cardiovascular health and operation. 
It is believed that oxalic acid or oxalate may also be an effective 
treatment for parvo. Also, oxalic acid or oxalate may be used as a 
hemostatic and antiseptic agent in and on animals. 
It is believed that oxalic acid or oxalate should be administered following 
exposure to X-ray radiation, X-rays, mammograms, radiation therapy, 
CAT-scans, nuclear or atomic exposure, radiation therapy, chemotherapy, 
radioactive pellet treatment, and the like, to prevent infectious or 
pathogenic bacterial or viral disease, or the formation of neoplasms, 
tumors, cancers, neoplasia by counteracting the destruction of oxalic acid 
or oxalate caused by the exposure or treatment. 
It is believed that a dosage of oxalic acid or oxalate may also provide a 
reserve of energy or nutrients. Hence, a food or beverage containing 
oxalic acid or oxalate could be ingested prior to strenuous activity in 
order to increase energy, stamina, strength and/or mental activity. 
It is also believed that oxalic acid or oxalate may prevent or relieve 
muscle soreness by helping eliminate lactic acid. 
It is also believed that oxalic acid or oxalate should be administered 
after exposure to specific oxalic acid or oxalate decomposing bacteria to 
prevent infectious bacterial or viral disease or the onset of tumors. For 
example, workers at poultry houses may take oxalic acid or oxalate to 
maintain a normal level of oxalic acid or oxalate to prevent tumor 
development and counteract exposure to bacteria. 
In addition to the administration or ingestion of oxalic acid or oxalate, 
it is believed that one should limit the intake of dairy products since 
these tend to counteract the beneficial effect of the oxalic acid or 
oxalate. 
It is believed that oxalic acid or oxalate should be administered prior to 
a transplant operation to purify the blood and improve the immune system. 
However, it is also possible that just prior to a transplant operation the 
body should be purged of oxalic acid to prevent aspergillis fungi 
infection. 
It is believed that strong magnetic fields, MRI imaging, computer 
terminals, power lines, cellular telephones, electronic equipment, 
microwave ovens, etc. may decompose oxalic acid or oxalate in the body and 
blood and allow the spread of infectious bacterial or viral disease and 
the formation of tumors, growths, cancers, etc. Hence, those subjected to 
strong magnetic fields and the like should increase their oxalic acid or 
oxalate intake to counteract such decomposition. 
It is also believed that the administration of oxalic acid or oxalate may 
delay, prevent, control, or treat the onset of Alzheimer's Disease, lessen 
the effects of the disease, or improve the quality of life of a person 
suffering from Alzheimer's Disease. 
It is also believed that oxalic acid or oxalate may be a control, 
treatment, remedy, or preventative for viral or auto immune-related 
diseases such as AIDS, HIV, SLE, BSE, CFS, and the like by preventing, 
lessening, or controlling the destruction of the bodies immune system. 
Hence, the administration, ingestion, injection, etc. of an effective 
amount of oxalic acid in one of its therapeutically effective forms 
including oxalate may serve to treat, prevent, or control the debilitating 
effects of auto-immune related diseases, viral diseases, bacterial 
infections, and the like. 
As described in "Oxalic Acid in Biology and Medicine", normal human blood 
typically has a mean value of about 288 .mu.g of anhydrous oxalic acid per 
100 ml of blood. In accordance with the present invention, if a subject's 
blood is tested and their oxalic acid level is below this mean value, it 
is believed that they should be administered oxalic acid in one of its 
forms including oxalate, easily metabolized by the body to increase their 
blood oxalic acid level. Also it is believed that if someone is suffering 
from cancer, tumors, AIDS, bacterial, viral, or microbial infection, etc. 
that they should be administered oxalic acid or oxalate in order to 
increase their blood oxalic acid level to a higher value than the typical 
mean value. 
In accordance with one embodiment of the present invention, a new scale is 
developed for canine and feline urine oxalate level. Since a typical human 
scale will not work for a canine or feline due to their different body 
structures and metabolism, a need exists for a canine and/or feline scale 
which will provide a quick-ready reference for a veterinarian or pet owner 
to test urine oxalate levels and adjust the oxalic acid intake in the diet 
accordingly. 
Oxalic acid is believed to be a reducing agent, bactericidal agent, 
sterilizing agent, disinfectant, bacteriostatic agent, chemopreventive, 
chemotherapeutic agent, curative drug, antimicrobial agent, and may be an 
antioxidant. 
In accordance with the present invention, it is believed that five or more 
items unnaturally constantly consumed are responsible for at least some 
bacterial or viral infectious disease, tumors or cancers, and the like. 
These items, calcium, vitamin B6, vitamin C, citric acid, and alcohol are 
believed to be oxalic acid or oxalate blockers. It is interesting to note 
that a variety of prepared foods eaten every day including cookies, cakes, 
canned foods, salad dressings, and the like, contain these items. Further, 
it is interesting to note that certain articles have proposed that persons 
on a low-fat diet showed less tumors or showed tumor reduction. Since red 
meat such as beef or liver contains vitamin B6 (pyridoxine hydrochloride) 
it follows that reduction or elimination from the diet also serves as a 
reduction or elimination of a blocker of oxalic acid or oxalate. Tables 
VII-XI list the pyridoxine hydrochloride content of meats and other foods. 
Although others have indicated that vegetables are cancer fighters, they 
have listed the cancer fighting agents as antioxidants, beta carotene, or 
citric acid. The literature is void of a reference to oxalic acid as being 
a cancer fighter or preventer. 
The literature suggests that tumors occur when the immune system fails to 
eliminate abnormal cells not consumed as a normal biological function of 
the body systems. In accordance with the present invention, it is believed 
that a low intake of oxalic acid or oxalate or a high intake of oxalic 
acid or oxalate blockers including alcohol, citric acid, ascorbic acid, 
and pyridoxine hydrochloride weakens the immune system or the body's 
natural cancer and disease fighting ability to the point where the body 
cannot control abnormal cell growth, tumors, cancer, neoplasms, bacterial 
or viral infectious disease, and the like. Changing the diet to include an 
increase in the intake of oxalic acid or oxalate and eliminating or 
drastically reducing the intake of oxalic acid or oxalate blockers, allows 
the body's immune system or natural cancer and disease fighting systems to 
function and eliminate abnormal cells and prevent disease. 
It is believed that carrots, spinach, parsley, chives, beet leaves, garlic, 
collards, radishes, carrot juice, and the like are relatively high in 
oxalic acid or oxalate and should be eaten or consumed in order to build a 
high concentration of oxalic acid or oxalate in the body. It is believed 
that if one can maintain a balanced diet and assure an adequate level of 
oxalic acid or oxalate in the system then the body's natural protection 
mechanisms, immune system, and the like can prevent, treat, and control 
tumors, growths, cancers, viral or bacterial diseases, chemical toxins, 
and the like. 
Over the years, many claims have been made regarding the beneficial health 
effects of many fruits, vegetables, plants, molds, etc. Recently, it has 
been claimed that garlic is believed to fight infection, cancer, bacteria, 
virus, and heart disease, strawberries are believed to help prevent 
prostate cancer, and tomatoes or spaghetti sauce are believed to prevent 
cancer and heart attacks. A recent study indicated that two cups of coffee 
a day can prevent suicide in women who work. 
On the other hand, plants, vegetables and chemicals which contain high 
levels of oxalic acid or oxalate are according to conventional wisdom 
thought to be poisons and to be eliminated from the diet or use. For 
example, those suffering from kidney stones are told to stay away from 
rhubarb leaves, spinach, Swiss chard, lambs quarter, and beet leaves which 
contain high amounts of oxalates. Also, they are told to stay away from 
black and green teas, and coffee which also contain oxalic acid. Further, 
nuts, chocolate and strawberries are cited by some as containing 
high-oxalate. 
Opposite conventional thinking, in accordance with the present invention, 
it is believed that oxalic acid or oxalate is the "miracle bullet", 
"silver bullet", "hall monitor", or "brevet boule" that treats, kills, 
controls, manages, or prevents infectious bacterial or viral disease, 
abnormal, tumor, cancer or unspecialized cells and, thereby, treats 
cancers, tumors, neoplasms, infectious or pathogenic bacterial, viral, or 
other microbial diseases, and maintains good health. Further, it has been 
discovered that a high oxalic acid or oxalate intake causes a disease or 
cancer patient to be more talkative, verbal, have increased dexterity, 
physical ability, mental ability, and appear invigorated, happier and more 
outgoing. 
The conventional treatments for cancer, tumors, growths and the like can 
themselves cause cancer, tumors, growths, infectious bacterial or viral 
disease, and the like. For example, X-rays can trigger malignant growths 
in certain people. Further, in accordance with the present invention, 
decomposition or reduction of oxalic acid or oxalate in the body caused by 
exposure or treatment of X-rays, CAT-scans, strong electromagnetic waves 
or fields, electron bombardment, microwaves, and the like reduce the level 
of oxalic acid or oxalate in the body and further increase the chance of 
growths, tumors, cancers, and bacterial or viral disease. Hence, it is 
believed that one should not only increase the intake of oxalic acid or 
oxalate, but also avoids exposure to or treatment of radiation, X-rays, 
electromagnetic fields and the like which tend to decompose or reduce the 
amount of oxalic acid or oxalate in the body. 
Along this same line, it is believed that conventional testing techniques, 
such as the testing of carcinogens on mice may provide faulty results in 
that the first step typically in such testing is to irradiate the mice 
with radiation to weaken their immune system so that they are more 
susceptible to disease and carcinogens. The radiation to weaken the immune 
system also causes a reduction or elimination of the oxalic acid or 
oxalate in the mice. In accordance with the present invention, it is 
believed that a normal level of oxalic acid or oxalate is required in the 
body to prevent cancers, growths, tumors, bacterial or viral disease, and 
the like. Hence, the researchers unknowingly introduced additional cancer 
and disease causing factor into the testing. 
In accordance with the present invention, an improved testing method would 
involve determining the normal oxalic acid or oxalate level of the test 
animal, weakening the immune system of the animal using radiation, and 
then administering or feeding to the animal a sufficient quantity of 
oxalic acid or oxalate to bring their oxalic acid or oxalate levels back 
up to normal prior to further testing. 
Also, in accordance with the present invention, it is believed that 
testing, research, and examinations which include X-rays or electronic 
scans to insure no cancer is present or to check on the size or location 
of the cancer can themselves bring on disease or cancer by decomposing 
oxalic acid or oxalate and irritating the skin or tissue. Further, if test 
animals are fed a diet high in oxalic acid or oxalate blockers such as 
calcium, vitamin B6, vitamin C, citric acid, and the like the effective 
level of oxalic acid or oxalate in the animal is reduced and the test 
results may be skewed and possibly not representative of the natural 
normal animal biochemistry or system. Hence, it is believed that improved 
human examination and animal testing involves a reduction in the use of 
X-ray or electronic scans, and the incorporation of a balanced diet 
containing oxalic acid or oxalate and a reduction in oxalic acid or 
oxalate blockers. 
In accordance with another embodiment of the present invention, an improved 
method of testing for disease or capcer includes the elimination of the 
use of X-rays or electronic scans during the testing process. 
In accordance with another embodiment of the present invention, an improved 
method of testing for disease or cancer allows for the use of X-rays or 
electronic scans to detect the presence or absence of disease or cancer, 
but requires that the oxalic acid or oxalate decomposed or reduced by the 
X-ray or electronic scan be replaced. 
In accordance with another embodiment of the present invention, an improved 
method of testing for disease or cancer employs the use of an improved 
animal feed which includes at least one form of oxalic acid or oxalate and 
with a reduced amount of oxalic acid or oxalate blockers from that of 
conventional feed. 
If one is to administer and ingest oxalic acid in one of its harsher forms 
such as oxalic acid dihydrate, for example, a gel cap filled with 500 
milligrams to 2 grams of oxalic acid dihydrate, this should be taken one 
hour before or after a meal and with a sufficient quantity of water such 
as 10 or more ounces of distilled water. In order to further reduce the 
possibility of harm or irritation to the digestive system, one can line 
the stomach before taking such an oxalic acid pill or gel cap using 
PeptoBismol, Tagamet, or Zyntec. 
In accordance with another aspect of the present invention, workers exposed 
to X-rays, CAT-scans, electromagnetic fields or waves, microwaves, radar, 
high voltage power lines, electronic equipment and the like are given 
sufficient quantities of foods, beverages, supplements, treats or the like 
containing an effective amount of at least one beneficial form of oxalic 
acid or oxalate to compensate for the decomposition or reduction caused by 
their working environment and thereby prevent the development of tumors, 
cancers, infections bacterial or viral disease, other diseases, poor 
health, etc. which may otherwise be caused by their work environment. 
In recent history, there has been an increase in breast cancer in women in 
the United States. In accordance with the present invention, it is 
believed that this increase in breast cancer may be due in part to the use 
of microwave ovens which emit microwaves (usually at about chest height), 
which when used in cooking or heating decompose the oxalic acid or oxalate 
in the food or beverage, the use of a myriad of electronic equipment 
including radios, televisions, computers, etc., and the consumption of 
processed foods which contain oxalic acid or oxalate blockers such as 
calcium, citric acid, vitamin C, vitamin B6, and the like. 
In recent history, there has been an increase in throat and mouth cancer in 
men in the United States. In accordance with the present invention, it is 
believed that this increase in throat and mouth cancer may be due in part 
to the use of microwave ovens which, when used in cooking or heating, 
decompose the oxalic acid or oxalate in the food or beverage, the use of a 
myriad of electronic equipment including electric blankets, electric 
razors, electric hair blowers or dryers, radios, televisions, computers, 
cell phones, and the like, as well as the consumption of processed foods 
which contain oxalic acid or oxalate blockers such as calcium, citric 
acid, vitamin C, vitamin B6, and combinations thereof, and an increased 
consumption of alcoholic beverages. 
In accordance with the present invention, it is respectfully believed that 
oxalic acid or oxalate is a natural chemopreventive, chemotherapeutic, 
bactericidal, viricidal, antiviral, and disease preventing, treating, and 
controlling agent. Because it is natural, it destroys, kills, and/or 
controls "bad" or harmful bacteria, viruses, microbes, cancer cells, 
abnormal cells, growths, and the like, while allowing "good" or healthy 
bacteria, viruses, microbes, cells, and tissues to thrive. For example, if 
one kills all the bacteria in the mouth of a human or other animal, they 
can develop a fungus or fungal infection referred to as thrush. Using the 
natural therapeutic oxalic acid or oxalate solution as a mouth rinse or 
gargle only kills the "bad" or infectious bacteria and, therefore, does 
not lead to an unwanted fungal infection. Further, since oxalic acid or 
oxalate in one of its therapeutic forms is believed to be a natural 
disease and cancer preventing, controlling, or treating agent, it is 
believed that the diseases or cancers being treated, controlled, or 
prevented, do not become immune to the oxalic acid or oxalate. 
In accordance with another embodiment of the present invention, a person 
who believes they have been subjected to radiation, strong electromagnetic 
waves or fields, microwaves, radar, strong TV or radio waves, or work in a 
dangerous environment where they may be subjected to X-rays or other 
elements which can decompose or reduce the oxalic acid or oxalate in the 
body, can test their blood, plasma or urine oxalic acid or oxalate level 
and if they find it is below normal, treat themselves with food, 
beverages, supplements, pills, capsules, and the like containing oxalic 
acid or oxalate to bring their level back up to a normal healthy level. 
Further, such a person can pre-treat themselves prior to exposure with 
oxalic acid or oxalate to reduce the chance that their levels will drop 
below normal levels. This should prevent or reduce the increased risk to 
developing cancers, tumors, viral or bacterial and viral diseases, and the 
like caused by having below normal oxalic acid or oxalate levels in the 
body. 
Solutions of oxalic acid are decomposed by radiation. This has been the 
basis of a method for measuring radiation dosage in the sterilization of 
food and medical products. The absorbed dose is determined from the 
decrease in oxalic acid concentration which occurs during irradiation 
(FIG. 1). 
In addition to the information provided in Table IV, nuts contain high 
concentrations of calcium, magnesium, iron and relatively high 
concentrations of oxalate. For example, almond, cashew, peanut, pecan, and 
walnut all contain oxalic acid concentrations ranging from 200 mg/100 
g-600 mg/100 g. Forage grasses and other pasture plants frequently contain 
high concentrations of minerals but many of them also contain high 
concentrations of oxalate. Further, many beverages including beers, wines, 
and fruit drinks contain low concentrations of oxalate but tea, coffee, 
cocoa, and chocolate contain relatively high concentrations of oxalate. 
Tea, in fact, is listed as being the largest single source of oxalate in 
English diets. 
According to Occupational Health Services, Inc. (OHS), oxalic acid has a 
CAS number: 144-62-7A a RTECS number: R0245000, trade names or synonyms 
ethanadoic acid, aktisal, aquisal, dicarboxylic acid, phosphotex 760 grain 
refiner, C.sub.2 H.sub.2 O.sub.4, and OHS17360. Oxalic acid is in the 
chemical family carboxylic acid, aliphatic and is listed as a poison with 
a level three out of a scale 0-3 for health, and a level 1 fire rating. 
In accordance with the present invention it is believed that conventional 
wisdom that the cause of acorn poisoning is tannic acid is wrong and that 
it is instead the oxalic acid which is extremely damaging to renal 
tissues. It is believed that the oxalic acid or oxalate level in oak trees 
is very high, especially in mold that grows on the bark. 
Also, it is believed that the treatment for oxalic acid or oak poisoning is 
to increase oxalic acid or oxalate blockers, such as pyridoxine 
hydrochloride, citric acid, calcium, magnesium, and alcohol such as 
ethanol to eliminate or carry the oxalic acid through the renal system. 
Oxalate nephrosis is probably the most common cause of toxic death in dogs. 
Typically, the source of oxalate poisoning is ethylene glycol 
(antifreeze). The ethylene glycol is metabolized to oxalate and oxalic 
acid by an enzyme called alcohol dehydrogenasc. Ethylene glycol by itself 
is not toxic, but when the enzyme, alcohol dehydrogenase, works on it to 
produce a toxic material (oxalate), then it becomes toxic. Antifreeze 
poisoning is treated with alcohol (ethanol) to keep the alcohol 
dehydrogenase enzyme busy so that the antifreeze can be eliminated, 
unaltered, and in a non-toxic state. A major contributor to death is also 
metabolic acidosis caused by oxalic acid accumulation. It is almost as 
important to control the acid-based status as it is worrying about the 
accumulation of oxalate. 
There are several other causes of oxalate nephrosis which are extremely 
rare. Overdoses of vitamin C have been shown to cause oxalate nephrosis in 
humans, and in at least one goat. Vitamin B6 (pyridoxine hydrochloride) 
deficiency and methoxyflurane anesthesia may also induce the condition. 
Aspergillus sp. fungi also produces high levels of oxalate and these fungi 
are almost ubiquitous and grow on many feed stuffs. There are a variety of 
plants other than oak, for example halogenten, greasewood, sorrel, dock, 
setaria grass, sugar beets, and several others that contain oxalic acid. 
Oxalate nephrosis produces a very specific lesion in the kidney when viewed 
under the microscope. You can actually see the oxalate crystals. A 
pathologist who is unaware of primary hyperoxaluria would obviously draw 
the conclusion that the kidney lesions were the result of oxalate 
nephrosis. 
Typically, cancer, tumors, growths, and the like are treated by invasive 
unnatural techniques, such as surgery, biopsy, X-ray radiation, 
oncological chemotherapy, and the like. In accordance with the present 
invention, it is believed that the primary treatment for cancer should be 
the all natural, non-invasive, use, administration, and the like of oxalic 
acid in one of its therapeutically effective forms including oxalate in a 
sufficient quantity and on a periodic basis to provide the desired 
therapeutic effect. 
Essiac tea was tested and found to have a pH of about 4.79 when the powder 
was added to boiling distilled water. 
The inventor continued to search for other uses of the "miracle bullet" 
oxalic acid or oxalate compositions for treating the body and immune 
system. The inventor used a dental hygiene composition of oxalic acid and 
distilled water (150 mg diluted in 300 ml of distilled water) on a 
disciplined daily schedule and noticed that besides the removal of and 
prevention of any build up of tarter or plaque in the mouth, that there 
was also a remarkable improvement in the condition of his gums and mouth 
tissue, including the tongue surface. There was no more occasional 
bleeding of the gums during daily brushing, and the surface of the tongue 
appeared to be more smooth with an even coloring across the surface. 
On another occasion, the inventor formulated a cream of powdered oxalic 
acid and a hydrophilic cream to topically treat small tumors on the skin 
surface of the inventors toy poodle. Following examination and application 
of the composition to 3 tumors on the poodle, the veterinarian applied the 
cream to a sore on his own hand having a red appearance and soreness of 
infection. Following one application of the cream the infection in the 
sore on the hand was eliminated and the sore healed quickly. 
During a veterinarian dental examination of the inventor's pet dogs, one 
dog had a moderate build up of tarter and plaque on the teeth and 
gingivitis in the upper gums, both sides of the mouth. At the completion 
of the exam, rather than treat the gingivitis with an injection of 
antibacterial medication followed by oral medication, it was agreed the 
inventor would commence daily brushing of the dog's teeth. The formula 
used for the brushing was a mix of 150 mg. of oxalic acid in 300 ml of 
distilled water. The inventor began a daily brushing of the dog's teeth 
paying particular attention to the upper gums. The brushing was done first 
thing in the morning before the dog had anything to eat or drink. After 
the fourth day of brushing, the inventor/owner of the dog, noticed the 
redness of the gingivitis was disappearing and after one week returned the 
dog to the veterinarian for a follow-up exam. The exam revealed no more 
evidence of gingivitis and no tarter but moderate plaque remained. The 
veterinarian recommended cleaning one side of the dogs upper teeth and 
continuing with the daily brushing routine. 
On another occasion, the inventor's pet poodle had torn a toenail which 
became infected. The infection was in an advanced stage which was 
extremely sensitive and the poodle would not use the leg while walking. 
The poodle was examined by the veterinarian, received an injection of a 
antibiotic, and oral capsules were to be given. The inventor began an 
immediate soaking of the paw in a composition or solution of 150 mg of 
oxalic acid in 300 ml of distilled water twice a day. After just two 
soakings the infection had improved dramatically, and the poodle used the 
leg without any signs of a limp. 
On another occasion while visiting the veterinary clinic, the inventor 
noticed the receptionist had symptoms of a cold, and upon questioning the 
receptionist learned she was treating a cold which was into the start of 
the second week. When the inventor suggested the receptionist use the 
solution formulated for dental hygiene as a remedy for the cold, the 
receptionist agreed to do so. The inventor advised the receptionist that, 
each morning immediately upon rising, and prior to any other substance 
being put into the mouth, she should take approximately one teaspoon of 
the solution in her mouth, holding it for a minimum of two minutes, 
swishing the solution gently around the mouth, then discarding the 
solution and rinsing the mouth with warm water two or three times. The 
procedure began Friday night and the following Monday morning the cold was 
gone. 
On another occasion the inventor's private attorney reported that canker 
sores (ulcers) inside his mouth which he had been experiencing over an 
extended period of time, disappeared one week after he began using the 
inventor's dental hygiene rinse on a once-a-day use of the composition. 
Also of significance was the attorney's Q-Tip application of the 
composition to a persistent sore on the inside of a nostril of his nose, 
and the sore healed. 
On yet another occasion a subject who complained of continuously being 
prescribed antibiotic pills without any improvement in continuous flu and 
cold-like symptoms began the present method of mouth rinse and gargle 
first thing each morning and last thing at night before retiring each day 
and reported experiencing significant improvement in the symptoms after 
three days of following the recommended usage. The dilute solution was the 
bench mark solution. 
On still another occasion a pharmacist, consultant to the inventor, awoke 
at 2:30 a.m. with a very sore throat, unable to swallow without severe 
pain, remembered the inventor's description of his own experience, mixed 
two teaspoons of the bench mark mixture and two teaspoons of warm water, 
held the mixture in the mouth for two minutes and gargled well. After a 
15-minute wait, repeated the procedure and then retired. Upon arising at 
6:30 a.m., repeated the procedure one time before leaving for the 
pharmacy. The pharmacist reported that at 11:30 a.m. all symptoms of the 
sore throat and flu virus were gone. 
On yet another occasion, a veterinarian associate on a call to a horse 
ranch for the birth of a foal encountered some complications during 
delivery and required assistance by the veterinarian and an extended stay 
following the birth and a delay in effecting personal hygiene which 
resulted in staph infection in scratches and skin abrasions which were 
treated by a topical application of a cream composition of Velvachol cream 
and oxalic acid and the disease and soreness was relieved. 
Two cases are recorded where use of the present dilute solution of oxalic 
acid and distilled water composition showed remarkable reduction of the 
effects of the flu virus. Rinsing of the mouth for a minimum of two 
minutes followed by a lengthy gargle three times a day for a period of 
four days completely removes all soreness of throat and nose and periodic 
use of a teaspoon of dried parsley placed between the lower lip and teeth, 
as one would use snuff, acted immediately as a decongestive agent to 
relieve soreness and congestion of the chest and further acted as an 
expectorant of heavy phlegm and an agent for drying of mucus. 
150 mg of oxalic acid in solution in 300 ml of distilled water is the 
preferred and bench mark solution or composition in the uses described 
above. In accordance with the present invention, an oxalic acid and 
distilled water solution or composition may contain anywhere from greater 
than zero to less than about 500 mg of oxalic acid per 300 ml of distilled 
water, preferably 50 to 425 mg of oxalic acid dihydrate per 300 mls of 
distilled water. Depending on the disease or condition being treated, the 
amount of oxalic acid may be increased or reduced from the bench mark 
solution of 150 milligrams of oxalic acid in solution in 300 ml liters of 
distilled water. For example, in treating a strong flu, one may dissolve 
400 milligrams of oxalic acid in a solution of 300 milliliters of 
distilled water. In treating a normal cold, one may use the bench mark 
solution of 150 mg of oxalic acid in solution in 300 ml of distilled 
water. For treating an infectious bacterial condition or disease, such as 
infection of a small cut or sore, one may use 50 to 75 mg of oxalic acid 
in solution in 300 ml of distilled water. Although there is mention of the 
use of a particular amount of 150 mg of oxalic acid in solution in 300 ml 
of distilled water to form the bench mark solution, it is to be understood 
that one may use, for example, 250 mg of oxalic acid in solution in 500 ml 
of distilled water and have the same concentration of oxalic acid in 
solution. 
Also in accordance with the present invention, it is contemplated that one 
may use 0.05 percent oxalic acid in a distilled water solution for use as 
eye drops, nose spray, and topical or cream applications. Also, a high 
level of 8 grams of oxalic acid in solution may be used in intravenous 
injection over a 24-hour period. The bench mark mouth rinse having 150 mg 
of oxalic acid in 300 ml of distilled water has a pH of about 2.3. In 
accordance with the present invention, a mouth rinse mats have a pH of 
about 6 to 1 depending on the application. Further, gelcaps and pills can 
be filled with from 1 mg in a pill to about 1 gram of oxalic acid and 
dihydrate (gr) in a gelcap. The exact concentration of oxalic acid 
required for treatment depends on the particular person being treated, the 
particular viral or bacterial infection, the stage of infection or 
treatment, and the like. 
If one undergoing treatment with oxalic acid or oxalate in one of its 
therapeutically effective forms experiences symptoms or believes that they 
have ingested too high a dosage of oxalic acid, they may eat 2 to 3 spoons 
of crushed pineapple to reduce heartburn or indigestion. 
In accordance with the present invention. it is preferred to use pure 
carrot juice as a dietary supplement or composition for administering 
oxalic acid to one undergoing treatment. One brand of frozen pure carrot 
juice has a pH of about 6.2. Another brand of canned pure carrot juice has 
a pH of 5.5. 
In accordance with another embodiment of the present invention, an oxalic 
acid or oxalate composition takes the form of a gelcap or capsule 
containing an effective amount of dried parsley in a fatty acid such as 
oleic and linoleic fatty acids like emu oil. 
In accordance with the present invention, it is believed that an adult 
human may be treated with an effective amount of oxalic acid or oxalate 
ranging from about 0.05 mg to about 8.0 gr per 24-hour period. 
In accordance with the present invention, those undergoing treatment with 
oxalic acid or oxalate in one of its therapeutic effective forms 
experience a return of good color to the skin, a boosting in the immune 
system, an increased vigor. 
Some forms of oxalic acid or oxalate which may prove beneficial to humans 
and other warm-blooded animals, include ethanedioic acid (free acid), 
ethanedioic acid anhydride, ethanedioic acid tri-potassium salt, 
ethanedioic acid barium salt, ethanedioic acid cooper salt, ethanedioic 
acid diamide, ethanedioic acid diamonium salt, ethanedioic acid diethyl 
ester, ethanedioic acid diethyl ester, ethanedioic acid disodium salt, 
ethanedioic acid magnesium salt, ethanedioic acid silver salt, ethanedioic 
acid strontium salt, ethanedioic acid dihydrate, dicarboxylic acid as well 
as other forms of oxalic acid or oxalate which may be metabolized by the 
body, injected into the circulatory system, administered by transdermal 
patch, administered by suppository, administered by topical application, 
or administered orally, and the like, to provide the desired therapeutic 
effect. Although one or more of the above may be considered poisons to 
humans and other warm-blooded animals, the proper administration of a 
selected dosage is believed to be therapeutically effective and 
instrumental in the treatment, prevention, control, and cure of infectious 
bacterial, viral or microbial disease and the maintenance of good health. 
It is not uncommon to provide a beneficial effect from an agent which is 
known as a poison. There is a myriad of hundreds or thousands of poisons 
which provide a beneficial effect to warm-blooded animals when 
administered in a proper dosage. 
In accordance with the present invention, a method of impeding the 
apoptosis of CD4 cells and persons infected with human immunodeficiency 
virus includes the steps of externally feeding or otherwise administering 
to the infected person or other animal a nutritional product which 
contains oxalic acid or oxalate in a therapeutic quantity sufficient to 
impede apoptosis of CD4 cells. 
In accordance with another embodiment of the present invention, oxalic acid 
or oxalate compositions and methods are used to treat, prevent, or control 
AIDS and HIV infection in humans and other animals by administering a 
therapeutic quantity of oxalic acid or oxalate composition, source of 
oxalic acid or oxalate, nutritional product, supplement, solution, agent, 
curative, control, impediment, food, feed stuff, rinse, mouthwash, mouth 
rinse, wash, formulation, dosage, pharmaceutical agent, dietary 
supplement, intermediate, product, composition, anti-AIDS or anti-HIV 
agent, vaccine, immune system stimulant, substance, drug, chemopreventive, 
chemical, chemosurgical agent, chemotherapy agent, chemotherapeutic agent, 
solution, solute, slurry, mixture, medicine, remedy, medication, salve, 
ointment, balm, cream, analgesic, medicinal agent, treating agent, 
preventing agent, retarding agent, impeding agent, delaying agent, 
controlling agent, anabolic agent, health improving agent, 
health-supplementary food, enriched fraction, oncological or oncologic 
agent, tumor treating agent, disease treating agent, infection treating 
agent, fungal treatment, remedy, antimicrobial agent, microbial treatment, 
bacterial treatment, and the agent for treating, controlling, improving, 
preventing, the symptoms of pathological diseases such as bacterial, 
viral, and the like, as well as a supplemental composition or treatment to 
be used in conjunction with conventional compositions and treatments, or 
the like. 
In accordance with still another embodiment of the present invention, 
oxalic acid or oxalate compositions and methods are used to improve 
sustained energy and as anabolic compositions and methods in humans and 
other warm-blooded animals. Oxalic acid or oxalate compositions provide 
for sustained energy and nutrition to support an anabolic physiological 
state in humans and other animals by providing or otherwise administering 
to the human or other animal a therapeutic quantity of oxalic acid or 
oxalate. The oxalic acid or oxalate compositions and methods may 
supplement other conventional compositions and methods such as lipids, 
bio-available minerals in the form of amino acid chelates, anabolic 
nutrients, vitamins, antioxidants, and lipotropic agents to provide an 
optimal sustained energy and anabolic nutrition formulation. When 
administered, it is believed that the oxalic acid or oxalate compositions 
facilitate sustained energy and delivery of nutrients to appropriate sites 
within the body for efficient utilization in the anabolic physiology. 
The Human Immunodeficiency V.sup.7 virus (HIV) causes AIDS. The virus 
attacks certain white blood cells, called T-cells and weakens the body's 
immune system. Acquired Immunodeficiency Syndrome (AIDS) occurs when an 
HIV-infected person develops a life-threatening condition or their number 
of disease fighting T-cells becomes dangerously low. Current data 
indicates that among persons age 25-44 years old, HIV infection is now the 
leading cause of death in men and is the third leading cause of death in 
women in the U.S. In 1995, approximately 40,000 Americans contracted HIV. 
Worldwide, one million people died from AIDS last year and reported cases 
increased by 19 percent. 
It has been about 15 years since the HIV/AIDS virus was first identified. 
Tragically, the AIDS epidemic has claimed 4.5 million lives, worldwide. 
Today, significant strides are being made in understanding the virus and 
ways to battle the disease. There are 42 approved medicines and over 120 
drugs currently being developed by pharmaceutical companies to fight 
HIV/AIDS. 
One promising advance in newly developed pharmaceuticals for fighting 
HIV/AIDS is a new class of medicines called protease inhibitors. Studies 
show that when a protease inhibitor is combined with one or more of the 
established HIV/AIDS medicines, they work together to attach the HIV virus 
at different stages of its progression. This combination or "cocktail" 
therapy has been shown to reduce the level of HIV in the bloodstream by up 
to 99 percent in some patients and, thereby, potentially halting or 
slowing the advancement of the disease. 
In accordance with the present invention, oxalic acid or oxalate 
compositions are used alone or combined with one or more of the 
established HIV/AIDS medicines to work together to inhibit, impede, fight, 
or the like, the HIV virus at one or more stages of its progression or 
development. Hence, a new combination or "cocktail" therapy includes 
protease inhibitors established HIV/AIDS medicines, and oxalic acid or 
oxalate compositions. 
Also in accordance with the present invention, oxalic acid or oxalate 
compositions alone or together with established HIV/AIDS medicines can be 
used to treat the symptoms of HIV/AIDS infection including swollen lymph 
glands, fever or night sweats, weight loss, fatigue, diarrhea, skin 
problems, sores in the mouth, cough, shortness of breath, vaginal yeast 
infections, and the like. Further, oxalic acid or oxalate compositions can 
be used to treat the serious illnesses that occur with AIDS including 
pneumonia, pneumocystis carinii pneumonia (PCP), kaposi's sarcoma (KS), 
skin cancer, organ tumors, infections of the nervous system which can 
damage the brain and spinal cord, opportunistic infections, including 
fungal, parasitic, viral, and bacterial infections, tuberculosis, and the 
like. 
Also in accordance with the present invention, oxalic acid or oxalate 
compositions are used as vaccines, immunomodulators, or immunosystem 
stimulant that help strengthen the immune system, thus helping the body 
fight off HIV/AIDS infection. Further, oxalic acid or oxalate compositions 
and methods are used as antimicrobial agents, antibacterial agents, 
anti-virals, therapies, anti-infectives, anti-microbials, and anti-cancer 
drugs or agents to treat the diseases and opportunistic infections 
associated with HIV/AIDS. 
It is believed that the oxalic acid and oxalate compositions and methods of 
the present invention will help HIV/infected people and other animals to 
be able to live longer, more productive and relatively symptom-free lives. 
In accordance with another embodiment of the present invention, a solution 
or mixture has a dilute concentration of oxalic acid or oxalate as the 
solute in distilled water. Such a solution of a dilute concentration of 
oxalic acid or oxalate in distilled water can be bottled and sold as a 
health improving, disease preventing, disease treating, controlling, 
impeding, delaying, or the like agent, pharmyiaceutical, supplement, 
chemotherapy, etc. Such a dilute oxalic acid or oxalate solution can be 
administered or given to, for example, astronauts prior to space travel, 
HIV or AIDS patients, persons or other animals suffering from bacterial, 
viral, microbiological, or other conditions or diseases, cancer patients, 
tumor patients, persons subjected to high levels of radiation or electric 
fields, and the like. The concentration of oxalic acid or oxalate in the 
solution is determined by the use of the solution or disease being 
treated, controlled, impeded, delayed, and the like. 
In accordance with another embodiment of the present invention, bottled 
water, sports drinks, electrolyte solutions, fruit drinks and the like are 
improved by adding a dilute concentration of oxalic acid or oxalate 
therein. The oxalic acid or oxalate is added to either counteract some of 
the negative effects of the items contained in these drinks and/or to 
supplement or improve the healthful benefit of such drinks. 
In accordance with another aspect of the present invention, oxalic acid or 
oxalate compositions and treatments are used in canine care by dissolving 
a therapeutic quantity of oxalic acid in distilled water to form an oxalic 
acid treatment solution for treating gingivitis, tartar build-up on the 
teeth, general health of teeth and gums, and as a topical antiseptic or 
antibiotic. For example, a half dachshund and half beagle canine was 
examined and found to have a build up of tartar on the teeth and 
gingivitis active with a slight pocket with one tooth with pus. The 
canine's teeth and gums were brushed regularly with the oxalic acid 
solution for dental hygiene and was returned to the veterinarian for 
examination. 
In accordance with another example, a poodle having a torn toenail which 
has become infected received an injection of antibiotic and capsules of 
AMP-250 to be given three times daily. Also, the poodle's injured paw was 
soaked three times daily in an oxalic acid/distilled water solution the 
same strength as the dental hygiene solution. 
In accordance with still yet another embodiment of the present invention, 
it is believed that oxalic acid or oxalate compositions can be used to 
prevent strokes in humans and other animals. An Oct. 29, 1996 ABC Evening 
News Report indicated that a group of seniors over age 60 had a very low 
rate of strokes compared to the national average. This group of some 80 
people were reported to have been on a special diet high in fruit and 
vegetables which were high in potassium. The report theorized that the 
potassium was responsible for a lower level of blood pressure in the diet 
group and thus a lower incidence of strokes. In accordance with the 
present invention, it is respectfully believed that the lower incidents of 
strokes was due to oxalic acid in the special diet high in fruit and 
vegetables rather than the potassium. Potassium oxalate and potassium 
oxalate monohydrate contain large amounts of oxalic acid which in 
accordance with the present invention the oxalic acid serves as the "hall 
monitor" of the blood system keeping the blood clean of plaque and 
abnormal cells. Hence, it is believed that the high level of oxalic acid 
in the potassium rich diet high in fruit and vegetables which led to the 
very low rate of strokes compared to the national average. 
In accordance with the present invention, oxalic acid or oxalate 
compositions and methods are used to treat, prevent, impede, delay, 
control, or the like strokes in humans and other warm-blooded animals by 
administering a therapeutic quantity of oxalic acid or oxalate on a 
periodic basis, for example, daily. 
In accordance with another embodiment of the present invention, an adult 
female human has been following a diet protocol to assist in the 
absorption of calcium to prevent osteoporosis. The female has also had 
operations to remove breast tumors which also required removal of the 
thyroid gland. The following protocol is designed to take calcium 
supplements and to add oxalic acid to a normal daily diet intake. 
Calcium supplements arc taken in the morning with water only. No foods or 
beverages containing oxalic acid are taken for two hours to allow for 
maximum calcium absorption without inhibiting by oxalic acid. The normal 
diet each day allows for vegetables and beverages (such as carrots, carrot 
juice, parsley) with oxalic acid in significant amounts to assure a 
constant normal or above normal oxalic acid level in the blood to prevent 
the growth of tumors. 
An elderly adult female with severe arthritis and low level of bone mineral 
(described as looking like Swiss cheese) began following a diet protocol 
to assist in the absorption of calcium to prevent osteoporosis and to 
increase bone mineral buildup. The elderly female reduced protein intake 
and increased carbohydrate intake using corn oil as a supplement for the 
carbohydrate intake. 
In accordance with another embodiment of the present invention, an oxalic 
acid cream made up of Velvachol cream plus 10% oxalic acid solution is 
used for topical application for removing, for examples growths, lesions, 
from the skin in warm-blooded animals including dogs. 
Also, in accordance with the present invention, a liquid-subcue injection 
solution of 0.1% oxalic acid in distilled water is used for subcutaneous 
injection treatment of, for example, skin lesions, tumors, infections, and 
the like, in warm-blooded animals including dogs. 
In accordance with a particular example of the present invention, a 10% 
oxalic acid cream was used to treat a poodle. 
In accordance with another particular example of the present invention, a 
0.1% oxalic acid injection solution was used to treat a quarter horse. 
In accordance with another particular example of the present invention, a 
horse with benign skin tumors was treated by adding parsley to the feed 
and carrots separately. 
In accordance with another particular example of the present invention, a 
horse with two viral tumors was treated by treating one tumor with direct 
injection of 30 cc of a mixture of 500 miligrams oxalic acid in 500 
milliliters of distilled water, the other tumor was treated with direct 
injection of a prescription drug. 
In accordance with another particular example of the present invention, two 
adult humans are using a mouthwash mixture of 150 milligrams oxalic acid 
in 300 milliliters of distilled water as a dental cleaner. 
In accordance with another embodiment of the present invention, a mouth 
rinse, wash, mouthwash, cleanser solution, gargle, or the like, contain 
about 150 milligram of oxalic acid dihydrate (from Chem One) dissolved in 
300 milliliters of distilled water. This solution is produced by heating 
the distilled water to boiling, mixing in the 150 milligrams oxalic acid 
with the warm water to form the solution. The solution is placed in 
sterile containers for later use. 
In accordance with another embodiment of the present invention, a 
therapeutically effective form of oxalic acid or oxalate may be used in 
treating AIDS, HIV, bacterial disease, viral disease, or the like when the 
disease, condition, or symptoms have become immune to other conventional 
treatments. 
In accordance with another embodiment of the present invention, an oxalic 
acid solution of 150 milligrams of oxalic acid dihydrate dissolved in 300 
milliliters of distilled water is used as a topical agent, mouth rinse or 
wash, dental cleanser, or the like for treating the flu, common cold, sore 
throat, bronchitis, and other infections, viral or bacterial diseases. 
The second weekend of November, 1997, a woman properly in her early 60's 
agreed that she would go on the oxalic acid diet of the present invention 
as near to 100% as possible. She had cancer of the pancreas and the liver. 
In both of these cancers, her prognosis was very poor. This woman had been 
through the conventional treatments and nothing more held any hope for 
her. At the time she started on the diet, she was showing a very slight 
yellowing of the skin. On Jan. 26, 1998, there was a call from a gentleman 
to report that she is doing just great. Her color has returned to normal, 
a very recent test showed the liver at 60% of normal and the tumors are in 
regression and her blood is clean. She told the gentleman who called to 
say she had passed the 600 pound mark of carrots. One more success for the 
present invention. 
In accordance with another embodiment of the present invention, astronauts 
and other space travellers who will be subjected to extreme magnetic 
forces, radiation, solar radiation, and the like, are given an effective 
amount of a therapeutically effective form of oxalic acid or oxalate prior 
to, during, and after space travel to maintain normal or above normal 
oxalic acid blood levels and thereby counteract the decomposition of 
oxalic acid caused by space travel, exposure to radiation, and the like. 
A man described a condition currently existing with his one year old child 
which sounded like the typical child's persistent low level cold. Mild 
chest congestion that would interfere with normal breathing at night, 
congested cough in the morning and persistent runny nose. We talked about 
what might help relieve the cold and discussed the possibility of a small 
amount of freeze-dried parsley placed in the child's mouth to work as a 
decongestant and an anti-viral biotic, It was agreed that having the child 
take a small amount of the parsley without water before going to sleep 
would be an effective way of providing oxalic acid without any side 
effects. 
He called on October 24 to tell me that on the 18th he did have success 
with having his daughter eat with him a small amount of the dried parsley 
and has done so each night since the 18th. There is no more congestion or 
running nose and the child is sleeping peacefully through the night. We 
agreed that lie should discontinue the procedure to avoid irritating the 
membrane of the mouth or throat. And if the symptoms do not return in the 
next couple of days the viral infection was cleared. 
We also discussed his using the procedure with an amount of 2 teaspoons 
every third night during the flu season as a protective measure. 
An adult male who has Hepatitis C has recently started on a high oxalic 
acid diet and trying hard to avoid the blockers. He has been infected for 
some time and knows the symptoms preceding the times when he has periods 
of effects from the virus. With careful monitoring, we will be able to 
tell if the oxalic acid is having the effect of killing the virus by 
either the period between attacks are longer or the effects themselves are 
less severe, or both. 
Also, his wife was diagnosed with viral pneumonia by X-ray examination. She 
was given antibiotics to ward off infections because of a weakened immune 
system. On Friday, September 26, she was provided the mouthwash of 150 mg 
of oxalic acid (OA) in 300 ml of distilled water. She started the 
recommended procedure of approximately 2 teaspoons of wash, holding in 
mouth for 2 minutes then gargle, spit out wash, then rinsing mouth at 
least twice with warm tap water. The procedure was repeated first thing in 
the morning immediately after rising and before anything else was put in 
mouth. It was done mid-day with nothing in mouth one hour prior to wash. 
At night, the procedure was repeated as the last item before retiring. By 
Sunday afternoon, the wife experienced nearly complete relief from the 
effects of the viral pneumonia. 
The following is a procedure using a mouth rinse of distilled water with 
oxalic acid dihydrate in solution. The rinse is used to brush the teeth 
and dentures to remove tartar and eliminate bacteria in the mouth and 
gums. The procedure being followed is, each morning immediately after 
rising, a small amount of solution (approximately 2 teaspoons) is held in 
the mouth and swished around teeth for a minimum of 2 minutes, removable 
dentures are removed, retaining maximum amount of rinse in mouth, teeth 
are then brushed outside and inside, specifically between teeth and at gum 
line, and the tongue is brushed. The rinse is then discarded and the mouth 
flushed 2 or more times with tap water. A denture brush is then used to 
clean the denture. Full dentures, upper and lower, may be cleaned using 
the rinse then removing the dentures to clean. Initially, the solution was 
500 mg oxalic acid, 500 ml distilled water, gradually reduced to 250 mg 
oxalic acid in 500 ml distilled water. 
George, an adult male, is a special case because he has just finished his 
first week of radiation and chemotherapy treatments at the Mayo Clinic, 
Rochester MN. He has a malignant tumor about grape size by an inner ear at 
the back of the skull. He receives 15 seconds of radiation from each side 
of his face and 30 seconds through the back of his throat and he will 
receive the treatment for 7 weeks, 5 treatments per week, with 6 
chemotherapy treatments spaced through the same period. George started the 
oxalic acid diet on October 9, had his first radiation on October 14, and 
began the oxalic acid rinse procedure on October 25. George is keeping a 
detailed log of his diet and will document any side effects and will ask 
the doctors each week about the progress in eliminating the tumor. I 
believe the tumor will be reduced more rapidly than the rate calculated by 
the radiologist and the doctor. 
A very significant item happened Thursday. October 24. On the evening news, 
there was an announcement that in clinical testing, nicotine may remove 
plaque in the brain and may reduce the effects of loss of memory of 
Alzheimer victims. We describe that oxalic acid may remove plaque from the 
blood. It is reported in Oxalic Acid in Biology and Medicine that tobacco 
contains oxalic acid. 
On Apr. 4, 1997, I had a visit with two gentlemen, Ken and his friend, Jon. 
They found out about the present research on oxalic acid. Jon had bone 
cancer and wanted the diet information. I told them I would not provide it 
unless they were willing to spend the time to not only listen, but to read 
the applicable research data also. They agreed. We spent 4 hours reviewing 
the data, and in questions and answers. Jon's bone cancer was verified by 
MRI and he had just previously had the first chemo treatment from his 
oncologist. And, in his words, "very painful and debilitating", and he did 
not want to take any more if it could be avoided. He was provided with the 
diet and lists of food and drink with oxalic acid, and list of foods with 
B6. Also, he was given a large container of Tone's dried parsley, cans of 
carrots and beets and advised to start immediately on the diet. In fact, 
while we were continuing to talk, he started eating the parsley and 
washing it down with distilled water. 
I then called Jon each subsequent Saturday morning to check on his feelings 
and to remind him of the diet, specifically the blockers. He delayed a 
scheduled second treatment and did tell his doctor he was on a diet, not 
what diet, and he wanted to see the results. He scheduled an MRI for the 
May 16. I called him May 17 and he was a very happy person. The 
technician, in Jon's words, "could not find the spots he was looking for". 
Another MRI was done later the afternoon of the 16th, with a higher 
radiation factor. Following the second MRI the technician told Jon, he 
could not give him the results, the "developer had troubles". The trouble 
was, he still could not find the spots and wanted to tell the oncologist 
first. 
I called Jon later and heard in his words "the SPOTS ARE GONE". His 
oncologist tried to get him to take another chemo treatment, saying the 
cancer had probably metastasized. 
He is continuing on the diet to make sure the blood is clean and the oxalic 
acid blood level is increased, and once a week will just before retiring 
with nothing taken for one hour before, take a calcium supplement to build 
up bone minerals. 
On CNN Prime Time News, there was a very short news item about a recent 
study that showed people with strong bones had a higher incident of cancer 
than people with weak bones. 
The study is very significant because oxalic acid inhibits calcium 
absorption by the body. High calcium absorption is necessary for 
development and maintenance of strong bones, and would not be possible if 
the body was high in oxalic acid. However, high oxalic acid in the body 
system would not only inhibit calcium absorption but also would prevent 
the development of cancer. 
Too high levels of oxalic acid could mean weak bones and osteoporosis. 
First, my dog Missy, half dachshund and half beagle, had a dental exam and 
found to have a build up of tartar on the teeth and gingivitis active with 
a slight pocket by one tooth with pus. Her teeth and gums will be brushed 
daily with the solution used for human dental hygiene and returned to the 
veterinarian for examination weekly. 
Second, my poodle, Turk, had a torn toenail which had become infected. He 
received an injection of an antibiotic, and capsules of Amp-250 to be 
given 3 times daily. Also, his injured paw will be soaked 3 times daily in 
an oxalic acid solution the same strength as the dental hygiene solution. 
During the week following May 16, 1996, an adult female who is assisting me 
in documenting the history of my discovery, has been following a diet 
protocol as follows to assist in the absorption of calcium to prevent 
osteoporosis. She has also had operations to remove breast tumors which 
also required removal of the thyroid gland. The protocol is designed to 
add calcium supplements to a normal daily diet intake. 
Calcium supplements are taken in the morning with water only. No foods or 
beverages containing oxalic acid are taken for 2 hours to allow maximum 
calcium absorption without inhibiting by oxalic acid. The normal diet each 
day allows for vegetables and beverages with oxalic acid in significant 
amounts to assure a constant normal or above oxalic acid level in the 
blood to prevent the growth of tumors. 
On Sep. 20, 1996, her mother with severe arthritis and low level of bone 
mineral (described as looking like Swiss cheese) was started on the above 
protocol as related to calcium and oxalic acid to increase bone mineral 
build up and was advised to reduce protein intake and increase 
carbohydrate intake using corn oil as a supplement for the carbohydrate 
intake. 
I received another call from a woman who went on the oxalic acid diet Jan. 
3, 1998 because there is an unidentified mass in her breast. She called 
today to tell me that she was diagnosed a year ago last October (1997) 
with diverticulitis and has had irritable bowel syndrome most of her life. 
She has not had attacks from eating foods now that before would cause 
diverticula attacks prior to starting on the diet. Her husband has been 
troubled for years with reflux from a hiatal hernia and constantly 
consumed Rolaids. He went on the oxalic acid diet with his wife to lose 
some weight and has discovered the reflux has disappeared and he has 
stopped using Rolaids. Oxalic acid must be clearing up any bacteria in 
both husband and wife. This stuff is amazing. 
The present invention is directed to oxalic acid or oxalate compositions 
and methods and formula for producing such compositions and for the 
utilizing oxalic acid or oxalate compositions including solutions, 
mixtures, products, creams, rinses, and the like, in the management, 
control, prevention, or the like, of infectious bacterial and infectious 
viral diseases or conditions in humans and other animals. 
Even though a viral origin for cancer has not been demonstrated in man, the 
inventor conducted investigative research on oncogenic viruses and their 
relationship to man, during development of U.S. patent application Ser. 
No. 08/629,538. Medical Microbiology by Jawets, Melnick & Adelbert, 8th 
Edition, 1968, writes on the general properties of tumor viruses. The 
tumor inducing viruses can be classified into two main groups, those which 
contain RNA as their generic material and those that contain DNA. DNA 
papilloma viruses as benign warts and molluscum contagiosum have been 
classed as natural tumors in man and serve as models in the quest for 
knowledge of viral carcinogenesis in man. 
When the inventor discovered the bactericidal activity of oxalic acid in 
the gingivitis reduction in his pet dog. The entire spectrum of the effect 
of oxalic acid in application for infectious bacterial and infectious 
viral conditions was studied, and many case studies were conducted with 
human volunteers among his peers. The observed interaction of oxalic acid 
and the infectious bacteria and infectious virus during these studies 
reveals that oxalic acid is indeed bactericidal and viricidal. It is 
stated in Medical Microbiology that the fundamental principal of 
chemotherapy is the principal of selective toxicity, which bay be stated 
as follows, "In order to be useful for systemic treatment of infectious 
disease, a substance must be harmful to parasites but relatively innocuous 
to host cells." 
Oxalic acid as a natural chemotherapy meets the stated principle. It can be 
administered at therapeutically acceptable levels sufficient to kill the 
bacterial and viral organisms and be completely innocuous to the host 
cells. Oxalic acid can be administered at the therapeutically acceptable 
levels for the time necessary to kill the organisms without any effect on 
host cells. It is believed that oxalic acid penetrates the encasing shell 
of the host cell and kills the viral nucleic acid core. 
In accordance with the present invention, antimicrobial oxalic acid or 
oxalate compositions and methods of treatment of warm-blooded animals 
including humans and pets is provided which includes at least one 
therapeutically effective form of oxalic acid or oxalate for controlling 
treating, or managing bacterial diseases and viral diseases caused by 
germs of infectious bacteria and infectious virus. The present invention 
encompasses treatment of the following: Bacterial diseases caused by 
Gram-Positive Cocci such as Staphylococcal infections of Pneumonia, 
Bacteremia, Osteomyelitis, Enterocolitis, and the like. Streptococcal 
infections such as Hemolytic, Viridans, Enterococci, Lactic, and the like. 
pneumococcal infections such as Pneumonia, Sinusitis, Otitis, Meningitis, 
and the like. Also bacterial diseases caused by Gram-Negative Cocci, 
Neisseria Aerobic infections such as Meningococcus, Gonococcus, and the 
like. Also bacterial diseases caused by Gram-Positive Bacilli infections 
such as Erysipelothricosis, Listeriosis, Anthrax, Nocardiosis, and the 
like. 
Also bacterial diseases caused by Gram-Negative Bacilli infections such as 
Enterobacteriaceac Salmonella, Shigellosis, Hemophilus, Tularemia, Plaque, 
Melioidosis, Bartonellosis, Campylobacter, and Noncholera Vibrio, and the 
like. Also bacterial diseases caused by Anaerobic Bacilli infections such 
as Clostridium Botulinum, Clostridium Tetany, Clostridia of Gas Gangrene 
Bacteroides, Mixed Anaerobic, Actinomycosis, and the like. 
Also diseases caused by Mycobacteria, infections such as Tuberculosis and 
Leprosy, and the like. 
Also bacterial diseases caused by Spirochetes such as Leptospirosis Lyme 
Disease, and Endemic Treponematoses. 
Further in accordance with the present invention, oxalic acid or oxalate 
composition and methods of treatment for infectious nucleic acid type 
Viral diseases such as deoxyribonucleic acid types (DNA), and ribonucleic 
acid (RNA), with natural cycle chiefly in humans, spread by 
person-to-person contact, and transmitted from nature to man and may also 
infect animals. Also, diseases such as Human Immunodeficiency Virus 
infection (HIV) and Acquired Immunodeficiency Syndrome (AIDS). 
Also Respiratory Tract Viral diseases, all serotypes, caused by Influenza, 
A, B, and C, Parainfluenza viruses 1-4, Rhonoviruses (common cold), Mumps 
virus, Adenoviruses, Reoviruses, and Epstein-Barr virus, and Infants and 
Adult Syncytial virus, also primary Atypical pneumonias and others. 
Also Nervous System Viral diseases, all serotypes, such as Polioviruses, 
Coxsackieviruses, Echoviruses and high numbered viruses, Epidemic 
gastroenteritis viruses, Rubeola virus, Rubella virus, Varicella-zoster 
virus, Herpes simplex, Human herpes virus type 6, Human Parvovirus B19, 
Cytomegalovirus, Hepatitis viruses Types A, B, C, D, Human Papillomavirus, 
Molluscum contagiosum virus, and also viruses transmitted from nature to 
man such as the Arboviruses, togaviruses, alphaviruses, flaviviruses, 
bunyaviruses, and the Orbivirus, Rabies virus, Herpesvirus simiae, 
Arenaviruses, Filoviruses, and the like. 
By way of general definition, "cancer" is any of various malignant 
neoplasms, a "tumor" is a neoplasm or abnormal growth of tissue, and a 
"neoplasm" is an abnormal new growth of tissue, or a tumor. Hence, it is 
respectfully believed that the words neoplasm and tumor are essentially 
synonymous and that a cancer is essentially any of various malignant 
neoplasms, tumors, or growths. 
As described in the present application, oxalic acid in one of its 
beneficial forms was used in connection with the treatment, management, 
control, or the like of a growth on a thigh, a growth on an eyebrow, 
polyps, abdominal cancer, bladder cancer, prostate cancer, mouth tumor, 
melanoma (skin cancer), oral tumor, cervical cancer, brain tumor, lymph 
node tumors, uterine tumor, bone cancer, stomach cancer, and breast 
cancer. Further, as described in the Examples of the present application, 
oxalic acid in one of its beneficial forms is used in connection with the 
treatment, control, management, or prevention of tumors, brain tumors, 
cancers, neoplasia, acne, skin cancer, growths, breast cancer, cervical 
cancer, and the like. It is respectfully believed that oxalic acid in one 
of its therapeutic forms is a natural chemotherapy which can be used to 
treat all types of tumors, growths, neoplasms, infectious bacterial or 
viral diseases, and the like, in warm-blooded animals, regardless of 
location or classification thereof. The oxalic acid diet of the present 
invention provides a natural chemotherapy which has been beneficial in the 
treatment, control, management, or prevention of growths, tumors, cancers, 
leukemia, bronchitis, and bacterial and viral infections, In other words, 
it is believed that oxalic acid in one of its therapeutic forms is a 
general or non-selective chemotherapeutic or chemopreventive agent, 
factor, or compound. In a recent Cancer Treatments publication, 
"chemoprevention" is described as an exciting new area of pharmaceutical 
cancer research that focuses on the prevention of cancer through a diverse 
group of natural and synthetic agents. It is respectfully believed that 
this publication indicates that chemoprevention is new and that prior to 
the invention by Applicant, one of ordinary skill in the art would not 
have known of the use of oxalic acid as a chemoprevention and it would not 
have been obvious to use oxalic acid as a chemoprevention. 
Further, if the use of oxalic acid as a cancer treatment or cure were known 
prior to the invention by Applicant, why will more than 1.3 million cases 
of cancer be diagnosed this year, why has over a trillion dollars been 
spent on trying to find a cure for cancer, and why did the U.S. commit 
itself to waging a "war" on cancer with the National Cancer Act of 1971. 
As described in the recent Cancer Treatments publication, a so-called 
"magic bullet"-a single medicine or treatment-that will cure cancer has 
not been found. Applicant respectfully believes that oxalic acid in one of 
its therapeutic forms may be the "magic bullet" that is being sought and 
may improve and extend lives when it is used as described in the present 
application. Although the activity of oxalic acid is not completely 
understood, Applicant respectfully believes that oxalic acid attacks the 
nucleic acid center of tumor, cancer, neoplasm, or growth cells or tissues 
and thereby kills or prevents the growth of the tumor, cancer, neoplasm, 
growth, or the like, Applicant respectfully believes that warm-blooded 
animals including humans, dogs, cats, horses, and the like will benefit 
from the use of oxalic acid in one of its therapeutic forms as described 
in the present application including as a composition, nutritional 
supplement, diet, food additive, dental prophylactic, preventative, 
control factor, treatment agent, or the like. 
Even further, in accordance with the present invention, it is contemplated 
that many different oxalic acid or oxalate containing compounds, foods, 
vegetables, and the like may be used in the controlling, managing, 
treatment, prevention, or the like of neoplasms, neoplasia, cancers, 
tumors, growths, abnormal cells and tissues, infectious bacterial or viral 
diseases, and the like. For example, oxalic acid dihydrate, dried parsley, 
dried chives, foods containing these items, nutritional supplements 
containing these items, juices such as carrot juice containing these 
items, and combinations thereof may be used to provide the desired 
chemotherapeutic affect. 
Applicant respectfully believes that oxalic acid in at least one of its 
therapeutically effective forms is a general, nonselective, 
chemotherapeutic or chemopreventive agent, factor, or compound and has 
described numerous compositions, methods, protocols, regimens, diets, 
nutritional supplements, rinses, washes, topical ointments, and the like 
for supplying oxalic acid in an effective amount and a beneficial form to 
a warm-blooded animal including humans and pets. 
The following are illustrative examples of methods, formulations and 
compositions according to the present invention. Although the examples 
utilize only selected compounds and formulations, it should be understood 
that the following examples are illustrative and are not limiting. 
Therefore, any of the aforementioned oxalic acids, oxalate, or related 
compounds may be substituted according to the teachings of the present 
invention in the following examples. 
EXAMPLE 1 
A therapeutic composition in the form of a nutritional supplement or 
multi-vitamin tablet containing an effective amount of oxalic acid, 8 
grams (gr) or less, preferably 500 milligrams (mg) or less of oxalic acid, 
together with conventional ingredients such as vitamins and minerals. 
EXAMPLE 2 
A treatment regimen or method including the oral administration of one such 
tablet, pill, multi-vitamin or supplement of Example 1 daily. 
EXAMPLE 3 
The therapeutic composition of Example 1 including 1 gram or less, 
preferably 500 milligrams or less of oxalic acid, together with 
conventional quantities of other vitamins and minerals except that one or 
more of the oxalic acid blockers, including vitamin C, vitamin B6, 
calcium, citric acid, alcohol,. resin, and the like are reduced or 
eliminated altogether from the pill, vitamin, multi-vitamin, supplement, 
etc. 
EXAMPLE 4 
A therapeutic composition containing oxalic acid as a topical skin 
treatment includes a mixture of 5 grams or less of oxalic acid, 40 
milliliters distilled water, and 5 milliliters propylene glycol. 
EXAMPLE 5 
The topical skin treatment composition of Example 4 serves as an exfoliate, 
anti-bacteria treatment, infectious skin bacteria disease treatment, 
infectious skin virus disease treatment, or combinations thereof. 
EXAMPLE 6 
A composition rinse, or gargle for rinsing the interior surfaces of the 
mouth and throat made of a dilute solution of oxalic acid in distilled 
water, preferably less than 500 mg of oxalic acid in 300 ml of distilled 
water. 
EXAMPLE 7 
A method of treating humans for the treating, controlling and managing 
mouth and throat bacteria and virus infections using the mouth rinse and 
throat gargle of Example 6. 
EXAMPLE 8 
A method of treating warm-blooded animals including the steps of testing 
the blood or urine oxalic acid or oxalate levels, administering an 
effective amount of oxalic acid, oxalate or blockers thereof, and 
monitoring the levels to determine if adjustments are necessary to achieve 
a desired level. 
EXAMPLE 9 
A single medicine, "silver bullet" or "magic bullet", composition for 
controlling, treating or managing infectious or pathogenic bacterial and 
viral disease, and the like, for preventing the spread or for otherwise 
therapeutically treating warm-blooded animals including pets and humans 
and including an effective amount of at least one therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 10 
The composition as described in Example 9 wherein the therapeutically 
effective form of oxalic acid or oxalate is selected from the group of 
oxalic acid in a free acid, ester, lactone or salt form, oxalate including 
sodium oxalate, a nutritional supplement containing at least one form of 
oxalic acid or oxalate, oxalic acid dihydrate, anhydrous oxalic acid, 
oxamide, oxalate salts, and combinations thereof. 
EXAMPLE 11 
The composition as described in Example 9 wherein the composition is oxalic 
acid dihydrate. 
EXAMPLE 12 
The composition as described in Example 9 further having a pharmaceutically 
acceptable carrier or diluent for the therapeutically effective form of 
oxalic acid or oxalate. 
EXAMPLE 13 
The composition a described in Example 12 wherein the carrier or diluent is 
at least one of a gel cap and distilled water. 
EXAMPLE 14 
A method for controlling, treating, or managing infectious or pathogenic 
bacterial or viral disease in warm-blooded animals including pets and 
humans having the steps of periodically administering a therapeutically 
effective dosage of the composition of Example 9. 
EXAMPLE 15 
The method as described in Example 14 wherein the composition is 
administered orally or sublingually in at least one of a gel cap, tablet, 
powder, food additive, food, drops, liquid, beverage, pill, and capsule 
form. 
EXAMPLE 16 
The method as described in Example 14 wherein the composition is 
administered by injection including venous injection, injection into the 
bacteria or virus infected tissue and/or injected adjacent to the 
bacterial or virus infected tissue. 
EXAMPLE 17 
The method as described in Example 14 wherein the composition is 
administered topically by at least one of transdermal patch, ointment, 
salve, cream lotion, gel, solution, and the like. 
EXAMPLE 18 
The method as described in Example 14 wherein the composition is 
administered internally by at least one of inhalation, suppository, or 
subcutaneous deposit. 
EXAMPLE 19 
The method described in Example 14 wherein the composition is administered 
at least once a day at a dosage of 50 mg to 6 g for humans or 1 mg to 3 g 
for pets. 
EXAMPLE 20 
The method as described in Example 14 further having the steps of reducing 
the intake of oxalic acid or oxalate blockers and/or increasing the intake 
of oxalic acid or oxalate enhancers. 
EXAMPLE 21 
The method as described in Example 20 wherein the blockers are selected 
from the group of citric acid, ascorbic acid, pyridoxine hydrochloride, 
calcium, alcohol, resins, clays, and combinations thereof. 
EXAMPLE 22 
The method as described in Example 20 wherein the blockers are selected 
from the group of dairy products containing calcium, fruits, coconut, 
beverages containing alcohol, ascorbic acid or citric acid including 
beverages such as beer, wine, vodka, gin, and the like, fruit juice based 
beverages, soda pop or soft drinks containing ascorbic acid or citric 
acid, other sports drinks, beverages or refreshments containing ascorbic 
acid or citric acid, red meats, or white meat of fowl including chicken, 
turkey, pheasant and the like containing pyridoxine, or other foods or 
beverages containing alcohol, citric acid, ascorbic acid or pyridoxine 
hydrochloride including breads or grains, resins, and combinations 
thereof. 
EXAMPLE 23 
A diet for treating, controlling, and managing or preventing infectious 
bacterial or viral disease and the like in warm-blooded animals including 
pets and humans having the steps of adding to the regular diet a dietary 
supplement of an effective amount of at least one therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 24 
The diet as described in Example 23 wherein the effective form of oxalic 
acid or oxalate is selected from the group of oxalic acid in a free acid, 
ester, lactone, or salt form, oxalate including sodium oxalate, a 
nutritional supplement containing at least one form of oxalic acid or 
oxalate oxalic acid dihydrate, anhydrous oxalic acid, oxamide, oxalate 
salts, natural or processed foods including plants or vegetables including 
parsley, chives, garlic, beets, carrots, spinach, and the like containing 
at least one form of oxalic acid or oxalate, beverages, liquids or juices 
such as carrot juice containing at least one form of oxalic acid or 
oxalate, and combinations thereof. 
EXAMPLE 25 
The diet as described in Example 23 further having the steps of reducing 
the intake of oxalic acid or oxalate blockers. 
EXAMPLE 26 
The diet as described in Example 25 wherein the blockers are selected from 
the group of dairy products containing calcium, fruits, coconut, beverages 
containing alcohol, ascorbic acid, or citric acid including adult 
beverages such as beer, wine, vodka, gin, and the like, fruit juice based 
beverages, soda pop or soft drinks containing ascorbic acid or citric 
acid, other sports drinks, beverages or refreshments containing ascorbic 
acid or citric acid or pyridoxine hydrochloride including breads or 
grains, resins, and combinations thereof. 
EXAMPLE 28 
A single medicine veterinary composition for controlling, treating or 
managing infectious bacterial or viral disease and the like, preventing 
reinfection or for otherwise therapeutically treating warm-blooded animals 
including cats, dogs, horses, cattle, or the like, including an effective 
amount of at least one therapeutically effective form of oxalic acid or 
oxalate. 
EXAMPLE 29 
The veterinary composition as described in Example 28 wherein the 
therapeutically effective form of oxalic acid or oxalate is selected from 
a group of oxalic acid in a free acid, ester, lactone or salt form, 
oxalate including sodium oxalate, a nutritional supplement containing at 
least one form of oxalic acid or oxalate, oxalic acid dihydrate, anhydrous 
acid, oxamide, oxalate salts, natural or processed foods including molds, 
plants or vegetables including parsley, chives, garlic, beets, carrots, 
spinach, and the like containing at least one form of oxalic acid or 
oxalate, beverages, liquids or juices containing at least one form of 
oxalic acid or oxalate, additives containing at least one form of oxalic 
acid or oxalate, and combinations thereof. 
EXAMPLE 30 
The veterinary composition as described in Example 29 wherein the 
composition is oxalic acid dihydrate. 
EXAMPLE 31 
The veterinary composition as described in Example 29 wherein the 
composition is at least one of carrots, boiled carrots, and parsley. 
EXAMPLE 32 
The veterinary composition as described in Example 29 further having a 
pharmaceutically acceptable carrier or diluent for the therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 33 
The veterinary composition as described in Example 32 wherein the carrier 
is a gel cap or distilled water. 
EXAMPLE 34 
A veterinary method for controlling, treating, or managing infectious or 
pathogenic bacterial and viral disease in warm-blooded animals including 
dogs and cats having the steps of periodically administering a 
therapeutically effective dosage of the veterinary composition of Example 
29. 
EXAMPLE 35 
The veterinary method as described in Example 34 wherein the composition is 
administered orally or sublingually in at least one of gel cap, tablet, 
powder, food additive, food, beverage, pill and capsule form, by injection 
including venous injection injected into the infected area or injection 
adjacent to the infected area, topically by at least one of transdermal 
patch, ointment, salve, cream, lotion, gel, solution, and the like, 
internally by inhalation, suppository or subcutaneous deposit, or 
combinations thereof. 
EXAMPLE 36 
The veterinary method as described in Example 34 wherein the composition is 
administered at least once a day at a dosage of about 1 mg to 3 g for dogs 
and cats. 
EXAMPLE 37 
The veterinary method as described in Example 34 further having the steps 
of reducing the intake of oxalic acid or oxalate blockers. 
EXAMPLE 38 
The veterinary method as described in Example 37 wherein the blockers are 
selected from the group of citric acid, ascorbic acid, pyridoxine 
hydrochloride, calcium, alcohol, resins, clays, and combinations thereof. 
EXAMPLE 39 
A therapeutic composition in cream or ointment form for topical 
administration of oxalic acid or oxalate having an effective amount of at 
least one therapeutically effective form of oxalic acid or oxalate, a 
solvent, and a cream or ointment base. 
EXAMPLE 40 
The therapeutic composition as described in Example 39 wherein the solvent 
is distilled water, acetone, propylene glycol, or polysorbate, and the 
base is a cream, ointment, gel, lotion, spray, stick, or powder. 
EXAMPLE 41 
A method of producing the therapeutic composition as described in Example 
39 having the steps of mixing a dilute concentration of at least one 
therapeutically effective form of oxalic acid or oxalate with a solvent 
such as distilled water, acetone, propylene glycol, polysorbate, or the 
like to form a solution, mixing the solution with a base such as a 
hydrophilic petrolatum, cream, ointment, gel, lotion, spray, stick powder 
or other base. 
EXAMPLE 42 
In pet food, the improvement of the addition of a therapeutically effective 
quantity of at least one therapeutically effective form of oxalic acid or 
oxalate. 
EXAMPLE 43 
In pet food, the improvement of the elimination or reduction of oxalic acid 
or oxalate blockers. 
EXAMPLE 44 
A method of treating infectious or pathogenic microbial, bacterial and 
viral disease, and the like including the steps of reducing or eliminating 
the ingestion or administration of oxalic acid or oxalate blockers, 
administering or ingesting high dosages of oxalic acid or oxalate to raise 
the blood or urine oxalic acid or oxalate level above normal, and, after 
cleansing the infectious microbial, bacteria or virus infected blood, 
reducing or eliminating the administration or ingestion of oxalic acid or 
oxalate to maintain a normal blood or urine oxalic acid or oxalate level. 
EXAMPLE 45 
A therapeutic composition for purifying the blood, controlling, treating or 
eradicating infectious or pathogenic microbial, bacterial or viral disease 
from the cardiovascular system or in the brain, and maintaining good 
cardiovascular health and operation, having a therapeutically effective 
amount of at least one therapeutically effective form of oxalic acid or 
oxalate. 
EXAMPLE 46 
An oral rinse, wash or gargle for controlling, treating or managing 
infectious bacterial or viral disease, and the like, for preventing new 
infections of bacterial or viral disease, or for otherwise therapeutically 
treating the mouth area, made up of a dilute solution of an effective 
amount of at least one therapeutically effective form of oxalic acid or 
oxalate. 
EXAMPLE 47 
A composition for treating parvo virus in animals including canines of a 
therapeutically effective amount of at least one therapeutically effective 
form of oxalic acid or oxalate. 
EXAMPLE 48 
A pharmaceutical composition to be administered orally to humans of a 
mixture of a non-toxic ingestible carrier and an effective amount of a 
therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 49 
The pharmaceutical composition as described in Example 48 wherein the 
composition is provided in a form selected from the group of pills, 
powders, granules, tablets, micro capsules, gel capsules nutritional 
supplements, processed foods, liquids, drops, beverages, additives, and 
solutions. 
EXAMPLE 50 
A Protocol for Treatment of Canine, Equine, Feline Species for the Control 
of Infectious Bacterial and Viral Disease 
Prior to the commencement of Protocol, a complete examination should be 
accomplished by the attending veterinarian. The examiner should complete 
and record the following: History since onset of the bacterial disease or 
virus infection based on owner's description; Specific diet to include all 
treats, and liquid intake; general activity level during previous period; 
age; weight; general examination; blood analysis; and urine analysis. 
Thereafter, administering the veterinary composition of at least one of 
Examples 28-33 by the method of at least one of Examples 34-38. 
EXAMPLE 51 
A method of treating animals using oxalic acid or oxalate in place of 
general antibiotics by administering at least one therapeutically 
effective form of oxalic acid or oxalate continuously to the patient in 
decreasing amounts to treat, control, and manage infectious bacterial and 
viral disease, and the like without deleteriously affecting normal cells. 
EXAMPLE 52 
A method of enhancing the beneficial effects of oxalic acid or oxalate in 
animals including humans and pets including the steps of eliminating the 
use of strong magnetic fields or radiation in the examination, treatment 
or diet (heating of food or drink) of the animal to prevent decomposition 
or reduction in the amount of oxalic acid or oxalate during treatment. 
EXAMPLE 53 
A mouthwash, gargle or oral rinse containing a dilute solution of oxalic 
acid and having a pH of 2.67. 
EXAMPLE 54 
The mouthwash, gargle or oral rinse of Example 53 containing a dilute 
solution of 150 mg of oxalic acid dihydrate per 300 ml of distilled water. 
EXAMPLE 55 
A method of treating terminally ill animals including humans including the 
steps of administering a high dosage of oxalic acid or oxalate to cleanse 
the blood and treat the condition or disease. 
EXAMPLE 56 
The method of Example 55 further including the steps of stopping other 
chemical or radiation treatments to prevent weakening of the body and 
prevent the decomposition or reduction of oxalic acid or oxalate in the 
body. 
EXAMPLE 57 
The method of Example 55 further including the steps of reducing the dosage 
of oxalic acid or oxalate after the blood has been cleansed and the 
condition or disease has improved. 
EXAMPLE 58 
The method of Examples 55, 56, 57, further including the steps of reducing 
the intake of oxalic acid or oxalate blockers and increasing the intake of 
oxalic acid or oxalate enhancers. 
EXAMPLE 59 
A therapeutic composition for the treatment of infectious or pathogenic 
microbial, bacterial, viral or other disease, cancers, neopiasms, or 
tumors is made up of freeze-dried parsley with a rounded tablespoon of 
freeze-dried parsley providing about 1 gram of oxalic acid. 
EXAMPLE 60 
A sufficient quantity of dried parsley is administered daily to provide the 
desired therapeutic effect and produce or maintain a desired blood oxalic 
acid or oxalate level for preventing, controlling, or treating infectious 
bacterial, viral or microbial disease, neoplasms, cancers, tumors, or the 
like. 
EXAMPLE 61 
A relatively large adult male human having an inoperable brain tumor is 
administered 4 tablespoonfuls of dried parsley daily, providing 
approximately 4 grams of oxalic acid per day, until the growth of the 
tumor is checked. Thereafter, he is administered 1 tablespoonful of dried 
parsley daily, or approximately 1 gram of oxalic acid per day. 
In addition to the administration of the dried parsley, his intake of 
oxalic acid blockers including calcium, pyridoxines, citric acid, ascorbic 
acid, alcohol, or combinations thereof is reduced. 
EXAMPLE 62 
A therapeutic composition for treating infectious or pathogenic microbial, 
bacterial, viral, or other disease, neoplasms, tumors, cancer, neoplasia, 
and the like, is made up of pure carrot juice which is administered orally 
in 2 ounce servings to provide between 4 and 6 ounces of carrot juice 
daily to provide the desired therapeutic effect and desired oxalic acid or 
oxalate blood or urine level. 
EXAMPLE 63 
The carrot juice of Example 63 is mixed with other juices and flavoring 
agents such as tomato juice, salt, pepper, parsley, and/or celery to 
enhance the flavor thereof. 
EXAMPLE 64 
A therapeutic composition in the form of a nutritional supplement or 
multi-vitamin, multi-mineral tablet containing a small quantity of oxalic 
acid, preferably 500 milligrams or less of oxalic acid, together with 
conventional ingredients such as vitamins and minerals. 
EXAMPLE 65 
A treatment regimen or method including the oral administration of one such 
tablet, pill, multi-vitamin, or supplement of Example 64 daily. 
EXAMPLE 66 
The therapeutic composition of Example 64 including 8 grams or less, 
preferably 500 milligrams or less oxalic acid, together with conventional 
quantities of other vitamins and minerals except that one or more of the 
oxalic acid blockers, including vitamin C, vitamin B6, calcium citric 
acid, resins, and the like, are reduced or eliminated altogether from the 
pill, vitamin, multi-mineral, supplement, etc. 
EXAMPLE 67 
Another therapeutic composition contains an effective amount of oxalic acid 
together with conventional pet foods. 
EXAMPLE 68 
A conventional pet food mixture is mixed with oxalic acid in sufficient 
quantity to provide the desired therapeutic effect. For example, 3 grams 
or less, preferably 500 milligrams or less of oxalic acid dihydrate is 
mixed with a single serving quantity or portion of dog food or cat food to 
provide a daily dosage of 3 grams or less, preferably 500 milligrams or 
less of oxalic acid (see Table XII). 
EXAMPLE 69 
The therapeutic composition of the above example except that one or more 
ingredients in pet food which are oxalic acid blockers are eliminated or 
reduced in quantity from that of conventional pet food. For example, the 
quantity of vitamin B6, vitamin C, calcium, citric acid, or combinations 
thereof are reduced or eliminated from conventional pet food in addition 
to the admixture of oxalic acid dihydrate. 
EXAMPLE 70 
A therapeutic composition in the form of a pet food that includes a 
conventional pet food mixed with a source of oxalic acid or oxalate such 
as carrot juice, carrots, parsley, chives, or combinations thereof to 
provide a pet food having an oxalic acid content of 3 grams or less, 
preferably 500 milligrams or less of oxalic acid per daily serving of pet 
food. 
EXAMPLE 71 
A therapeutic composition containing oxalic acid as a topical skin 
treatment includes a mixture of 5 grams or less of oxalic acid, 40 
milliliters distilled water, and 12 milliliters propylene glycol. 
EXAMPLE 72 
The topical skin treatment composition of Example 71 serves as an 
exfoliate, acne treatment, skin cancer treatment, growth treatment, 
treatment for infectious microbial, bacterial or viral disease, or 
combinations thereof. 
EXAMPLE 73 
A therapeutic composition for the treatment of infectious bacterial or 
viral disease, neoplasms, tumors, cancer, growths, neoplasia, and the like 
is made up of an effective amount of dried chives. 
EXAMPLE 74 
A sufficient quantity of the dried chives of Example 73 is administered on 
a periodic basis to provide the desired therapeutic effect. 
EXAMPLE 75 
A therapeutic composition or remedy for the maintenance of good health, 
prevention, treatment, or control of infectious bacterial or viral 
disease, neoplasms, tumors, growths, or cancer, and the like is made up of 
a food item such as bread, cereal, or other prepared food including oxalic 
acid or plant or vegetable containing oxalic acid like parsley or chives, 
in a sufficient quantity to provide the desired therapeutic effect. 
EXAMPLE 76 
A composition for improving and maintaining good health in warm-blooded 
animals including humans and pets and having a composition selected from 
oxalic acid, oxalate, oxalic acid dihydrate, a nutritional supplement 
containing oxalic acid, a nutritional supplement containing oxalate, a 
nutritional supplement containing oxalic acid dihydrate, or combinations 
thereof. 
EXAMPLE 77 
A flavor enhancer including at least one form of oxalic acid. 
EXAMPLE 78 
A preservative including at least one form of oxalic acid. 
EXAMPLE 79 
In a prepared food product, the improvement including an effective amount 
of at least one form of oxalic acid. 
EXAMPLE 80 
In a prepared food product, the improvement including the elimination of 
citric acid and the addition of an effective amount of at least one form 
of oxalic acid. 
EXAMPLE 81 
A method of enhancing or promoting the growth or the spread of infectious 
bacterial or viral disease, neoplasms, tumors, growths, neoplasia, and the 
like in warm-blooded animals such as test animals including the steps of 
reducing the intake of oxalic acid or oxalate in the diet, destroying the 
oxalic acid or oxalate in the animal, and/or increasing the intake of 
oxalic acid or oxalate blockers. 
EXAMPLE 82 
In a diet for promoting good health in warm-blooded animals including 
humans, the improvement including increasing the quantity of oxalic acid 
or oxalate-containing foods, and reducing the intake of oxalic acid or 
oxalate blockers. 
EXAMPLE 83 
A method of inhibiting the therapeutic effect of oxalic acid or oxalate in 
warm-blooded animals such as test animals including the steps of 
increasing the ingestion of oxalic acid blockers such as calcium, alcohol, 
red meat, citric acid, vitamin B6, vitamin C, potassium, dairy products, 
resins, and the like, administering oxalic acid blockers, such as calcium, 
alcohol, citric acid, vitamin C. vitamin B6, and the like, and/or 
destroying or decomposing some or all of the oxalic acid or oxalate in the 
animal. 
EXAMPLE 84 
A method for inhibiting, preventing, treating, or controlling the 
deleterious effects of diarrhea, indigestion, damage to digestive tract, 
kidney damage, or renal failure caused by high levels of oxalic acid 
including the steps of at least one of reducing the ingestion or 
administration of oxalic acid, oxalate, oxalic acid dihydrate, a 
nutritional supplement containing oxalic acid, a nutritional supplement 
containing oxalate, a nutritional supplement containing oxalic acid 
dihydrate, foods containing oxalic acid, foods containing oxalate, foods 
containing oxalic acid dihydrate, carrot juice, and combinations thereof, 
increasing the ingestion or administration of oxalic acid or oxalate 
blockers including crushed pineapple, monitoring the levels of oxalic acid 
or oxalate in the blood or urine, adjusting the ingestion or 
administration of oxalic acid or oxalate-containing compounds and the 
ingestion or administration of oxalic acid or oxalate blockers to achieve 
the desired oxalic acid or oxalate levels. 
EXAMPLE 85 
A method of counteracting, inhibiting, treating, controlling, or reducing 
the deleterious effects of high levels of oxalic acid including the steps 
of administering or ingesting a therapeutically effective amount of 
vitamin B6, vitamin B6-containing nutritional supplements, foods 
containing vitamin B6, or combinations thereof. 
EXAMPLE 86 
A method of treating a warm-blooded animal including the steps of 
determining the oxalic acid blood level or oxalate urine level of the 
animal, comparing this level with a scale indicating below normal, normal, 
and above normal oxalic acid or oxalate levels, increasing the 
administration or ingestion of oxalic acid or oxalate if the level is 
below normal, reducing the ingestion or administration of oxalic acid or 
oxalate blockers if the level is below normal, maintaining current 
ingestion or administration of oxalic acid or oxalate if the oxalic acid 
or the oxalate level is normal, reducing the ingestion or administration 
of oxalic acid or oxalate if the level is above normal, or increasing the 
ingestion or administration of oxalic acid or oxalate blockers if the 
level is above normal. 
EXAMPLE 87 
The method as described in Example 86 wherein the oxalic acid or oxalate 
level scale has differing below normal, normal, and above normal level 
categories for different health conditions. 
EXAMPLE 88 
In a multivitamin and mineral supplement, the improvement including the 
addition of at least one therapeutically effective form of oxalic acid. 
EXAMPLE 89 
The multivitamin and mineral supplement as described in Example 88 further 
including the improvement of the reduction or elimination of oxalic acid 
or oxalate blockers therein. 
EXAMPLE 90 
An oxalic acid treatment method including the step of mixing carrot juice 
with other juices and flavoring agents such as tomato juice, salt, pepper, 
parsley, celery, and the like to enhance the flavor thereof. 
EXAMPLE 91 
A therapeutic composition for the maintenance of good health and the 
prevention, treatment, or control of infectious or pathogenic microbial, 
bacterial, or viral disease, neoplasms, tumors, growths, cancer, 
neoplasia, and the like of a food or beverage including a therapeutically 
effective amount of at least one therapeutically effective form of oxalic 
acid such as a plant or vegetable containing oxalic acid or oxalate like 
carrot, carrot juice, parsley, or chives. 
EXAMPLE 92 
A therapeutic composition of sourdough bread made from flour, water, yeast, 
sourdough starter, and an additional oxalic acid ingredient selected from 
the group of dried, chopped parsley, freeze-dried chives, oxalic acid, 
oxalate, foods containing oxalic acid, foods containing oxalate, vegetable 
juice such as carrot juice, or combinations thereof to provide 
approximately 2 g. of oxalic acid per 4 lb. loaf of sourdough bread. 
EXAMPLE 93 
A method of therapeutically treating a warm-blooded animals including 
humans having the steps of periodically administering a portion of the 
sourdough bread of Example 92 to provide a dosage of oxalic acid of up to 
about 1 g. oxalic acid per day. 
EXAMPLE 94 
A method of delaying, preventing, controlling or treating the onset of 
Alzheimer's Disease, Hodgkin's Disease, Parkinson's Disease, and the like, 
lessening the effects of the disease, or improving the quality of life of 
a person suffering from the disease having the steps of periodically 
administering a therapeutically effective amount of at least one 
therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 95 
A canine and feline urine oxalate level scale having above normal, normal, 
and below normal levels by weight of the animal and providing a 
quick-ready reference for a veterinarian or a pet owner to test urine 
oxalate levels and adjust the oxalic acid or oxalate intake of the canine 
or feline accordingly. 
EXAMPLE 96 
A method for causing the sloughing off of the inner surface of the 
intestinal membrane in a warm-blooded animal including humans having the 
steps of administering daily doses of a therapeutically effective amount 
of at least one therapeutically effective form of oxalic acid or oxalate 
such as carrots or dried parsley for a period of weeks or months thereby 
causing the sloughing off of the interior surface of the intestinal 
membrane and removing old bacteria, food, waste, and intestinal cells and 
membrane. 
EXAMPLE 97 
A method of treating or preventing oxalate nephrosis in animals including 
dogs, goats, humans, cattle, and the like, including periodically 
administering a therapeutically effective amount of at least one oxalic 
acid or oxalate blocker. 
EXAMPLE 98 
A composition for cleaning oral or dental bridgework made of a dilute 
solution of oxalic acid and distilled water. 
EXAMPLE 99 
A composition for cleaning a toothbrush made of a dilute solution of oxalic 
acid and distilled water. 
EXAMPLE 100 
A composition for cleaning and rinsing the interior surfaces of the mouth 
and teeth made of a dilute solution of oxalic acid and distilled water, 
for example, less than 500 mg oxalic acid dihydrate in 300 ml of distilled 
water. 
EXAMPLE 101 
In a mouthwash, the improvement including the addition of a low 
concentration of oxalic acid. 
EXAMPLE 102 
In a tartar control rinse, the improvement being the addition of a small 
amount of oxalic acid. 
EXAMPLE 103 
A test kit for detecting the oxalate level in urine of warm-blooded animals 
including humans having a sample holder and a liquid reagent which upon 
addition of a selected quantity of reagent to a sample of urine in the 
sample holder provides a colormetric indication of the presence or absence 
of oxalate. 
EXAMPLE 104 
The Relationship Between Oxalic Acid and Blockers 
A Program For Tumor Reduction 
Improved Dietary Procedure Plan 
This Dietary Procedure Plan is drawn from research data in the United 
States patent application for Oxalic Acid or Oxalate Composition and 
Method of Treatment for Tumors. Oxalic acid is considered to be a natural 
chemotherapy in the reduction and prevention of tumor growth. 
Certain vegetables such as carrots, carrot juice, spinach, parsley, chives, 
beets and beet leaves, garlic, collards, and radishes are high among 
vegetables containing oxalic acid and should be eaten or drank in order to 
build a high concentration of oxalic acid in the body fluids. Almonds, 
cashews, peanuts, walnuts, and many other nuts and seeds contain oxalic 
acid and may be eaten. Especially walnuts which are high in oleic and 
linoleic fatty acids and increase oxalic acid absorption in the lower 
intestine and should be eaten. Coffee, tea, cocoa made with distilled 
water, and natural fruit juices are acceptable for drinking, especially 
cocoa which is very high in oxalic acid content. All beverages should be 
free of citric acid. 
There are certain items in the normal diet that are blockers to absorption 
of oxalic acid which reduces the acid available in the system for reducing 
tumors and preventing the forming of tumors. These items arc citric acid, 
-calcium-pyridoxine (Vitamin B6), alcohol, and in certain instances 
Ascorbic acid (Vitamin C), soda pop, thirst-Quenchers, sport drinks and 
flavored drinking waters, should absolutely be avoided as they are high in 
citric acid. All dairy products must be avoided as calcium prevents 
absorption of oxalic acid, and when combined form calcium-oxalate kidney 
stones. All red meats, chicken and turkey breasts (generally white meat) 
are high in pyridoxin (B6), and should be avoided. No alcohol should be 
consumed. Excessive intake of ascorbic acid should be avoided. It is 
absolutely necessary to read the ingredients on all food and drink items 
consumed while on the diet. Citric and ascorbic acids are widely used as a 
preservative in many products, including frozen and bakery goods. 
As oxalic acid is built up In the system, one may experience indigestion 
known as heartburn or a nagging backache. These are indicators that the 
acid is being ingested in too large a quantity, or the system is absorbing 
the acid at a rate faster than it can be utilized. Indigestion or 
heartburn can be relieved by taking 2 or 3 teaspoonful of crushed 
pineapple. Relief for the backache can be accomplished by taking one 100 
mg B6 pill. You will learn a slight moderation of the diet will avoid 
either of the above conditions. Maximum effect of oxalic acid on tumor 
reduction would be accomplished if an acid level can be maintained just 
below the discomfort level. Research shows that 5 to 7 days after start of 
the diet, an increase in energy may be experienced. Some people notice a 
body weight loss. 
Improvement in condition of visible tumors may be noticed after 12 to 15 
days. If there are multiple tumors, the newest tumors will regress first, 
and the core (first) tumor will require a longer diet time. Once tumors 
begin to shrink and disappear and when finally all trace of cancer has 
been cleared in the blood system, a balanced diet of all foods may be 
resumed while being sure to maintain an adequate level of oxalic acid in 
the system to prevent resumption of tumor growth. 
The microwave should not be used for cooking or heating any foods or 
beverage in the diet because it reduces the strength of the acid. Also, do 
not use electric blanket, electric razor, and electric hair blower/dryer 
because strong electric fields can reduce the acid. 
This same procedure can be used to treat other infections and disease. 
EXAMPLE 105 
A dietary supplement for everyday optimum nutritional balance having 
between 0.5 to 1.5 g. of oxalic acid. 
EXAMPLE 106 
A test kit for detecting the presence and quantity of oxalic acid in a 
blood sample of a warm-blooded animal including humans having a sample 
support surface, a reagent, and a mixing container for mixing together the 
blood sample and reagent to allow the reagent to undergo a color change 
and provide a colormetric determination of the presence and quantity of 
oxalic acid in the sample. 
EXAMPLE 107 
A method of treating warm-blooded animals including the steps of testing 
the blood or urine oxalic acid or oxalate levels, administering oxalic 
acid, oxalate or blockers thereof, and monitoring the levels to determine 
if adjustments are necessary to achieve a desired level. 
EXAMPLE 108 
A composition remedy or agent for controlling, treating or managing 
infectious or pathogenic microbial, bacterial, or viral disease, 
neoplasms, neoplasia, tumors, brain tumors, cancer, growths, and the like, 
for preventing the new growth of disease or different or abnormal cells or 
tissues, or for otherwise therapeutically treating warm-blooded animals 
including pets and humans and including at least one therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 109 
The composition as described in Example 108 wherein the therapeutically 
effective form of oxalic acid or oxalate is selected from the group of 
oxalic acid in a free acid, ester, lactone or salt form, oxalates 
including sodium oxaiate, a nutritional supplement containing at least one 
form of oxalic acid or oxalate, oxalic acid dihydrate, anhydrous oxalic 
acid, oxamide, oxalate salts, natural or processed foods including molds, 
plants or vegetables including parsley, chives, garlic, beets, carrots, 
spinach, and the like containing at least one form of oxalic acid or 
oxalate, beverages, liquids or juices such as carrot juice containing at 
least one form of oxalic acid or oxalate, additives containing at least 
one form of oxalic acid or oxalate, and combinations thereof. 
EXAMPLE 110 
The composition as described in Example 109 wherein the composition is 
oxalic acid dihydrate. 
EXAMPLE 111 
The composition as described in Example 109 wherein the composition is 
carrots, carrot juice or dried parsley. 
EXAMPLE 112 
The composition as described in Example 109 further having a 
pharmaceutically acceptable carrier or diluent for the therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 113 
The composition as described in Example 112 wherein the carrier or diluent 
is at least one of a gel cap and distilled water. 
EXAMPLE 114 
A method for controlling, treating or managing infectious bacterial or 
viral disease, neoplasms, neoplasia, tumors, growths, cancers, abnormal 
cells or tissues, and the like, in warm-blooded animals including pets and 
humans having the steps of periodically administering a therapeutically 
effective dosage of the composition of Example 108. 
EXAMPLE 115 
The method as described in Example 114 wherein the composition is 
administered orally or sublingually in at least one of gel cap, tablet, 
powder, food additive, food, drops, liquid, beverage, pill and capsule 
form. 
EXAMPLE 116 
The method as described in Example 114 wherein the composition is 
administered by injection including venous injection, injection into the 
diseased area, tumor, neoplasia, cancer, or growth, or injection adjacent 
the diseased area, tumor, neoplasia, cancer, or growth. 
EXAMPLE 117 
The method as described in Example 114 wherein the composition is 
administered topically by at least one of transdermal patch, ointment, 
salve, cream, lotion, gel, solution, and the like. 
EXAMPLE 118 
The method as described in Example 114 wherein the composition is 
administered internally by at least one of swallowing, inhalation, 
suppository, and subcutaneous deposit. 
EXAMPLE 119 
The method as described in Example 114 wherein the composition is 
administered at least once a day at a dosage of up to 8 g, preferably 50 
mg to 6 g for humans or up to 4 g, preferably 1 mg to 3 g for pets. 
EXAMPLE 120 
The method as described in Example 114 further having the steps of reducing 
the intake of oxalic acid or oxalate blockers and/or increasing the intake 
of oxalic acid or oxalate enhancers. 
EXAMPLE 121 
The method as described in Example 120 wherein the blockers are selected 
from the group of citric acid, ascorbic acid, pyridoxine hydrochloride, 
calcium, alcohol, resins, clays, and combinations thereof. 
EXAMPLE 122 
The method as described in Example 120 wherein the blockers are selected 
from the group of dairy products including calcium, fruits, coconut, 
beverages containing alcohol, ascorbic acid or citric acid including adult 
beverages such as beer, wine, vodka, gin, and the like, fruit juice based 
beverages, soda pop or soft drinks containing ascorbic acid or citric 
acid, other sports drinks, beverages or refreshments containing ascorbic 
acid or citric acid, red meat or white meat of fowl including chicken, 
turkey, pheasant and the like containing pyridoxines, or other foods or 
beverages containing alcohol, citric acid, ascorbic acid or pyridoxine 
hydrochloride including breads or grains, resins, and combinations 
thereof. 
EXAMPLE 123 
A composition for controlling, treating or managing infectious disease or 
hyperplasia including swollen or enlarged prostate, and the like, for 
preventing new swelling or enlargement of tissues, or for otherwise 
therapeutically treating warm-blooded animals including pets and humans 
and including at least one therapeutically effective form of oxalic acid 
or oxalate. 
EXAMPLE 124 
The composition as described in Example 123 wherein the therapeutically 
effective form of oxalic acid or oxalate is selected from the group of 
oxalic acid in a free acid, ester, lactone or salt form, oxalates 
including sodium oxalate, a nutritional supplement containing at least one 
form of oxalic acid or oxalate, oxalic acid dihydrate, anhydrous oxalic 
acid, oxamide, oxalate salts, natural or processed foods including molds, 
plants or vegetables including parsley, chives, garlic, beets, carrots, 
spinach, and the like containing at least one form of oxalic acid or 
oxalate, beverages, liquids or juices such as carrot juice containing at 
least one form of oxalic acid or oxalate, additives containing at least 
one form of oxalic acid or oxalate, and combinations thereof. 
EXAMPLE 125 
A method for controlling, treating or managing infectious disease or 
hyperplasia including swollen or enlarged prostate, and the like for 
preventing new swelling or enlargement of tissues, or for otherwise 
therapeutically treating warm-blooded animals including pets and humans 
having the steps of periodically administering a therapeutically effective 
dosage of the composition of Example 123. 
EXAMPLE 126 
The method as described in Example 125 further having the steps of reducing 
the intake of oxalic acid or oxalate blockers. 
EXAMPLE 127 
A diet for treating, controlling, and preventing infectious or pathogenic 
microbial, bacterial, or viral disease, neoplasms, cancer, tumors, 
neoplasia, and the like in warm-blooded animals including pets and humans 
having the steps of adding to the regular diet a dietary supplement of at 
least one therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 128 
The diet as described in Example 127 wherein the therapeutically effective 
form of oxalic acid or oxalate is selected from the group of oxalic acid 
in a free acid, ester, lactone or salt form, oxalates including sodium 
oxalate, a nutritional supplement containing at least one form of oxalic 
acid or oxalate, oxalic acid dihydrate, anhydrous oxalic acid, oxamide, 
oxalate salts, natural or processed foods including molds, plants or 
vegetables including parsley, chives, garlic, beets, carrots, spinach, and 
the like containing at least one form of oxalic acid or oxalate, 
beverages, liquids or juices such as carrot juice containing at least one 
form of oxalic acid or oxalate, additives containing at least one form of 
oxalic acid or oxalate, and combinations thereof. 
EXAMPLE 129 
The diet as described in Example 127 further having the steps of reducing 
the intake of oxalic acid or oxalate blockers. 
EXAMPLE 130 
The diet as described in Example 129 wherein the blockers are selected from 
the group of citric acid, ascorbic acid, pyridoxine hydrochloride, 
calcium, alcohol, resins, clays, and combinations thereof. 
EXAMPLE 131 
The diet as described in Example 129 wherein the blockers are selected from 
the group of dairy products including calcium, fruits, coconut, beverages 
containing alcohol, ascorbic acid or citric acid including adult beverages 
such as beer, wine, vodka, gin, and the like, fruit juice based beverages, 
soda pop or soft drinks containing ascorbic acid or citric acid, other 
sports drinks, beverages or refreshments containing ascorbic acid or 
citric acid, red meat or white meat of fowl including chicken, turkey, 
pheasant, and the like containing pyridoxine, or other foods or beverages 
containing alcohol, citric acid, ascorbic acid or pyridoxine hydrochloride 
including breads or grains, resins, and combinations thereof. 
EXAMPLE 132 
A veterinary composition for controlling, treating or managing infectious 
disease, neoplasms, neoplasia, tumors, brain tumors, cancer, growths, and 
the like, for preventing the new growth of different or abnormal cells or 
tissues, or for otherwise therapeutically treating warm-blooded animals 
including dogs and cats of a composition including at least one 
therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 133 
The veterinary composition as described in Example 132 wherein the 
therapeutically effective form of oxalic acid or oxalate is selected from 
the group of oxalic acid in a free acid, ester, lactone or salt form, 
oxalates including sodium oxalate, a nutritional supplement containing at 
least one form of oxalic acid or oxalate, oxalic acid dihydrate, anhydrous 
oxalic acid, oxamide, oxalate salts, natural or processed foods including 
molds, plants or vegetables including parsley, chives, garlic, beets, 
carrots, spinach, and the like containing at least one form of oxalic acid 
or oxalate, beverages, liquids or juices such as carrot juice containing 
at least one form of oxalic acid or oxalate, additives containing at least 
one form of oxalic acid or oxalate, and combinations thereof. 
EXAMPLE 134 
The veterinary composition as described in Example 133 wherein the 
composition is oxalic acid dihydrate. 
EXAMPLE 135 
The veterinary composition as described in Example 133 wherein the 
composition is at least one of carrots, boiled carrots, carrot juice, and 
dried parsley. 
EXAMPLE 136 
The veterinary composition as described in Example 133 further having a 
pharmaceutically acceptable carrier or diluent for the therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 137 
The veterinary composition as described in Example 136 wherein the carrier 
or diluent is a gel cap or distilled water. 
EXAMPLE 138 
A veterinary method for codestrolling, treating or managing infectious 
disease, neoplasms, oneoplasia, tumors, growths, cancers or abnormal 
tissues in warm-blooded animals including dogs and cats having the steps 
of periodically administering a therapeutically effective dosage of the 
veterinary composition of Example 133. 
EXAMPLE 139 
The veterinary method as described in Example 138 w herein the composition 
is administered orally or saeblingually in at least one of gel cap, 
tablet, powder, food additive, food, beverage, pill and capsule form, by 
injection including venous injection, injection into the tumor, neoplasia, 
cancer, or growth, or injection adjacent the tumor, neoplasia, cancer, or 
growth, topically by at least one of transdermal patch, ointment, salve, 
cream, lotion, gel, solution, wash, gargle, rinse, and the like, 
internally by swallowing, inhalation, suppository or subcutaneous deposit, 
or combinations thereof. 
EXAMPLE 140 
The veterinary method as described in Example 138 wherein the composition 
is administered at least once a day at a dosage of about 1 mg to 3 g for 
dogs and cats. 
EXAMPLE 141 
The veterinary method as described in Example 138 further having the steps 
of reducing the intake of oxalic acid or oxalate blockers. 
EXAMPLE 142 
The veterinary method as described in Example 141 wherein the blockers are 
selected from the group of citric acid, ascorbic acid, pyridoxine 
hydrochloride, calcium, alcohol, resins, clavs, and combinations thereof. 
EXAMPLE 143 
A method of treating warm-blooded animals including pets and humans 
afflicted with bacteria, virus, or tumor cells sensitive to an oxalic acid 
compound including the steps of periodically administering to the animal 
an oncolytic amount of at least one therapeutically effective oxalic acid 
or oxalate compound. 
EXAMPLE 144 
A process for preparing an antimicrobial or anti-tumor agent including the 
steps of mixing at least one therapeutically effective form of oxalic acid 
or oxalate with a pharmaceutically acceptable carrier or diluent. 
EXAMPLE 145 
The process as described in Example 144 wherein the therapeutically 
effective form of oxalic acid or oxalate is selected from the group of 
oxalic acid in a free acid, ester, lactone or salt form, oxalates 
including sodium oxalate, a nutritional supplement containing at least one 
form of oxalic acid or oxalate, oxalic acid dihydrate, anhydrous oxalic 
acid, oxamide, oxalate salts, natural or processed foods including molds, 
plants or vegetables including parsley, chives, garlic, beets, carrots, 
spinach, and the like containing at least one form of oxalic acid or 
oxalate, beverages, liquids or juices such as carrot juice containing at 
least one form of oxalic acid or oxalate, additives containing at least 
one form of oxalic acid or oxalate, and combinations thereof. 
EXAMPLE 146 
The process as described in Example 144 wherein the pharmaceutically 
acceptable carrier or diluent is selected from the group of distilled 
water, heated water, pharmaceutically acceptable liquids, nutritional 
supplements, natural or processed foods, and the like. 
EXAMPLE 147 
A composition for treating infectious viral or auto immune-related diseases 
such as HIV, SLE, AIDS, BSE, CFS, and the like, and having a 
therapeutically effective amount of at least one therapeutically effective 
form of oxalic acid or oxalate. 
EXAMPLE 148 
A method of treating, preventing or controlling infectious viral or auto 
immune-related diseases such as AIDS, HIV, SLE, BSE, CFS, and the like, 
preventing, lessening or controlling the destruction of the body's immune 
system, or purifying the blood including the steps of periodically 
administering a therapeutically effective amount of the composition of 
Example 147. 
EXAMPLE 149 
A composition for counteracting the decomposition or reduction of oxalic 
acid or oxalate caused by radiation exposure, radiation treatment, X-rays, 
strong electromagnetic waves or fields, microwaves, and the like or for 
returning the body's oxalic acid or oxalate level to at least a normal 
level following radiation treatment, X-rays, CAT- scans, MRI-scans, and 
the like including a therapeutically effective amount of at least one 
therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 150 
A method for counteracting the decomposition or reduction of oxalic acid or 
oxalate caused by radiation exposure, radiation treatment, X-rays, strong 
electromagnetic waves or fields, microwaves, and the like or for returning 
the body's oxalic acid or oxalate level to at least a normal level 
following radiation treatment, X-rays, CAT-scans, MRI-scans, and the like 
having the steps of administering a therapeutically effective amount of 
the composition of Example 149 following the treatment or exposure. 
EXAMPLE 151 
The method as described in Example 150 further including the steps of 
administering a therapeutically effective amount of the composition of 
Example 149 prior to the treatment or exposure. 
EXAMPLE 152 
A method of enhancing the therapeutic effect of oxalic acid or oxalate 
including the steps of decreasing or eliminating the ingestion or 
administration of one or more of oxalic acid or oxalate blockers. 
EXAMPLE 153 
The method as descril Red in Example 152 wherein the blockers are selected 
from the group of calcium, alcohol, citric acid, ascorbic acid, pyridoxine 
hydrochloride, resins, and combinations thereof. 
EXAMPLE 154 
A method of treating brain tumors, infectious disease, colds, flu, 
diverticulitis, acid reflux, infection, and the like, including the steps 
of ingesting or administering a therapeutically effective amount of at 
least one therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 155 
The method as described in Example 154 wherein the therapeutically 
effective form of oxalic acid or oxalate is dried chopped parsley. 
EXAMPLE 156 
A treatment regimen for treating infectious disease, microbial disease, 
neoplasms, tumors, cancers, growths, neoplasia, and the like, including 
infectious bacterial and viral disease, brain tumors, breast cancer 
cervical cancer, and others, including the steps of reducing or 
eliminating the ingestion or administration of oxalic acid or oxalate 
blockers, administering or ingesting high dosages of oxalic acid or 
oxalate to raise the blood or urine oxalic acid or oxalate level above 
normal, and, after cleansing the blood of tumor, cancer or abnormal cells, 
administering or ingesting a more moderate level of oxalic acid or oxalate 
to maintain a normal blood or urine oxalic acid or oxalate level. 
EXAMPLE 157 
The regimen as described in Example 156 further including the steps of 
increasing the administration or ingestion of oxalic acid or oxalate 
enhancers. 
EXAMPLE 158 
A therapeutic composition in cream or ointment form for topical 
administration of oxalic acid or oxalate having at least one 
therapeutically effective form of oxalic acid or oxalate, a solvent, and a 
cream or ointment base. 
EXAMPLE 159 
The therapeutic composition as described in Example 158 wherein the solvent 
is distilled water, acetone, propylene glycol, or polysorbate, and the 
base is a cream, ointment, gel, lotion, spray, stick, or powder base. 
EXAMPLE 160 
A method of producing the therapeutic composition as described in Example 
158 having the steps of mixing a dilute concentration of at least one 
therapeutically effective form of oxalic acid or oxalate with a solvent 
such as distilled water, acetone, propylene glycol, polysorbate or the 
like to form a solution, mixing the solution with a base such as a 
hydrophilic petrolatum, cream, ointment, gel, lotion, spray, stick, powder 
or other base. 
EXAMPLE 161 
An improved canned or dry pet food including conventional ingredients along 
with the addition of a therapeutically effective quantity of at least one 
therapeutically effective form of oxalic acid or oxalate. 
EXAMPLE 162 
The improved pet food of Example 161 including the elimination or reduction 
of oxalic acid or oxalate blockers 
EXAMPLE 163 
A method of treating infectious disease, microbial disease, neoplasms, 
tumors, cancers, growths, neoplasia and the like including bacterial and 
viral infections, brain tumors, breast cancer, cervical cancer, and others 
in a person suffering from osteoporosis including the steps of reducing or 
eliminating the ingestion or administration of oxalic acid or oxalate 
blockers, administering or ingesting high dosages of oxalic acid or 
oxalate to raise the blood or urine oxalic acid or oxalate level above 
normal, and, after cleansing the blood of infectious disease, microbial 
disease, tumor, cancer, or abnormal cells, reducing or eliminating the 
administration or ingestion of oxalic acid or oxalate to maintain a below 
normal blood or urine oxalic acid or oxalate level. 
EXAMPLE 164 
A method of treating osteoporosis including the steps of increasing calcium 
intake and decreasing oxalic acid or oxalate intake. 
EXAMPLE 165 
A therapeutic composition for purifying the blood, controlling, treating or 
eradicating infectious disease, microbial disease, abnormal cells, 
controlling, treating or affecting cholesterol plaque and fat buildup in 
the cardiovascular system or in the brain, and maintaining good 
cardiovascular health and operation, having a therapeutically effective 
amount of at least one therapeutically effective form of oxalic acid or 
oxalate. 
EXAMPLE 166 
An oral rinse or wash for smokers or snuff users for controlling, treating 
or managing infectious or pathogenic bacterial or viral disease, 
neoplasms, neoplasia, tumors, cancers, growths, and the like, for 
preventing the new growth of infectious disease, different or abnormal 
tissues, or for otherwise therapeutically treating the mouth area, having 
a dilute solution of at least one therapeutically effective form of oxalic 
acid or oxalate. 
EXAMPLE 167 
A method of manufacturing a dry processed dog food containing at least one 
form of oxalic acid or oxalate including the steps of mixing a slurry of 
conventional dog food ingredients together with a dilute solution of 
oxalic acid or oxalate in heated water to form an oxalic acid or oxalate 
containing slurry, forming the slurry into pellets and drying the pellets. 
EXAMPLE 168 
The method as described in Example 167 wherein the oxalic acid is oxalic 
acid dihydrate and each pellet contains approximately 1 mg of oxalic acid 
so that one pound of dry dog food contains about 1 g of oxalic acid. 
EXAMPLE 169 
A dietary supplement for treating a patient diagnosed with infectious 
bacterial or viral disease or an active cancer, tumor, growth, or 
neoplasia having about 1 g to 6 g, preferably 2 g to 4 g of oxalic acid 
per day based on 70 kilograms of body weight and a pharmaceutically 
acceptable carrier or diluent. 
EXAMPLE 170 
A composition for treating parvo virus in animals including canines of a 
therapeutically effective amount of at least one therapeutically effective 
form of oxalic acid or oxalate. 
EXAMPLE 171 
A pharmaceutical composition to be administered orally to humans of a 
mixture of a non-toxic ingestible carrier and a therapeutically effective 
form of oxalic acid or oxalate. 
EXAMPLE 172 
The pharmaceutical composition as described in Example 171 wherein the 
composition is provided in a form selected from the group of pills, 
powders, granules, tablets, microcapsules, gel capsules, nutritional 
supplements, processed foods, liquids, juices, drops, beverages, additives 
and solutions 
EXAMPLE 173 
In a pet treat such as a jerky strip, dog bone, chew, rawhide, and the 
like, the improvement of the addition of microgram amounts of at least one 
therapeutically effective form of oxalic acid or oxalate, whereby the 
treats provide for the maintenance of good pet health. 
EXAMPLE 174 
Treatment For Infectious Disease, Cancer or Tumor Reduction 
Our research indicates the following as a treatment for infectious disease 
and the reduction of cancers or tumors: 
Carrots, carrot juice, spinach, parsley, chives, beets and beet leaves, 
garlic, collards and radishes are high among vegetables containing Oxalic 
Acid and should be eaten or drank in order to build a high concentration 
of acid in the body fluids. Almonds, cashews, peanuts, and, especially 
walnuts which are high in oleic and linoleic fatty acids and increase 
oxalic acid absorption may be eaten. 
Red meats, chicken and turkey breasts, (generally white meat) are 
considered high in Pyridoxine (Vitamin B6), and should be avoided during 
the treatment. Alcohol and products containing citric acid (soda pop, 
other soft drinks, and thirst quenchers are generally high in citric 
acid), and ascorbic acid (Vitamin C) are considered blockers of oxalic 
acid and should be avoided since they retard the build up of oxalic acid 
in the system. It is absolutely necessary to read the ingredients on all 
food and drinks consumed while on the treatment. Citric and ascorbic acids 
are widely used as a preservative in many products, including frozen and 
bakery goods. 
All dairy products should also be avoided while following the treatment. 
Calcium inhibits oxalic acid and when combined can form calcium oxalate 
stones (kidney). 
Coffee, cocoa, regular tea, made with distilled water, and natural fruit 
juices are acceptable for drinking. All beverages should be free of citric 
acid. 
As oxalic acid is built up in the system one may experience indigestion 
known as heart burn or a nagging backache. These indicate that the acid is 
being ingested in too large a quantity or the system is digesting the acid 
at a rate faster than it can be absorbed. Indigestion can be relieved by 
taking 2 or 3 teaspoonfuls of crushed pineapple. Relief for the backache 
can be accomplished by taking one 100 mg Vitamin B6 pill. A slight 
reduction of the intake of oxalic acid will avoid either of the above 
conditions. Maximum effect of oxalic acid on tumor reduction would be 
accomplished if a acid level can be maintained just below the discomfort 
level. 
Our research shows that five to seven days after start of the treatment, an 
increase in energy will be experienced. Some people notice a body weight 
loss. Improvement in condition of the tumor should be noticed after 10 to 
12 days. 
If there are multiple tumors, the newest tumors will regress first, while 
older (core) tumors will require a longer time. Once tumors begin to 
shrink and disappear and when finally all trace of cancer has been cleared 
in the blood system a balanced diet of all foods may be resumed while 
being sure to maintain an adequate level of oxalic acid in the system to 
prevent resumption of tumor growth. 
The microwave should not be used for cooking or heating any foods or 
beverage in the diet because it reduces the strength or amount of the 
oxalic acid. 
EXAMPLE 175 
Oxalic Acid Dietary Plan 
Our research indicates the following as a diet for the treatment of 
infectious disease or the reduction of tumors: 
Carrots, carrot juice, spinach, parsley, chives, beets and beet leaves, 
garlic, collards and radishes are high among vegetables containing oxalic 
acid or oxalate and should be eaten or drank in order to build a high 
concentration of oxalic acid in the body fluids. Almonds, cashews, 
peanuts, and, especially walnuts which are high in oleic and linoleic 
fatty acids and increase oxalic acid absorption may be eaten. 
Red meats, chicken and turkey breasts, (generally white meat) are 
considered high in Pyridoxine (Vitamin B6), and should be avoided during 
the treatment. Alcohol and products containing citric acid (soda pop, 
other soft drinks and thirst quenchers are generally high in citric acid), 
and ascorbic acid (Vitamin C) are considered blockers of oxalic acid or 
oxalate and should be avoided since they retard the build up of oxalic 
acid in the system. It is absolutely necessary to read the ingredients on 
all food and drinks consumed while on the diet. Citric and ascorbic acids 
are widely used as a preservative in many products, including frozen and 
bakery goods. 
All dairy products should also be avoided while following the treatment. 
Calcium inhibits oxalic acid and when combined can form calcium oxalate 
stones (kidney). 
Coffee, cocoa, regular tea, made with distilled water, and limited amounts 
of natural fruit juices are acceptable for drinking. All beverages should 
be free of citric acid. 
As oxalic acid is built up in the system one may experience indigestion 
known as heart burn or a nagging backache. These are indicators that the 
oxalic acid is being ingested in too large a quantity or the system is 
digesting the acid at a rate faster than it can be absorbed. Indigestion 
can be relieved by taking 2 or 3 teaspoonfuls of crushed pineapple. Relief 
for the backache can be accomplished by taking one 100 mg Vitamin B6 pill. 
A slight reduction or moderation of the intake of oxalic acid or oxalate 
will avoid either of the above conditions. Maximum effect of oxalic acid 
on tumor reduction would be accomplished if an oxalic acid level can be 
maintained just below the discomfort level. 
Our research shows that five to seven days after start of the treatment, an 
increase in energy will be experienced. Some people notice a body weight 
loss. Improvement in condition of the tumor should be noticed after 10 to 
12 days. 
If there are multiple tumors, the newest tumors will regress first, while 
older (core) tumors will require a longer time. Once tumors begin to 
shrink and disappear and when finally all trace of cancer has been cleared 
in the blood system a balanced diet of all foods may be resumed while 
being sure to maintain an adequate level of oxalic acid or oxalate in the 
system to prevent resumption of tumor growth. 
The microwave oven should not be used for cooking or heating any foods or 
beverage in the diet because it reduces the strength or amount of the 
oxalic acid. 
EXAMPLE 176 
Protocol for Treatment of Canine, Equine, Feline Species for the Control of 
Infectious Disease or Neoplasia (Tumors) Research and Development Phase 
Prior to the commencement of protocol a complete examination should be 
accomplished by the attending veterinarian. 
The examiner should complete and record the following: History since the 
onset of the neoplasia based on owners description; specific diet, to 
include all treats, and liquid intake; general activity level during 
previous period; age; weight; general examination; physical examination to 
determine the location, type, and size of the tumor(s); MRI, CAT-scan, or 
X-ray should be used if procedure is available; blood analysis, including 
(CBC) liver and kidney profiles; and urine analysis, including analysis 
for oxalates. 
Based on veterinarian's diagnosis of the animal's condition, the maximum 
amount of oxalic acid or oxalate formula will be recommended for the first 
14 days. At the completion of 14 days, a blood and urine analysis will be 
completed and if results are satisfactory, the animal will be placed on a 
diet, based on the animal's weight, of regular dry dog food, supplemented 
by oxalic acid or oxalate formula. Dosage will be at the maximum computed 
on the above blood and urine analysis. Repeat urine checks will be 
completed, as determined by the veterinarian, and the amount of oxalic 
acid or oxalate formula will be adjusted as required. 
After initiation of the protocol the veterinarian will observe the level of 
oxalates in the urine. The urine oxalate level will be maintained at the 
desired level, based on the weight of the animal, using urine oxalate 
scales of the present invention. 
EXAMPLE 177 
Animal Feed Supplement Mixes 
The supplement is to be added to the normal feed/food, by weight, to add 
the amount of oxalic acid desired. 
Equine Mix 
Ingredients 
Ground oats, ground corn, ground barley, wheat middlings, soybean meal, 
cane molasses, dried hydrolyzed whey, dried whey, soy flour, animal fat, 
vegetable fat, dehydrated alfalfa meal, dicalcium phosphate, 
calciumcarbonate, salt, magnesium sulfate, potassium sulfate, smectite, 
vermiculite, ferrous sulfate, ferric choline citrate, zinc oxide, 
manganous oxide, copper oxide, copper sulfate, cobalt carbonate, ethylene 
diamine dihydroiodide, sodium selenite, and oxalic acid. 
Feline Mix 
Ingredients 
Ground corn, poultry by-product meal, corn gluten meal animal fat, 
(preserved with BHA propyl gallate), brewers rice, chicken liver digest, 
potassium chloride, choline chloride, calcium sulfate, taurine, 
ethoxyquin, (a preservative), ferrous sulfate, zinc oxide, copper 
chloride, manganous oxide, cobalt carbonate, calcium iodate, sodium 
selenite, and oxalic acid. 
Canine Mix 
Ingredients 
Ground corn, soybean meal, meat and bone meal, soy whole, beet pulp, salt, 
corn gluten meal, soy oil, dicalcium phosphate, poultry fat, and oxalic 
acid. 
In each of the above feed supplements oxalic acid is added at one gram of 
oxalic acid to one pound of dried food. Crude protein, crude fat, crude 
fiber, and moisture will be blended at different formula for the life 
stage of the animals. 
Oxalic acid feed supplement will be added to the daily diet as determined 
by the attending veterinarian for each of the above mixes. 
EXAMPLE 178 
Supplement Mixes 
The supplement is to be added to the normal feed/food, by weight, to add 
the amount of oxalic acid or oxalate desired. 
Equine Mix 
Ingredients 
Ground oats, ground corn, ground barley, wheat middlings, soybean meal, 
cane molasses, dried hydrolyzed whey, dried whey, soy flour, animal fat, 
vegetable fat, dehydrated alfalfa meal, dicalcium phosphate, 
calciumcarbonate, salt, magnesium sulfate, potassium sulfate, smectite, 
vermiculite, ferrous sulfate, ferric choline citrate, zinc oxide, 
manganous oxide, copper oxide, copper sulfate, cobalt carbonate, ethylene 
diamine dihydroiodide, sodium selenite, and oxalic acid or oxalate. 
Feline Mix 
Ingredients 
Ground corn, poultry by-product meal, corn gluten meal animal fat, 
(preserved with BHA propyl gallate), brewers rice, chicken liver digest, 
potassium chloride, choline chloride, calcium sulfate, taurine, 
ethoxyquin, (a preservative), ferrous sulfate, zinc oxide, copper 
chloride, manganous oxide, cobalt carbonate, calcium iodate, sodium 
selenite, and oxalic acid or oxalate. 
Canine Mix 
Ingredients 
Ground corn, soybean meal, meat and bone meal, soy whole, beet pulp, salt, 
corn gluten meal, soy oil, dicalcium phosphate, poultry fat, and oxalic 
acid or oxalate. 
In each of the above feed supplements oxalic acid or oxalate is added at 
one gram of oxalic acid or oxalate to one pound of dried food. Crude 
protein, crude fat, crude fiber, and moisture will be blended at different 
formula for the life stage of the animals. 
The feed supplement will be added to the daily diet as determined by the 
attending veterinarian for each of the above mixes. 
EXAMPLE 179 
Canine Supplement Mix 
The supplement is to be added to the normal feed/food, by weight, to add 
the amount of oxalic acid or oxalate desired. 
Ingredients 
Ground corn about 55.99%, soybean meal 8.53%, meat and bone meal 15.85%, 
soy whole 2.54%, beet pulp 1.9%, salt 0.45%, corn gluten meal 9.35%, soy 
oil 1.87%, dicalcium phosphate 0.47%, poultry fat 3.00%, and oxalic acid 
0.0023%, with moisture about 0-10%. 
In the above feed supplement oxalic acid or oxalate is added at about one 
gram of oxalic acid or oxalate to one pound of dried food. Crude protein, 
crude fat, crude fiber, and moisture will be blended at different formula 
for the life stage of the animals. 
The feed supplement will be added to the daily diet as recommended by the 
attending veterinarian. 
EXAMPLE 180 
A method of counteracting the deleterious effects of a mammogram, CAT-scan, 
X-ray, and the like, exposure or treatment including the steps of about 3 
weeks prior to the exposure increasing the intake of oxalic acid or 
oxalate continuing the increased oxalic acid or oxalate during the 
treatment and for 3 weeks following treatment. Thereafter, checking the 
blood or urine oxalic acid or oxalate levels of the patient and if they 
are normal, continuing with that level of intake of oxalic acid or 
oxalate, if they are above normal, reducing the intake of oxalic acid or 
oxalate, and if they are below normal, increasing the intake of oxalic 
acid or oxalate. Thereafter, monitoring the levels and adjusting the 
intake on a periodic basis. 
EXAMPLE 181 
An oxalic acid or oxalate containing bread including about 1 gram of oxalic 
acid or oxalate per loaf of bread. 
EXAMPLE 182 
The bread of Example 181 wherein the oxalic acid is oxalic acid dihydrate 
dissolved in distilled water prior to being added to the bread during 
manufacturing of the loaf. 
EXAMPLE 183 
The bread of Example 182 further containing about 2 cups of trail mix 
including nuts, dried fruits, and the like, per loaf of bread with the 
trail mix being added during the manufacture of the loaf. 
EXAMPLE 184 
A dry dogfood is prepared with 300 lbs. of dry dogfood having added thereto 
101/2 ounces of oxalic acid dihydrate to provide about 1 gram of oxalic 
acid per pound of dry dogfood. The oxalic acid dihydrate powder is added 
to 90.degree. C. distilled water and mixed into the conventional dogfood 
slurry. 
EXAMPLE 185 
The dogfood of Example 184 with the exception that any Vitamin B6 is 
removed from the conventional dry mix. 
EXAMPLE 186 
An oxalic acid intake adult management control plan includes four phases. 
In the first phase, the adult is administered about 13/4 to 2 grams of 
oxalic acid or oxalate per day for 5-7 days to eliminate infectious 
disease, microbial disease, abnormal cells, or otherwise clean the blood 
of the patient for a 70 kilogram weight adult. For larger adults, the 
dosage would have to be increased. Also, oxalic acid and oxalate levels 
are checked in the blood, plasma and/or urine to determine the exact 
amount of oxalic acid or oxalate required for the individual subject. In 
the second phase of the treatment, the subject is given about 3/4 gram of 
oxalic acid or oxalate for an additional 15-20 days until the infectious 
disease, microbial disease, or the growth or expansion of the tumor or 
malignancy has stopped and the tumor is in regression, eliminated, or 
inert. In the third phase the subject is given about 1/2 gram of oxalic 
acid or oxalate per day to continue infectious disease, microbial disease 
or tumor reduction or until the body is clean. In the fourth phase or 
maintenance phase, the subject is given about 50 mg of oxalic acid or 
oxalate per day for maintenance of good health and to keep all disease or 
cancers in remission or in check. Again, these dosages arc provided for an 
average 70 kilogram adult and the individual's oxalic acid or oxalate 
levels need to be checked periodically and the dosages adjusted as 
necessary. 
EXAMPLE 187 
The control plan of Example 186 wherein a computer model of the chemical 
balance of the human body is used in addition to the oxalic acid and 
oxalate level information to determine the proper dosage for that 
individual. 
EXAMPLE 188 
An animal testing method for testing, for example, the disease or 
carcinogenic effect of one or more agents or irritants on an animal such 
as a mouse or rat, including the steps of determining the normal oxalic 
acid or oxalate blood or urine level of the animal, irradiating the animal 
to weaken its natural immune system and administering a dosage of oxalic 
acid or oxalate to the animal as necessary to bring its oxalic acid or 
oxalate blood or urine level back up to a normal level prior to further 
testing of the animal. 
EXAMPLE 189 
A method of treating an animal suffering from bovine spongiform 
encephalopathy (BSE) by feeding the animal a feed high in oxalic acid or 
oxalate, for example Halogeton or Setavia plants or grass. 
EXAMPLE 190 
The method of Example 189 including the step of treating the animal 
directly by an intravenous administration of oxalic acid. 
EXAMPLE 191 
A method of treating humans having Creutzfeldt-Jakob Disease (CFS) by 
administering a therapeutic quantity of at least one therapeutically 
effective form of oxalic acid or oxalate. 
EXAMPLE 192 
The method of Example 191 including the step of administering oxalic acid 
directly by intravenous administration. 
EXAMPLE 193 
A method of preventing BSE or CFS in warm-blooded animals including cattle 
and humans including the steps of increasing the intake of at least one 
form of oxalic acid or oxalate. 
EXAMPLE 194 
A method of treating animals using oxalic acid or oxalate in place of or in 
addition to conventional chemotherapy and administering at least one 
therapeutically effective form of oxalic acid or oxalate continuously to 
the patient in decreasing amounts to treat, control, or prevent cancer, 
tumors, growths, bacterial disease, viral disease, chemical disease, and 
the like without deleteriously affecting normal cells. 
EXAMPLE 195 
A method of enhancing the beneficial effects of oxalic acid or oxalate in 
animals including humans and pets including the steps of eliminating the 
use of microwave cooking for heating food or drink of the animal to 
prevent the decomposition or reduction in the amount of oxalic acid or 
oxalate in their food or drink. 
EXAMPLE 196 
The method of Example 195 further including the step of eliminating the use 
of the microwave oven for cooking or heating to prevent exposure to 
microwaves and thereby prevent decomposition or reduction in oxalic acid 
or oxalate in the animal being exposed. 
EXAMPLE 197 
The method of Example 196 further including the steps of eliminating the 
use of radiation, X-ray, CAT-scan, mammogram, strong electromagnetic 
waves, excessive heat, or other exposures or treatments which would 
decompose or reduce the amount of oxalic acid or oxalate in the animal. 
EXAMPLE 198 
A mouthwash containing a dilute solution of oxalic acid and having a pH of 
about 2.3. 
EXAMPLE 199 
An oxalic acid or oxalate containing drink including carrot juice having a 
pH of about 5.5. 
EXAMPLE 200 
A mouthwash or oral rinse containing a dilute solution of 500 milligrams or 
less of oxalic acid dihydrate per 500 milliliters of distilled water. 
EXAMPLE 201 
A method of treating terminally ill animals including adult humans 
including the steps of administering a high dosage of oxalic acid or 
oxalate to cleanse the blood and treat the condition or disease. 
EXAMPLE 202 
The method of Example 201 further including the steps of stopping 
conventional oncological chemotherapy treatments to prevent the weakening 
of the body and prevent the decomposition or reduction of oxalic acid or 
oxalate in the body. 
EXAMPLE 203 
The method of Example 201 further including the steps of reducing the 
dosage of oxalic acid or oxalate after the blood has been cleansed and the 
condition or disease has improved. 
EXAMPLE 204 
The method of Examples, 201, 202, or 203 further including the step of 
reducing the intake of oxalic acid or oxalate blockers and increasing the 
intake of oxalic acid or oxalate enhancers. 
EXAMPLE 205 
Antimicrobial oxalic acid or oxalate compositions and methods of treatment 
or prevention of warm-blooded animals including humans and pets is 
provided which includes at least one therapeutically effective form of 
oxalic acid or oxalate for controlling, treating, preventing, or managing 
bacterial diseases and viral diseases caused by germs of infectious 
bacteria, including bacterial diseases caused by Gram-Positive Cocci such 
as Staphylococcal infections of Pneumonia, Bacteremia, Osteomyelitis, 
Enterocolitis, and the like, Streptococcal infections such as Homolytic, 
Viridans, Enterococci, lactic, and the like, Pneumococcal infections such 
as Pneumonia, Sinusitis, Otitis, Meningitis, and the like, also bacterial 
diseases caused by Gram-Negative Cocci, Neisseria Aerobic infections such 
as Meningococcus, Gonococcus, and the like, also bacterial diseases caused 
by Gram-Positive Bacilli infections such as Erysipelothricosis, 
Listeriosis, Anthrax, Nocardiosis, and the like, also bacterial diseases 
caused by Gram-Negative Bacilli infections such as Enterobacteriaceac 
Salmonella, Shigellosis, Hemophilus, Tularemia, Plaque, Melioidosis, 
Bartonellosis, Campylobacter, and Noncholera Vibrio, and the like, also 
bacterial diseases caused by Anaerobic Bacilli infections such as 
Clostridium Botulinum, Clostridium Tetany, Clostridia of Gas Gangrene 
Bacteroides, Mixed Anaerobic, Actinomycosis, and the like, also diseases 
caused by Mycobacteria, infections such as Tuberculosis and Leprosy, and 
the like, and also bacterial diseases caused by Spirochetes such as 
Leptospirosis Lyme Disease, and Endemic Treponematoses. 
EXAMPLE 206 
Antimicrobial oxalic acid or oxalate compositions and methods of treatment 
or prevention of warm-blooded animals including humans and pets is 
provided which includes at least one therapeutically effective form of 
oxalic acid or oxalate for controlling, treating, preventing, or managing 
bacterial diseases and viral diseases caused by infectious viruses, 
including infectious nucleic acid type Viral diseases such as 
deoxyribonucleic acid types (DNA), and ribonucleic acid (RNA), with 
natural cycle chiefly in humans, spread by person-to-person contact, and 
transmitted from nature to man and may also infect animals, diseases such 
as Human Immunodeficiency Virus infection (HIV) and Acquired 
Immunodeficiency Syndrome (AIDS), also Respiratory Tract Viral diseases, 
all serotypes, caused by Influenza, A, B, and C, Parainfluenza viruses 
1-4, Rhonoviruses (common cold), Mumps virus, Adenoviruses, Reoviruses, 
and Epstein-Barr virus, and Infants and Adult Syncytial virus, also 
primary Atypical pneumonias and others, also Nervous System Viral 
diseases, all serotypes, such as Polioviruses, Coxsackieviruses, 
Echoviruses and high numbered viruses, Epidemic gastroenteritis viruses, 
Rubeola virus, Rubella virus, Varicella-zoster virus, Herpes simplex, 
Human herpes virus type 6, Human Parvovirus B19, Cytomegalovirus, 
Hepatitis viruses Types A, B, C, D, Human Papillomavirus, Molluscum 
contagiosum virus, and also viruses transmitted from nature to man such as 
the Arboviruses, togaviruses, alphaviruses, flaviviruses, bunyaviruses, 
and the Orbivirus, Rabies virus, Herpesvirus simiae, Arenaviruses, 
Filoviruses, and the like. 
TABLE I 
______________________________________ 
Oxalic Acid Content of Selected Vegetables 
Oxalic Acid 
Vegetable (g/100 g) 
______________________________________ 
Amaranth 1.09 
Asparagus .13 
Beans, snap .36 
Beet leaves .61 
Broccoli .19 
Brussels sprouts .36 
Cabbage .10 
Carrot .50 
Cassava 1.26 
Cauliflower .15 
Celery .19 
Chicory .21 
Chives 1.48 
Collards .45 
Coriander .01 
Corn, sweet .01 
Cucumbers .02 
Eggplant .19 
Endive .11 
Garlic .36 
Kale .02 
Lettuce .33 
Okra .05 
Onion .05 
Parsley 1.70 
Parsnip .04 
Pea .05 
Pepper .04 
Potato .05 
Purslane 1.31 
Radish .48 
Rutabaga .03 
Spinach .97 
Squash .02 
Sweetpotato .24 
Tomato .05 
Turnip .21 
Turnip greens .05 
Watercress .31 
______________________________________ 
TABLE II 
______________________________________ 
Oxalic Acid Contents of Foods 
Oxalic acid.sup.a 
Method of (mg/100 g of 
Food Preparation fresh material) 
______________________________________ 
Vegetables 
Asparagus Fresh 1.7 
Bean, runner Boiled 7.2-61.8 
Beet root Boiled 96.8-121.0 
Brussels sprouts Boiled 2.1-3.6 
Cabbage Boiled 0.6-2.0 
Carrot Boiled 7.4-22.7 
Cauliflower Boiled 1.1 
Celery Fresh 13.0-17.5 
Chive Fresh 1.1 
Lettuce Fresh 1.7-2.7 
Marrow Fresh 0.5 
Mushroom Fresh 2.0 
Onion Boiled 3.0 
Parsley Fresh 166.0 
Pea, green Boiled 0.8-1.3 
Potato Boiled 2.3-7.1 
Radish Fresh 0.3 
Rhubarb Stewed 260-620 
Spinach Boiled 356-780 
Tomato Fresh 5.3 
Turnip Boiled 0.8 
Fruit 
Apple Fresh 1.5 
Apricot Fresh 2.8 
Banana, ripe Fresh 0.7 
Gooseberry Stewed 2.6 
Grapefruit Fresh 0.0-6.6 
Melon Fresh 2.7 
Orange Fresh 6.2 
Peach Canned 1.2-3.7 
Pear Canned 1.3-1.7 
Pineapple Canned 0.0-3.7 
Plum Stewed 1.1-3.4 
Raspberry Fresh 2.2 
Strawberry Fresh 1.9-11.5 
Preserves 
Jam, red plum -- 0.5 
Jam, strawberry -- 9.4 
Marmalade -- 4.5-10.8 
Meat 
Bacon, streaky Fried 0.6-3.3 
Beef Roasted 0.2 
Beef, corned Fresh 0.2 
Chicken Roasted 0.3-1.9 
Ham Steamed 0.4-1.6 
Kidney Braised 1.6-5.1 
Liver Braised 3.6-7.1 
Mutton Roasted 1.6 
Pork Roasted 1.7 
Soups 
Chicken (Fray Bentos) Heated 3.0 
Oxtail (Fray Bentos) Heated 1.0 
Dairy products 
Butter Fresh 0.0 
Cheese, Cheshire Fresh 0.0 
Eggs, whole Boiled 0.0-0.9 
Margarine Fresh 0.0 
Milk, cow Fresh 0.5-0.9 
Fish 
Haddock Boiled 0.2 
Plaice Boiled 0.3 
Sardines Canned 1.6-4.8 
Cereals 
Biscuits (Marie) -- 4.5-13.8 
Bread, white Fresh 4.9-8.6 
Bread, Allinson's Fresh 15.8-26.3 
Cake, fruit -- 11.8 
Cake, sponge -- 7.4 
Cornflakes -- 4.4-5.6 
Corn cob Fresh 9.1 
Oatmeal porridge Cooked 1.0 
Rice pudding Cooked 0.0 
Chocolate 
Cadbury's plain -- 123.5 
Cadbury's milk -- 56.2 
Beverages 
Beer, mild Draught 0.9-1.6 
Beer, bitter Draught 0.9-1.9 
Beer (Double Diamond) Draught 0.8 
Beer (Double Diamond) Bottled 1.9-2.0 
Beer (Guinness) Draught 1.4 
Beer (Guinness) Bottled 2.8-3.9 
Cocoa (Rowntree's) Powder 623.0 
Coca Cola Canned 1.12 
Coffee, infusion 2 g per 100 ml, 1.0 
infused 5 min. 
4.4 g per 100 ml, 7.3 
infused 13 min. 
Coffee essence (Camp) Undiluted 9.0 
Coffee (Nescafe) Powder 57.0-230.0 
Dandelion coffee Powder 25.0 
Horlicks Powder 4.1 
Lager (Skol) Draught 0.6 
Lemon squash (Robertson's) -- 1.5 
Lucozade -- 0.1 
Orange squash (Robertson's) -- 1.2 
Ovaltine Powder 45.9 
Oxo cubes -- 1.6 
Tea, leaves Fresh, dried 375-1,450 
Tea, infusion 1 g per 100 ml, 4.6 
infused 2 min. 
2.0 g per 100 ml, 7.0-10.8 
infused 2 min. 
2.0 g per 100 ml, 10.1-14.5 
infused 5 min. 
2.0 g per 100 ml, 11.5-16.1 
infused 10 min. 
2.0 g per 100 ml, 12.6-17.2 
infused 15 min. 
Wine, Beaujolais -- 3.1 
______________________________________ 
.sup.a Expressed as the anhydrous acid (COOH).sub.2. From Oxalic Acid in 
Biology and Medicine, Pgs. 196-199. 
TABLE III 
______________________________________ 
Oxalate Content of Foods per 100 GM. EDIBLE PORTION 
OXALATE 
FOOD mg. 
______________________________________ 
Cereal and Cereal Products 
Bread, white 4.9 
Cake, fruit 11.8 
Cake, sponge 7.4 
Cornflakes 2.0 
Crackers, soybean 207.0 
Egg noodle (chow mein) 1.0 
Grits (white corn) 41.0 
Macaroni, boiled 1.0 
Oatmeal, porridge 1.0 
Spaghetti, boiled 1.5 
Spaghetti in tomato sauce 4.0 
Wheat germ 269.0 
Milk and Milk Products 
Butter 0.0 
Cheese, cheddar 0.0 
Margarine 0.0 
Milk 0.15 
Meats and Eggs 
Bacon, streaky fried 3.3 
Beef, canned corned 0.0 
Beef, topside roast 0.0 
Chicken, roast 0.0 
Eggs, boiled 0.0 
Fish: 
Haddock 0.2 
Plaice 0.3 
Sardines 4.8 
Ham 1.6 
Hamburger, grilled 0.0 
Lamb, roast trace 
Liver 7.1 
Pork, roast 1.7 
Vegetables 
Asparagus 5.2 
Beans, green boiled 15.0 
Beans in tomato sauce 19.0 
Beet root, boiled 675.0 
Beet root, pickled 500.0 
Broccoli, boiled trace 
Brussels sprouts, boiled 0.0 
Cabbage, boiled 0.0 
Carrots, canned 4.0 
Cauliflower, boiled 1.0 
Celery 20.0 
Chard, Swiss 645.0 
Chive 1.1 
Collards 74.0 
Corn, yellow 5.2 
Cucumber, raw 1.0 
Dandelion greens 24.6 
Eggplant 18.0 
Escarole 31.0 
Kale 13.0 
Leek 89.0 
Lettuce 3.0 
Lima beans 4.3 
Mushrooms 2.0 
Mustard greens 7.7 
Okra 146.0 
Onion, boiled 3.0 
Parsley, raw 100.0 
Parsnips 10.0 
Peas, canned 1.0 
Pepper, green 16.0 
Pokeweed 476.0 
Potatoes, white boiled 0.0 
Potatoes, sweet 56.0 
Radishes 0.3 
Rice, boiled 0.0 
Rutabagas 19.0 
Spinach, boiled 750.0 
Spinach, frozen 600.0 
Squash, summer 22.0 
Tomatoes, raw 2.0 
Turnips, boiled 1.0 
Watercress, early fine curled 10.0 
Fruits 
Apples, raw 3.0 
Apricots 2.8 
Avocado 0.0 
Banana, raw trace 
Berries: 
Black 18.0 
Blue 15.0 
Dew 14.0 
Green goose 88.0 
Raspberries, black 53.0 
Raspberries, red 15.0 
Strawberries, canned 15.0 
Strawberries, raw 10.0 
Cherries: 
Bing 0.0 
Sour 1.1 
Currants: 
Black 4.3 
Red 19.0 
Fruit salad, canned 12.0 
Grapes: 
Concord 25.0 
Thompson, seedless 0.0 
Lemon Peel 83.0 
Lime Peel 110.0 
Mangoes 0.0 
Melons: 
Cantaloupe 0.0 
Casaba 0.0 
Honeydew 0.0 
Watermelon 0.0 
Nectarines 0.0 
Orange, raw 4.0 
Peaches: 
Alberta 5.0 
canned 1.2 
Hiley 0.0 
Stokes 1.2 
Pears: 3.0 
Bartlett, canned 1.7 
Pineapple, canned 1.0 
Plums: 
Damson 10.0 
Golden gage 1.1 
Green gage 0.0 
Preserves: 
Red plum jam 0.5 
Strawberry jam 9.4 
Prunes, Italian 5.8 
Rhubarb: 
canned 800.0 
stewed, no sugar 860.0 
Nuts 
Peanuts, roasted 187.0 
Pecans 202.0 
Confectionery 
Chocolate, plain 117.0 
Jelly, with allowed fruit 0.0 
Marmalade 10.8 
Sweets, boiled (plain candies) 0.0 
Beverages, Non-alcoholic 
Barley water, bottled 0.0 
Coca-Cola trace 
Coffee (0.5 g Nescafe/100 ml) 3.2 
Lemon Squash drink (lemonade) 1.0 
Lucozade, bottled (soda) 0.0 
Orange Squash drink (orangeade) 2.5 
Ovaltine drink, 2 gm in 100 ml 10.0 
Pepsi-Cola trace 
Ribena, concentrate 2.0 
(black currant drink) 
Tea, Indian: 
2 min. infusion 55.0 
4 min. infusion 72.0 
6 min. infusion 78.0 
Tea, rosehip 4.0 
Juices 
Apple juice trace 
Cranberry juice 6.6 
Grape juice 5.8 
Grapefruit juice 0.0 
Orange juice 0.5 
Pineapple juice 0.0 
Tomato juice 5.0 
Beverages, alcoholic 
Beer: 
bottled 0.0 
draft 1.0 
Lager draft, Tuborg Pilsner 4.0 
Stout, Guiness Draft 2.0 
Cider 0.0 
Sherry, dry trace 
Wine: 
Port trace 
Rose 1.5 
White 0.0 
Miscellaneous 
Cocoa, dry powder 623.0 
Coffee powder (Nescafe) 33.0 
Chicken noodle soup 1.0 
Lemon juice 1.0 
Lime juice 0.0 
Ovaltine, powder canned 35.0 
Oxtail soup 1.0 
Pepper 419.0 
Tomato soup 3.0 
Vegetable soup 5.0 
______________________________________ 
From: Krause & Mahen, Food, Nutritient Diet Therapy, 7th ed., 1984, W. B. 
Saunders, Phila. 
TABLE IV 
______________________________________ 
Concentrations of oxalic acid, calcium and magnesium in foods 
Oxalic Acid 
Calcium Magnesium 
(mmol/kg fresh (mmol/kg fresh (mmol/kg fresh 
Food wt) wt) wt) 
______________________________________ 
Vegetables 
Cabbage 0.11 16.2 8.5 
Cauliflower 0.12 5.9 6.4 
Onion 0.33 7.1 4.8 
Potato 0.25 2.2 -- 
Lettuce 0.19 6.5 4.1 
Rhubarb 28.9 3.1 4.0 
Beet root 13.5 4.7 15.5 
Spinach 86.6 27.7 31.6 
Fruit 
Apple 0.17 0.85 2.05 
Orange 0.69 0.87 5.70 
Pear 0.19 1.0 1.85 
Plum 0.38 3.57 3.33 
Strawberry 0.21 4.10 4.73 
Tomato 0.59 2.50 4.11 
Meat, fish and 
dairy products 
Beef, roasted 0.04 1.92 11.7 
Fish (haddock) 0.02 4.22 11.6 
Milk (cow) 0.005 28.7 4.3 
Cereals 
Bread, white 0.54 27.0 10.0 
Cornflakes 0.62 2.2 14.8 
Beverages 
Ovaltine, powder 5.1 31.5 13.6 
Tea (1 g/100 ml, 0.51 0.07 0.25 
infused for 2 min) 
Tea (1.5 g/100 ml, 0.92 0.13 1.03 
infused for 6 min) 
______________________________________ 
Zarembski and Hodgkinson (1962b). 
TABLE V 
______________________________________ 
Dietary intake of oxalate by man and animals 
Oxalic acid (anhydrous) 
mg/kg day 
Description 
Mean Range Mean Range Reference 
______________________________________ 
Man 
British 920 850- 12.3 10.1- Archer et al. 
980 13.6 (1957a) 
British 97 70-150 1.4 1.0-2.1 Zarembski and 
Hodgkinson 
(1962b) 
British -- 145- -- -- Anderson et al. 
175 (1971) 
Indian on 139.4 -- -- Singh et al 
hospital diet (1972) 
Indian on common 77.8 -- -- -- Singh et al. 
rural diet (1972) 
Indian on seasonal 2045.0 -- -- -- Singh et al. 
rural diet (1972) 
Indian on urban 168.5 -- -- -- Singh et al. 
diet, lower income (1972) 
group 
Indian on urban 606.4 -- -- -- Singh et al. 
diet, upper income (1972) 
group 
Indian from -- 260- -- -- Dhar and Kaul 
Kashmir 450 (1973) 
Sheep -- 2160- -- 31.7- Brune (1955) 
5000 73.5 
Cow (Heifer) -- 60700 -- 243- Talapatra et al. 
286 (1942) 
71500 -- Talapatra et al. 
(1942) 
Rat 
Wistar (300 g) -- 14-28 -- 46-92 Hodgkinson 
(unpublished 
results) 
Sand rat (200 g) -- 300- -- 1500- Shirley and 
500 2500 Schmidt- 
Nielsen (1967). 
______________________________________ 
*Oxalic Acid in Biology and Medicine, pg. 160. 
TABLE VI 
______________________________________ 
Some recent estimates of the concentration of oxalic acid 
in human and animal blood 
Oxalic acid 
(.mu.g anhydrous 
acid/100 ml) 
Analytical method 
Mean Range Reference 
______________________________________ 
Man 
Fluorimetry 146.0 100-235.sup.a Hodgkinson and Zarembski 
169.0 127-254.sup.c (1968) 
Fluorimetry 256.0 150-480.sup.a Endo (1969) 
Chemical kinetics .sup. 124.0.sup.b -- Eswara-Dutt and Mottola 
(1974) 
Enzymic 118.0 80-140.sup.b Knowles and Hodgkinson 
Decarboxylation (1972) 
Enzymic 130.4 73-199.sup.b,d Hatch et al. (1977) 
decarboxylation 261.1 136-465.sup.b,e 
Ion exchange and -- 117-250.sup.a Krugers Dagneaux 
colorimetry et al. (1976) 
[.sup.14 C] oxalic acid 16.5 -- Williams et al. (1971) 
[.sup.14 C] oxalic acid 13.0 11.8-14.3.sup.a Hodgkinson and Wilkinson 
(1974) 
Sheep 
[.sup.14 C] oxalic acid -- 52.6-74.4.sup.a McIntosh and Belling 
(1975) 
______________________________________ 
*Oxalic Acid In Biology and Medicine, pg. 174. 
.sup.a Plasma 
.sup.b Serum 
.sup.c Whole blood 
.sup.d Male 
.sup.e Female 
TABLE VII 
______________________________________ 
Vitamin B-6 (Pyridoxine) Content of Pork and Pork Products 
Cooked 
Broiled/ Cooked Cooked 
Pork Raw Braised Roasted Pan Fried 
______________________________________ 
Composite of Retail Cuts 
.445 .394 
All Lean and Fat 
Leg, Loin & Shoulder .508 .434 
Composite of Retail Cuts 
All Lean and Fat 
Leg (Ham) Whole .401 .402 
Lean and Fat 
Leg (Ham) Whole .500 .400 
Lean Only 
Loin Whole .472 .460 .382 
Lean and Fat 
Loin Whole .527 .492 .404 
Lean Only 
Back Ribs .395 .307 
Lean and Fat 
Loin Chops .370 .297 .337 
(braised) 
Lean and Fat .381 
(broiled) 
Bacon Cured .14 .27 
Canadian Style, Bacon .38 .45 
Unheated (unheated) 
Ham, Boneless .38 .35 
Extra Lean & Regular (unheated) 
Ham, Boneless (11% Fat) .34 .31 
Extra Lean and Regular (unheated) 
______________________________________ 
Source: 
U.S. Department of Agriculture Agriculture Handbook 810 Rev. 1992 
TABLE VIII 
__________________________________________________________________________ 
Vitamin B-6 (Pyridoxine) Content of Beef and Beef Products 
All Grades 
Good Choice Prime 
Beef Raw 
Cooked 
Raw 
Cooked 
Raw 
Cooked 
Raw 
Choice 
__________________________________________________________________________ 
Composite Retail Cuts .36 .31 .37 .32 .36 .31 .34 .29 
Lean and Fat 
Composite Retail Cuts .43 .38 .44 .38 .43 .38 .43 .38 
Lean Only 
__________________________________________________________________________ 
Beef Raw Roasted 
Broiled 
__________________________________________________________________________ 
Large Ribs .28 .22 .26 
Lean and Fat 
Rib-Eye Small Ribs .38 .32 .36 
Lean and Fat 
Whole Prime Ribs .30 .25 .29 
Lean and Fat 
__________________________________________________________________________ 
Beef Mg/100 Grams 
__________________________________________________________________________ 
Beef Cured Frankfurter .12 
Lebanon Bologna .24 
Pastrami .18 
Sausage Cooked and Smoked .11 
Beef Cured and Corned .13 
Liver Pan Fried 1.43 
Kidney Cooked .52 
Ground Lean Fried .28 
Ground Lean Baked .20 
__________________________________________________________________________ 
Source: 
U.S. Department of Agriculture Agriculture Handbook 813 1986 
TABLE IX 
______________________________________ 
Vitamin B-6 (Pyridoxine) Content of Veal and Lamb 
Meat Raw Cooked 
______________________________________ 
Veal .41 .31 
All Retail Cuts 
Lean and Fat 
Lamb .13 .13 
All Retail Cuts 
Lean and Fat 
Lamb .16 .16 
All Retail Cuts 
Lean 
______________________________________ 
Source: 
USDA Department of Agriculture Agriculture Handbook 817-1989 
TABLE X 
______________________________________ 
VITAMIN B-6 (PYRIDOXINE) CONTENT OF CHICKEN 
Fried Fried 
Batter- Flour 
Chicken Raw Dipped Dipped Roasted Stewed 
______________________________________ 
Broilers or Fryers 
.34 .32 .42 .38 .22 
All Meat with Skin 
Broilers or Fryers .43 .48 .53 .47 .26 
All Meat Flesh Only 
Broilers or Fryers .48 .39 .54 .52 .27 
Light Meat with Skin 
Broilers or Fryers .54 .63 .65 .60 .26 
Light Meat Flesh Only 
Broilers and Fryers .25 .25 .32 .31 .17 
Dark Meat with Skin 
Broiler and Fryers .26 .26 .33 .31 .17 
Thigh with Skin 
Broiler and Fryers .29 .27 .34 .33 .18 
Leg with Skin 
Ground Turkey .35 .39 
(Cooked) 
______________________________________ 
Source: 
U.S. Department of Agriculture Agriculture Handbook 85-1978 
TABLE XI 
______________________________________ 
VITAMIN B-6 (PYRIDOXINE) CONTENT OF 
SELECTED BAKED GOODS 
Breads Mg/100 G 
______________________________________ 
Bagels: Plain, Onion, Poppy 
.051 
Seed, Sesame 
Bagels, Date Bran .000 
Bagels, Egg .084 
Bagels, Cinnamon Raisin .000 
Biscuits, Commercially Baked .047 
Plain or Buttermilk 
Cornbread .113 
Cracked Wheat Bread .304 
French and Vienna Bread .043 
Italian Bread .048 
Mixed Grains 7 Bread .333 
Oat Bran Bread .000 
Pumpernickel .126 
Rye Bread .075 
Wheat Bran Bread .064 
Whole Wheat Commercial Bread .179 
______________________________________ 
Source: 
U.S. Department of Agriculture Agriculture Handbook 818 Rev. 1992 
TABLE XII 
______________________________________ 
Dry Dog Food, Test Run Data 
E325 Processing 
Conditions: Run #1 Comment 
______________________________________ 
Product Dry Dog Food 
Feeder Speed (RPM) 11 rpm (420 lbs/hr) 
Feeder Speed (Hertz) 34.7 
Cond. Cyl. Temp 206 
(.degree. F.) 
Cond. Cyl. Water 10 
(% gauge) 
Extruder Speed (RPM) 421 
Extruder Current 24 
(Amps) 
Extruder Water 0 
(% gauge) 
Extruder Steam 0 
Injection 
#2 Head Temp. CW 
(CW or ST) 
#3 Head Temp. CW 
(CW or ST) 
#4 Head Temp. CW 
(CW or ST) 
#5 Head Temp. CW 79 deg F. 
(.degree. F.) 
#6 Head Temp. CW 129 deg F. 
(.degree. F.) 
Die Pressure (PSI) 350 
Knife Speed (Hertz) 55.9 
Dryer Temperature 223 
(.degree. F.) 
Dryer Retention 17.9 
(minutes) 
Formula: See Dry Feed formula 2.7# OA to 
2.2% Oxalic acid 100# water 
solution added at 0.7 
lbs/min 
Comments: The oxalic acid 
solution was made up 
in hot water (160.degree. F.) 
and pumped into 
conditioning cylinder 
Screw Configuration: 
#1 Screw Single Flight Tapered Inlet Straight Rib Head 
#1 Steamlock Spacer 
#2 Screw Single Flight Uncut Spiral Rib Head 
#2 Steamlock Spacer 
#3 Screw Single Flight Uncut Spiral Rib Head 
#3 Steamlock Spacer 
#4 Screw Single to Double Flight Uncut Straight Rib Head 
#4 Steamlock Small 
#5 Screw 2 Flight cut flight Straight Rib Head 
#5 Steamlock Large 
#6 Screw 2 Flight cut flight cone Spiral Rib Cone 
Head 
Die Configuration: 
Spacer 1" thick 
Backup Die No 
Dieplate 1 1/4" central insert die #825440-3 
Insert 1/4" round hole #101-509 
______________________________________ 
Thus, it will be appreciated that as a result of the present invention, a 
highly effective oxalic acid or oxalate compositions and methods are 
provided by which the principal object, among others, is completely 
fulfilled. It is contemplated, and will be apparent to those skilled in 
the art from the preceding description that modifications and/or changes 
may be made in the prescribed embodiments without departure from the 
present invention. Accordingly, it is expressly intended that the 
foregoing description is illustrative of preferred embodiments only, and 
not limiting with respect to the true spirit and scope of the present 
invention.